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Summary
Effort to predict the genetic consequences for humans of exposure to ionising 
radiation has been one of the most important issues of human genetics over the 
past 60 years. To date, there has been little experimental knowledge on the genetic 
risks of human exposure to ionising radiation. Radiation-induced deleterious 
hereditary effects have not been detected in human populations - not even 
among the offspring of atomic bomb survivors in Hiroshima and Nagasaki. This 
does not mean deleterious hereditary effects do not exist in humans, but rather 
that they are small and/or difﬁcult to detect because the normal incidence of 
inherited abnormalities is quite high in the human population. Thus, assessment 
of radiation-induced hereditary risks in humans has been based on the common 
knowledge of human heredity and on animal experiments. However, recent data 
have suggested that hyper-variable tandem repeat minisatellite loci provide a 
useful and sensitive experimental approach for monitoring radiation-induced 
germline mutations in humans.
In order to investigate the feasibility of the minisatellite mutation screening 
system in assessing radiation-induced hereditary risks in humans, we examined 
the amount of hereditary minisatellite mutations among the offspring of Estonian 
Chernobyl cleanup workers. The men studied received a median radiation 
dose of 109 mSv while working on the cleanup activities after the Chernobyl 
accident.  We compared the minisatellite mutation rates of 155 children born to 
147 Estonian Chernobyl cleanup workers after the accident to those of their 148 
siblings born prior to it. In addition, 44 Estonian families, where the father had 
not been exposed to radiation, composed an additional control group.
In all of these families, the paternity of the children was ascertained by 
using 5 minisatellite loci (APOB, HRAS, MCOB19, MCT118, and YNZ-22) in 
PCR-based analyses. Other 8 minisatellite loci (B6.7, CEB1, CEB15, CEB25, 
CEB36, MS1, MS31, and MS32) were used for minisatellite mutation screening 
by using Southern blot-based analyses. In these analyses, the parental origin and 
germline length change were determined for all detected minisatellite mutations 
at the eight tested loci. Out of these mutations 107 were de novo paternal 
minisatellite mutations (52, 42, and 13 mutants among children born after the 
accident, before the accident, and in additional control families, respectively) 
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and 46 were de novo maternal minisatellite mutations (21, 17, and 8 mutants 
among children born after the accident, before the accident, and in additional 
control families respectively). In addition, 8 paternal and 6 maternal mutations 
were detected in children born after the accident to fathers who were exposed 
to radiation during the Chernobyl cleanup activities in 22 families which had 
no children born before Chernobyl.
The detected minisatellite mutation rates were statistically tested to 
be non-signiﬁcantly increased among children born after the accident when 
compared with their siblings born prior to it (mutation frequencies of 0.042 
and 0.036; OR 1.33, 95% CI 0.80-2.20). When the data were divided into three 
dose groups, the minisatellite mutation rates were similar among children born 
before and after the Chernobyl accident to fathers exposed to less than 100 mSv 
(OR 0.95, 95% CI 0.44-2.05) or to 100-190 mSv (OR 1.14, 95% CI 0.47-2.77). 
The mutation rate among offspring born after the accident to workers who had 
received doses of 200 mSv or above was three times higher when compared with 
their siblings born before the accident (OR 3.00, 95% CI 0.97-9.30). However, no 
clear linear dose response could be detected in the studied minisatellite mutations 
(OR 1.00, 95% CI 0.96-1.04). The minisatellite mutation rate was not associated 
with the father’s age (OR 1.04, 95% CI 0.94-1.15) or the sex of the child (OR 0.95, 
95% CI 0.50-1.79). 
In conclusion, the minisatellite screening system proved an efﬁcient method 
for detecting germline mutations in a human population. However, the radiation 
doses to which the studied Estonian men were exposed in this study were so low 
that the results of this study were consistent with either no effect of radiation on 
minisatellite mutations or a slight increase at dose levels exceeding 200 mSv.
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Yhteenveto
Säteilyaltistuksen aiheuttaman perinnöllisen riskin arviointi väestössä on ollut 
yksi ihmisgenetiikan haasteista jo 60 viime vuoden ajan. Toistaiseksi on ollut 
saatavilla hyvin vähän kokeellista tietoa ihmisen säteilyaltistukseen liittyvistä 
perinnöllisistä riskeistä, sillä säteilyn aiheuttamia vahingollisia perinnöllisiä 
vaikutuksia ei ole pystytty osoittamaan edes Hiroshiman ja Nagasakin atomipom-
mitusten uhrien jälkeläisillä. Tämä ei kuitenkaan merkitse sitä, että muista 
eläimistä poiketen ihmisellä ei esiintyisi säteilyn aiheuttamia vahingollisia 
perinnöllisiä muutoksia. Ihmisellä esiintyvät säteilyn aiheuttamat perinnölliset 
muutokset ovat ilmeisesti kuitenkin niin pieniä ja/tai vaikeasti havaittavia, että 
niiden osoittaminen on ongelmallista ihmispopulaatiossa esiintyvien muiden 
perinnöllisten poikkeavuuksien varsin korkeiden taustaesiintyvyyksien takia. 
Tämän vuoksi säteilyn aiheuttamien perinnöllisten riskien arviointi ihmisellä on 
perustunut yleiseen tietämykseen ihmisen perinnöllisyydestä sekä eläinkokeiden 
tuloksiin. Viimeaikaiset tutkimustulokset ovat kuitenkin osoittaneet, että 
peräkkäisiä toistoja sisältävät minisatelliittilokukset ovat käyttökelpoinen 
ja herkkä lähestymistapa tutkia säteilyn aiheuttamia ituradan mutaatioita 
ihmisellä.
Tämän työn tarkoituksena oli tutkia minisatelliittimutaatioiden kartoitus-
menetelmän soveltuvuutta säteilyn aiheuttaman perinnöllisen riskin arviointiin 
ihmisellä. Tutkittujen 147 virolaisen perheen isät altistuivat keskimäärin 
109 mSv:n säteilyannokselle työskennellessään Tshernobylin onnettomuuden 
jälkeisissä puhdistustehtävissä. Selvitimme perinnöllisten minisatelliittimutaa
tioiden määrän näiden miesten lapsissa. Tutkimuksessa vertasimme minisatel
liittimutaatioiden määrää 155 Tsernobylin onnettomuuden jälkeen syntyneellä 
lapsella ja heidän 148 sisaruksellaan, jotka olivat syntyneet perheeseen ennen 
Tshernobylin onnettomuutta ja isän altistumista säteilylle.
Isyys varmistettiin kaikissa perheissä käyttäen viittä minisatelliittilokusta 
(APOB, HRAS, MCOB19, MCT118 ja YNZ-22) PCR- pohjaisissa analyyseissä. 
Kahdeksan muun minisatelliitti lokuksen (B6.7, CEB1, CEB15, CEB25, CEB36, 
MS1, MS31 ja MS32) avulla tutkittiin minisatelliittimutaatioiden määrä Southern 
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blot -pohjaisella menetelmällä. Näissä analyyseissa alleelin vanhempi alkuperä 
ja toiston pituuden muutos verrattuna vanhempien alleeleihin määriteltiin 
kaikissa kahdeksassa tutki-tussa lokuksessa havaituissa minisatelliittimutaa-
tioissa. Havaituista mutaatioista 107 oli isältä perittyjä de novo -minisatelliitti
mutaatiota (52, 42 ja 13 mutaatiota onnettomuuden jälkeen syntyneillä lapsilla, 
ennen sitä syntyneillä lapsilla ja kontrollilapsilla) ja 46 oli äidiltä perittyjä de 
novo -mutaatiota (21, 17 ja 8 mutaatiota onnettomuuden jälkeen syntyneillä 
lapsilla, ennen sitä syntyneillä lapsilla ja kontrollilapsilla). Tutkimuksessa 
havaittiin myös 8 isältä perittyä ja 6 äidiltä perittyä mutaatiota lapsilla, jotka 
olivat syntyneet Tsernobylin onnettomuuden jälkeen puhdistustöissä säteilylle 
altistuneille isille 22 perheessä, joissa ei ollut ennen Tsernobyliä syntynyttä 
lasta.
Havaittujen minisatelliittimutaatioiden frekvenssit eivät olleet 
tilastollisesti merkitsevästi suurempia onnettomuuden jälkeen syntyneillä 
lapsilla verrattuna heidän ennen onnettomuutta syntyneisiin sisaruksiinsa 
(vastaavat mutaatiofrekvenssit olivat 0,042 ja 0,036; OR 1,33; 95 % CI 0,80 - 
2,20). Kun aineisto jaettiin kolmeen annosryhmään, Tsernobylin onnettomuuden 
jälkeen syntyneiden lasten mutaatiofrekvenssi ei poikennut ennen onnettomuutta 
syntyneiden lasten mutaatiofrekvenssistä alle 100 mSv:n annoksen saaneilla 
miehillä (OR 0,95; 95 % CI 0,44 - 2,05) eikä myöskään 100 - 190 mSv:n annoksen 
ryhmässä (OR 1,14; 95 % CI 0,47 - 2,77). Sen sijaan 200 mSv:n tai suuremman 
annoksen saaneilla miehillä onnettomuuden jälkeen syntyneiden lasten 
mutaatiofrekvenssi oli kolminkertainen sitä ennen syntyneisiin lapsiin nähden 
(OR 3,0; 95 % CI 0,97 - 9,30). Isän saamalla säteilynnoksella ei kuitenkaan 
todettu olevan selvää lineaarista yhteyttä minisatelliittimutaatioiden määrään 
(OR 1.00, 95 % CI 0.96 - 1.04). Isän ikä (OR 1,04; 95 % CI 0,94 - 1,15) tai lapsen 
sukupuoli (OR 0,95; 95 % CI 0,50 - 1,79) eivät vaikuttaneet minisatelliittimutaa-
tioiden frekvensseihin. 
Yhteenvetona voidaan todeta, että minisatelliittimutaatiot osoittautuivat 
tehokkaaksi menetelmäksi havaita ituradan mutaatioita ihmispopulaatiossa. 
Tutkitut virolaiset miehet altistuivat kuitenkin Tshernobylissä työskennessään 
keskimäärin niin pienille säteilyannoksille, että tutkimuksen tuloksen tulkinta 
ei ole yksiselitteistä. Havaitut tulokset voidaan yhtä hyvin tulkita niin, että 
säteilyllä ei ole vaikutusta minisatelliittimutaatioden yleisyyteen kuin niinkin, 
että minisatelliittimutaatiot lisääntyivät hieman isillä, joiden saama säteilyannos 
ylitti 200 mSv.
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1 Introduction
One of the major challenges for modern genetics is to apply recent advances in 
mutation research to improve the accuracy of the estimation of hereditary risks for 
humans. It has long been known that ionising radiation induces both somatic and 
germinal mutations in a wide variety of biological systems, and the development 
of radiation genetics began with the discovery of the mutagenic effects of ionising 
radiation in Drosophila (Muller 1927), maize, and barley (Stadler 1928a, b). It 
has been recognized that ionising radiation not only increases mutation rates in 
the exposed somatic and germinal cells but also results in an elevated mutation 
rate with many cell divisions after the initial irradiation damage (Kadhim 
et al. 1992; Morgan et al. 1996). Despite convincing evidence for radiation-
induced deleterious hereditary effects in experimental animals, there is little 
experimental evidence for these in human populations. The atomic bombs in 
Hiroshima and Nagasaki in 1945 and the Chernobyl accident in 1986 exposed 
large groups of people to non-natural environmental radiation. These events led 
to a dramatic change in the awareness of genetic risks from radiation exposure. 
Radiation-induced hereditary mutation was considered an important potential 
environmental health hazard. It was assumed that radiation-induced hereditary 
diseases were similar to those occurring naturally as a result of spontaneous 
germ cell mutations. However, the lack of efﬁcient mutation monitoring systems 
has resulted in considerable uncertainty concerning the effects of environmental 
radiation on germline mutations in the human population. 
Attempts have been made to predict these effects through genetic risk 
estimation, in which it is considered that even a low radiation dose can cause 
an increase in the mutation rate or disease incidence in the human population. 
The radiation exposure of human populations is usually delivered as small doses 
at high dose rates (e.g., diagnostic radiology), or are greatly protracted (e.g., 
continuous exposure from natural and man-made sources) (UNSCEAR 2001). 
Therefore, in radiation risk estimates, the radiation conditions are generally 
taken to be low-LET radiation at low doses and low-dose-rate. The risk due 
to radiation has conventionally been expressed as the expected number of 
cases of genetic disease above the baseline incidence occurring naturally in the 
population. However, it has to be kept in mind that induced genetic changes that 
are incompatible with viability (e.g., deletions or dominant lethal mutations) are 
not seen in live births. They will add to the already high number of spontaneously 
occurring genetic changes that are normally eliminated as zygotic deaths, early 
embryonic losses, or spontaneous abortions. 
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The germ cell stages most at risk for hereditary effects are the stem cell 
spermatogonia in males and immature oocytes in females (Searle 1987). However, 
the detection of changes in the germline mutation rate in human populations 
is extremely difﬁcult since the spontaneous mutation frequency is very low at 
most loci. Traditionally used methods for evaluating the mutational load in 
human populations have been, e.g., the search for newborns with congenital 
malformations and other genetic diseases, evaluation of mortality and the 
incidence of cancer among children as well as protein electrophoresis. When these 
classical methods are used, a large number of samples are required to detect de 
novo mutation or an increase in mutation rates. Therefore, the sensitivity of these 
approaches for monitoring radiation-induced mutations remains highly uncertain 
(Sankaranarayanan 1999). For that reason, germline mutation induction in 
mice is still used as the main source of experimental data for evaluating the 
genetic risk of human exposure to ionising radiation (Sankaranarayanan and 
Chakraborty 2000a; UNSCEAR 2001). The induction rates of mutations and 
chromosomal aberrations in mammalian experimental systems are converted into 
estimates of risk of radiation-induced hereditary diseases in human populations. 
Such an extrapolation has not been experimentally validated and is consequently 
unproven. 
It is increasingly clear that reliable estimates of the genetic risk of human 
exposure to ionising radiation can only be derived from the relevant experimental 
data on germline mutation induction in human populations. This requires new 
experimental approaches and there has been a shift from the purely classical 
approaches to human molecular biology. Molecular techniques have been increas-
ingly used to study radiation-induced germline mutations. Compared with 
traditional protein analysis, DNA analysis is more informative and it can be done 
in minute or degraded material. In addition, DNA genotype can be obtained from 
any tissue whereas the analysis of protein markers is restricted to cells where 
these proteins are expressed. Very high rates of spontaneous germline mutations 
altering the length of minisatellite loci has been found in human populations, 
thus enabling the detection of induced mutation rate in relatively small sample 
sizes. Germline mutations at tandem repeat minisatellite loci have been shown 
to be remarkably sensitive to ionising radiation, both in mice (Dubrova et al. 
1993, 1998a, b, 2000; Yauk et al. 2002) and in humans (Dubrova et al. 1996, 
1997, 2002a, b). The ﬁnding that this radiation-induced germline instability in 
minisatellite mutations persists for at least two generations in mice (Barber et 
al. 2002) has raised important issues of risk evaluation in humans. However, the 
lack of reliable approaches for monitoring germline mutation currently presents 
the main obstacle on how to evaluate the hereditary risk of human exposure to 
ionising radiation.
15
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Progress in genetic risk estimation will be intimately linked to advances 
in human molecular genetics and the results of the Human Genome Project, 
providing important insights into the nature and mechanisms of origin in naturally 
occurring genetic diseases and their potential to be induced by radiation. Human 
studies have shown that at low doses, the hereditary risks are likely to be small 
compared with the baseline risks of naturally occurring genetic diseases. There 
are several poorly known genetic fenomena (e.g., individual radiosensitivity and 
genetic instability) that may show to be of ultimate importance of hereditary risk 
evaluation even for very low radiation doses. On the other hand, as increasing 
numbers of childhood cancers are successfully treated with high-dose, high-
dose-rate irradiation, the need to estimate hereditary risks for these radiation 
conditions may also become more important in the coming years. 
As new methods for radiation risk assessment are potentially needed both 
in very low and very high doses and as minisatellites currently provide the only 
loci appropriate for the efﬁcient monitoring of germline mutation in human 
populations, the present study was designed in order to investigate the potential 
of minisatellites for monitoring radiation-induced germinal mutations and to 
examine the applicability of the minisatellite mutation screening system for 
future demands in evaluating radiation-induced hereditary risks in humans. 
In the present work, the hereditary effects of low radiation doses were 
examined by comparing the minisatellite mutation rates of children born to 
Estonian Chernobyl cleanup workers after the accident with those of their 
siblings born prior to it. Correlation was sought between the individual radiation 
doses of the Estonian Chernobyl cleanup workers and the amount of minisatellite 
mutations found in their offspring born after the accident. Furthermore, additional 
information was provided by detecting maternal minisatellite mutations in the 
same families and control families as well as paternal mutations in control 
families.
16
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2 Review of the literature
2.1 The human genome
2.1.1 Physical structure of the human genome
The human genome is made up of two components: the nuclear genome and the 
mitochondrial genome. The nuclear genome consists of approximately 3 300 000 
kilobases (3 300 Mb) of deoxyribonucleic acid (DNA). DNA is a double-stranded 
helix containing a sugar(deoxyribose)-phosphate backbone and four different 
nucleotide bases: adenine (A), cytosine (C), guanine (G), and thymine (T). DNA 
strands are linked by hydrogen bonds between A and T and between C and G 
in opposite DNA strands. Nuclear DNA is arranged in 22 pairs of linear DNA 
molecules (chromosomes, autosomes) together with an X and Y chromosome (sex 
chromosomes, XX for females and XY for males). Except for mature red blood cells, 
each of the approximately 1013 cells in the adult human body contains a complete 
genome. The vast majority of human cells are diploid and they contain two copies 
of the human genome and 46 chromosomes. These are called somatic cells, in 
contrast to sex cells or gametes, which are haploid and have 23 chromosomes 
(one of each autosome and one sex chromosome). The mitochondrial genome is a 
maternally inherited, circular 16 569 bp DNA molecule. Cells have about 8 000 
copies of the mitochondrial genome, about 10 in each mitochondrion. 
2.1.2 Organization of the human genome
Since the discovery of the structure of DNA in 1953, knowledge of the composition 
and organization of the human genome has accumulated rapidly. The Human 
Genome Project (HGP) started in 1990 and led in April 2003 to the complete, 
high-quality sequence of the 3.3 . 109 bases that constitute the human genome. 
However, despite the knowledge of the entire human sequence, the exact number 
of genes encoded by it is still uncertain. An estimation of the human gene 
number of about 30 000 genes (Venter et al. 2001) bisects the gene number 
from the earlier estimate of 60 000-70 000 genes (Fields et al. 1994). Nearly 
40% of these predicted 30 000 human genes have already been established (see 
2.7.2). The size of human genes varies widely between 0.1 kb and 2 500 kb. An 
approximate average length of a human gene is 6–10 kb. Each human gene has 
its own DNA sequence and structure. Most human genes consist of coding (exon) 
and noncoding (intron) sequences. The average size of a human exon is 180–200 
17
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bp with comparatively little length variation. Some exceptionally long exons 
have been reported (e.g., 7.6 kb exon 26 of the APOB gene). Human intron size 
varies enormously from a few bp to several kb (e.g., 0.5 kb in the b-globin gene 
and 30.0 kb in the dystrophin gene). Some genes contain a considerable number 
of introns and in a few human genes (e.g., histone genes, interferon genes, and 
mitochondrial genes) there are no introns. Venter et al. (2001) detected that only 
1.1% of the human genome is spanned by exons. The rest 98.9% of the human 
genome consists of introns (23.9%) and intergenic DNA (75%) whose functions 
may include providing chromosomal structural integrity and regulating where, 
when, and in what quantity proteins are made. The small human mitochondrial 
genome consists of 37 genes. These include two ribosomal RNA-, 22 transfer RNA-, 
and 13 polypeptide-encoding genes. The organization of the human genome is 
presented in Figure 1.
2.1.3 Function of the human genome
The knowledge of the entire human DNA sequence alone does not automatically 
provide understanding of how each segment contributes to the whole cell or 
organism. Each DNA molecule (chromosome) contains many genes. In any given 
tissue, only a relatively small proportion of the genes are expressed. Individual 
genes represent a single unit of information (speciﬁc sequence of nucleotide 
bases) which must be expressed in a coordinated manner to give life to a cell 
or organism. Protein-coding genes contain open reading frames (ORFs). The 
ORF consist of a series of codons that specify the amino acid sequence of the 
protein that the gene codes for. Upstream from the initiation codon there are 
a number of noncoding sequences, promoters. Further upstream there are a 
number of cis-acting regulatory elements of deﬁned sequence. Some of these 
(TATAAA and CCAAT motifs) play a role in constitutive gene expression. Other 
regulatory elements (enhancers) increase transcription as a response to particular 
proteins in a tissue-speciﬁc manner. When genes are expressed, the genetic 
information (base sequence) of DNA is ﬁrst copied to a molecule of messenger 
RNA (mRNA) (transcription). RNA is a close chemical relative of DNA. RNA is 
usually a single-stranded molecule where nucleotide uracil (U) replaces DNA’s 
thymine (T) and sugar is ribose instead of deoxyribose in DNA. The set of mRNA 
transcripts generated for a cell is called its transcriptome. Both exons and introns 
are transcribed into precursor mRNA, out of which regions transcribed from 
introns are later excited and removed (splicing). Therefore, intron sequences 
do not form mRNA and thus do not specify the primary structure of the gene 
product. The accuracy of the excision is determined by the invariant GT and 
AG dinucleotides present at the 5’ and 3’ exon-intron junctions. An unusual 
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nucleotide called a cap is attached at the 5´end and a poly (A) tail is attached 
to the 3´end of the mRNA (end-modiﬁcation). Chemical modiﬁcation of mRNA 
is uncommon but it is seen in a diverse group of eukaryotes (RNA editing). 
After these processing events (splicing, end-modiﬁcation, and RNA editing) 
the mRNA is transported to the cytoplasm for protein synthesis (translation) 
to occur on ribosomes (cellular components composed of proteins and another 
class of RNA). In translation, the mRNA is the direct molecular instruction for a 
speciﬁc protein’s synthesis. Each speciﬁc sequence of three DNA bases (codons) 
forming the genetic code directs the cells protein-synthesizing machinery to add 
speciﬁc amino acids. Translation begins with an initiation codon, which is almost 
always AUG, specifying methionine (a few cases are known where ACG, CUG, 
or GUG are used instead) and ends with a termination codon (i.e., UAA, UAG, 
or UGA in the case of nuclear-encoded mRNA; UAA, UAG, AGA, or AGG in the 
case of mitochondrial-encoded mRNA). Ribosomes read the genetic code from the 
mRNA, and transfer RNAs (tRNAs) transport amino acids to the ribosomes for 
attachment to the growing protein. As with DNA and RNA, proteins are synthe-
sized like ‘beads on a string’, but with 20 different kinds of beads (amino acids) 
rather than the four of DNA or RNA. In addition to 20 normal amino acids, 
two abnormal amino acids, selenocysteine and pyrrolysine, have been found. 
These are coded by codons (UGA and UAG), which are normally termination 
codons. The synthesized polypeptide is inactive until it is folded into its correct 
tertiary structure that deﬁnes its particular function and the activities that the 
cell is able to carry out. Selective gene readout in the form of RNA can govern 
the identity and quantity of proteins. The constellation of proteins in a cell is 
called its proteome. Proteins regulate cell replication, survival, and even death. 
Proteins work often by assembling into larger multiprotein complexes, which 
execute functions as protein synthesis and degradation, cell-to-cell signalling, 
and a host of other operations.
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2.2 Polymorphic markers
The human genome is highly polymorphic and many different types of genetic 
variation can be observed in the DNA of modern humans. With the exception 
of identical twins, each person has a unique combination of genetic variants 
and will differ at many positions from the DNA sequence of the human genome 
resulting from The Human Genome Project. These individual variations in 
the DNA sequence can be studied by polymorphic markers. A polymorphism 
is a Mendelian or monogenic trait that exists in the population in at least two 
phenotypes (and presumably at least two genotypes), neither of which occurs 
with a frequency of less than 1-2%. In terms of DNA sequence, polymorphism 
exists in the human genome in a wide variety of forms. The most widespread is 
simple base substitution type of variation, but other types of variation, including 
tandem repeat variation, can be both extensive and functionally important. In 
the early 1980s, various polymorphic DNA markers provided, for the ﬁrst time, 
a set of markers that were sufﬁciently numerous and spaced across the entire 
human genome to be used for searching variation in the human genome. 
2.2.1 Minisatellites
Minisatellites are the ﬁrst multiallelic polymorphic loci described in human DNA 
(Wyman and White 1980; Higgs et al. 1981; Bell et al. 1982). They form a new 
type of DNA markers based on the insertion or deletion of DNA. Minisatellites 
are characterised by successive blocks of oligonucleotides of variable lengths, 
thus this variation in the number of short, tandemly repeated sequences is also 
referred to as a variable number of tandem repeats (VNTRs) (Jeffreys et al. 1985; 
Nakamura et al. 1987; Wong et al. 1987a). Family studies have demonstrated 
that simple tandem repeat loci are inherited in a co-dominant Mendelian fashion 
(Kovacs et al. 1990). 
2.2.1.1  Structure and localization of human minisatellites
Minisatellites are very commonly used polymorphic markers in the human 
genome, consisting of tandemly repeated DNA sequences. Minisatellites are 
generally GC-rich sequences characterized by a variable number of tandem 
repeats of identical 6-100 bp units. They are composed of repetitive highly variable 
(‘hypervariable’) sequences with a very large number of alleles. Minisatellites 
are highly informative because of this multiallelicity. Exceptionally high levels of 
polymorphic variation at these loci are due to variation in the number of tandem 
repeats. In addition to repeat number polymorphism (variation in array length), 
minisatellites also show core sequence polymorphism (variation in internal allelic 
structure) comprising different core variants and variation in the order in which 
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these variants are iterated in tandem. However, minisatellites share a common 
core sequence, GGGCAGGAXG (Jeffreys et al. 1985), which is similar in size 
and in G content to the chi sequence, a signal for generalized recombination in 
E. coli. Minisatellites can be grouped into sets according to their core sequence 
that is exclusive to each set and is shared by all members of that set. It has been 
suggested (Jeffreys et al. 1985) that core sequence may act as recombination 
signal in the generation of hypervariable regions (HVRs). Minisatellite alleles 
are rarely, if ever, sequence-homogeneous, but instead are composed of two or 
more variant repeat types present along the repeat array (Jeffreys et al. 1985; 
Wong et al. 1987a). The minisatellite repeat sequences are repeated from tens to 
thousands of times and thus the overall size of minisatellite clusters, in humans, 
can range from 0.5 to 100 kb. By using minisatellite variant repeat mapping by 
the PCR (MVR-PCR) method (Jeffreys et al. 1991a; Stead and Jeffreys 2002), 
the interspersion patterns of variant repeats within minisatellite alleles can be 
analysed by PCR ampliﬁcation between a universal primer which anneals outside 
the repeat array, and primers which bind to speciﬁc variant repeats within the 
array. This method provides detailed internal structural information on an allele. 
MVR-PCR has been developed for several minisatellites and it has revealed 
that variant repeats are common and are almost always heavily intermingled 
with each other along an allele, implying that the germline mutation process 
must actively scramble the order of the repeat units. Given the high mutation 
rate of minisatellites, the true level of allelic diversity in humans is likely to 
be enormous, e.g., with ³108 different and distinguishable minisatellite alleles 
present at MS32 locus in the world population (Jeffreys et al. 1991a).
Minisatellites are usually located in noncoding DNA, i.e., introns or 
untranslated regions (UTRs). However, there are few exceptional minisatellites 
that form a part of a gene (see 2.2.1.4.). There are altogether >104 potential 
minisatellite loci in the human genome. Minisatellites have been found to occur 
at over 2 000 highly polymorphic (hypervariable) loci dispersed throughout the 
genome with a relatively high frequency. Most (90%) of human minisatellites are 
found in subtelomeric regions (Royle et al. 1988). However, several minisatellite 
DNA sequences also occur at other chromosomal locations. 
2.2.1.2 Mutation mechanisms and types at human minisatellites
In humans, instability at GC-rich minisatellites seems to involve different 
mutation processes operating in somatic and germline cells. Minisatellites 
are spontaneously unstable during germ cell development, although they are 
generally stable during somatic (blood) cell division. Low-frequency somatic 
minisatellite mutations are simple intra-allelic rearrangements; they consist 
usually of gains (duplications) or losses (deletions) of only few repeat units 
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located at random along the repeat array (Jeffreys et al. 1994; May et al. 1996; 
Jeffreys and Neumann 1997; Buard et al. 2000). The simple changes in new length 
alleles in blood could arise by mitotic recombination or unequal sister chromatide 
exchange; replication slippage does not appear to be a dominant process (Wolff 
et al. 1989; Jeffreys et al. 1997). 
In sharp contrast to the simple minisatellite mutations in blood cells, 
sperm mutants can be very complex. Enhanced minisatellite mutation rate 
can result from damage accumulated in germ cells before meiosis, but does not 
necessarily indicate that the mutation events themselves occur pre-meiotically 
rather than later, for example at meiosis (Bois and Jeffreys 1999; Jeffreys et al. 
1999; Tamaki et al. 1999; Buard et al. 2000; Stead and Jeffreys 2000). If so, then 
exposure to ionising radiation could potentially affect the stability of minisatellite 
loci over a very short interval of meiosis. New alleles at these highly unstable 
loci generally arise by germline-speciﬁc complex recombination events, including 
both interallelic gene conversions and intra-allelic rearrangements (Armour et al. 
1993; Buard and Vergnaud 1994; Jeffreys et al. 1994, 1997, 1999; May et al. 1996; 
Jeffreys and Neumann 1997; Tamaki et al. 1999). Mutants are also generated 
via a crossover pathway, but at a lower frequency (Jeffreys et al. 1998a; Buard 
et al. 2000). Unequal crossing over due to misalignment of sister chromatids 
at mitosis or homologous chromosomes at meiosis leads to random increase by 
duplication or decrease by deletion of repeat units. 
Most minisatellite loci show a bias toward minisatellite mutation in 
the male germline (Henke and Henke 1995; Dubrova et al. 1997). Sperm 
mutation is dominated by the inter-allelic transfer of blocks of repeat units 
from one allele (the donor) to the other (the recipient). While some transfers are 
simple, the majority are complex, with rearrangements including deletions or 
duplications in the recipient allele, scrambling of repeat units during transfer, 
and imperfect reduplications of donor-recipient junctions. In some cases, these 
rearrangements can be so extreme as to profoundly remodel allele structure in 
a single, astonishingly complex, sperm mutation event (Jeffreys et al. 1994). 
When individual sperm cells were studied, all studied minisatellite loci showed 
a bias towards gaining rather than loosing repeats (Jeffreys et al. 1994; May et 
al. 1996). Some minisatellite loci show polarity, with mutation events targeted 
to one end of the repeat array (Jeffreys et al. 1991a, 1994). 
The polarity of the minisatellite mutations show that the minisatellite 
mutation process does not just reﬂect the instability of tandem repeat DNA, but it 
is actively controlled by elements external to the tandem repeats. It appears that 
minisatellites themselves are not so unstable; rather the instability is directed 
from a locally acting regulator. Flanking DNA contains elements necessary to 
initiate recombination and conversion and it basically switches minisatellite 
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allele on. A cis-acting regulator of minisatellite mutation is demanded for the 
allele to be activated for mutation. This initiator creates a double strand break 
(DSB) at the beginning of the repeat unit. The resulting gap is repaired using 
information from the other sister chromatid (or more often from the other 
allele). DSB or staggered nicks in the recipient allele are followed by pairing 
with the other allele and strand invasion and they produce a recombination 
complex. In most instances, and for unknown reasons, this complex is aborted 
to yield a conversion product. The abortion process must be complex to give 
the extraordinary rearrangements that can accompany gene conversion, which 
involves chunks of DNA being shifted from one allele to another during the 
mutation process. Occasionally, the recombination complex is correctly processed 
to yield a true meiotic recombinant. This model predicts the existence of a 
recombination/conversion initiator, adjacent to the repeat array, which controls 
tandem repeat instability and then variation in mutation rates across different 
loci could reﬂect differences in initiator efﬁciency. It has indeed been shown 
that there is a highly localized recombination hotspot upstream of the MS32 
minisatellite extending into the beginning of the minisatellite (Jeffreys et al. 
1998b). Also mutational process of CEB1 has been shown to be driven by the 
presence of meiotic recombination hotspot located just upstream of the repeat 
region and extending into the 5´region of the array (Buard et al. 2000). These 
recombination hotspots are responsible for driving repeat turnover at CEB1 and 
MS32 and thus minisatellites may evolve as by-products of localized meiotic 
recombination in the human genome.
The mutational processes among minisatellite loci are not completely solved 
and exceptional cases may be revealed by additional studies. One example is 
minisatellite MS1 which is an unusual minisatellite because it has a short repeat 
unit of 9 bp, it shows somatic instability in colorectal carcinomas (suggesting that 
replication or repair errors might contribute to MS1 repeat instability), and it has 
two distinct classes of structural change (Berg et al. 2003). These authors state 
that structural changes of the ﬁrst class involves large and frequently complex 
rearrangements most likely arising by recombinational processes as seen at 
other minisatellites. However, structural changes of the second class generate 
exclusively single-repeat deletions restricted to sequence-homogeneous regions 
of alleles. The frequency of these changes depends on the length of uninterrupted 
repeats. The hyperinstability threshold seems to be similar in length to that 
observed at triplet-repeat loci showing expansions driven by dynamic mutation. 
The longest homogeneous repeats can have 0.7-1.3 deletions/sperm cell making 
these repeats extremely short-lived. These deletions can be generated by slippage 
during meiotic recombination or by post-meiotic repair. Post-meiotic repair has 
been seen in mice transgenic for Huntington disease CAG repeats, in which 
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expansion arises in post-meiotic haploid cells via repair of DNA breaks generated 
during sperm maturation (Kovtun and McMurray 2001). Berg et al. (2003) had 
no explanation for how these hyperdeleting repeats can come into existence and 
persist in human populations.
2.2.1.3 Spontaneous mutation frequencies of minisatellite loci
Minisatellite loci show high inter-allelic, inter-locus, inter-individual and inter-
species variation in mutation rates. In humans, spontaneous minisatellite 
mutation frequencies are lower in somatic cells, i.e., between 2 . 10-5 to 7 . 10-5 
(Jeffreys and Neumann 1997). However, in the germline, minisatellite mutation 
frequencies of the order of 10-1 to 10-3/locus/ gamete/generation are much higher 
than the classical mutation rate of most protein-coding genes of 10-5 to 10-6/locus/
gamete/generation (Jeffreys et al. 1985, 1988, 1991b, 1997; Kovacs et al. 1990). 
Spontaneous germline mutation frequencies vary not only between minisatellites 
but also between alleles at a given minisatellite locus (Monckton et al. 1994; May 
et al. 1996; Buard et al. 1998; Tamaki et al. 1999). For example, the mean mutation 
rate for individual alleles in men at the MS205 minisatellite locus varies up to 
20-fold (Zheng et al. 2000). Therefore, there is no general mutation rate for each 
minisatellite locus because the number of elements at any of these loci may vary 
from individual to individual and because the mutation rate depends upon the 
number of repeats. Minisatellite mutation shows a curious dependence on allele 
length; for minisatellites B6.7 and CEB1 minisatellite mutation rate increases 
steadily up to 40–50 repeats, above which it appears to reach a plateau (Jeffreys 
et al. 1997; Buard et al. 1998). The mutation rate of a newly arising allele differs 
from that of its parent. Germline mutation frequency variation has also been 
linked to a ﬂanking polymorphism that appears to inﬂuence hotspot activity 
(Jeffreys et al. 1998b; Buard et al. 2000).
Minisatellites include some of the most variable loci in the human genome, 
and therefore minisatellite mutations are relatively easy to detect. The most 
dramatic variation is observed at CEB1, where sperm mutation rates vary 
from <0.05% to 25%/allele, the latter being the highest rate yet observed at a 
minisatellite (Buard et al. 1998). A minisatellite is classiﬁed as hypermutable 
if its average mutation rate in the germline is over 0.5%. Some 10% of human 
minisatellites are thus classiﬁable as hypermutable loci (Bois 2003). The observed 
high mutation rates are true both for human and mouse (expanded simple tandem 
repeats, ESTRs in mouse) minisatellite loci (e.g., Jeffreys et al. 1987, 1988, 1997; 
Kelly et al. 1989, 1991; Kovacs et al. 1990; Suzuki et al. 1993; McKusick 1998). 
These higher mutation rates lead to a much higher level of polymorphism between 
unrelated individuals within a population. At the same time, the mutation 
frequency is low enough for minisatellite alleles to be followed easily in classical 
breeding studies.
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2.2.1.4 Biological function of human minisatellites
The great majority of hypervariable minisatellite DNA sequences are not 
transcribed, except for elements occurring within noncoding intragenic sequences. 
However, there are a few exceptional cases in the human genome, and a fair 
number of cases outside the human genome, of minisatellites that actually 
form part of genes. There are tandem repeated DNA sequences [e.g., mucin 
(MUC1) locus on 1q] that code for tandem repeated protein sequences. MUC1 
locus encodes a glycoprotein found in several epithelial tissues and body ﬂuids. 
It is highly polymorphic as a result of extensive variation in the number of 
minisatellite-encoded repeats (Swallow et al. 1987a, b; Lancaster et al. 1990). 
Another example of coding minisatellites is human apolipoprotein family. Each 
member of this family contains a coding minisatellite with a repeat unit of 33 
or 66 bp (Boguski et al. 1986). Apolipoproteins are capable of binding lipids, 
each being associated with a lipoprotein of speciﬁc density (Mahley et al. 1984). 
This speciﬁcity is due to the variable coding minisatellite region in each gene. 
In addition, involucrin, loricrin and small proline-rich (SPR) genes (Eckert and 
Green 1986; Gibbs et al. 1993a) as well as the D4 dopamine receptor (D4DR) 
(Van Tol et al. 1992; Lichter et al. 1993) contain coding minisatellites. The coding 
polymorphisms observed in D4DR gene have been shown to affect its ligand-
binding afﬁnity (Van Tol et al. 1992; Asghari et al. 1994). It is also associated 
with cognitive and emotional disorders as a consequence of the high level of 
D4DR expression in the limbic areas of the brain (Benjamin et al. 1996, 1997; 
Ebstein et al. 1996, 1997). In addition, the prion protein gene contains a 24 bp 
repeat region coding for an octapeptide. Some inherited forms of prion diseases, 
including Creutzfeldt-Jakob disease (CJD) and Gerstmann-Sträussler Scheinker 
syndrome (GSS) are associated with the ampliﬁcation of 4–9 extra repeats in the 
coding repeated region (Palmer and Collinge 1993). The biological consequences 
of these ampliﬁcations remain unclear. Finally, minisatellite CEB205 appears to 
contribute to the coding sequence itself (Denoued et al. 2003). 
Hypervariable minisatellite DNA has been reported as a hotspot for 
homologous recombination in human cells (Wahls et al. 1990). Minisatellites 
may act as ‘harmless’ places for homologous recombination, thus minimizing the 
effects of possible errors (mutations) in this process. The minisatellite mutation 
process, controlled by some elements near the minisatellite, may reﬂect some 
basic biological process going on in DNA. Although most minisatellite mutations 
are likely to be without phenotypic consequence, there are some exceptions where 
the minisatellites have been implicated as regulators of gene expression (for 
example, at levels of transcription, alternative splicing, or imprint control) or 
as a part of bona ﬁde open reading frames (see 2.2.1.5). Minisatellites have also 
been associated with chromosome fragile sites and are proximal to a number of 
recurrent translocation breakpoints (Sutherland et al. 1998).
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2.2.1.5  Possible mechanisms of repeat diseases
Tandem mini- and microsatellite (see 2.2.2) repeats can cause different human 
diseases (Table 1) by several possible mechanisms. The best-studied examples are 
diseases caused by an expanded trinucleotide repeat. Diseases caused by expansion 
of an unstable CAG repeat within a gene are all late-onset neurodegenerative 
diseases and except for spinal and bulbar muscular atrophy (Kennedy disease, 
On-Line Mendelian Inheritance in Man = OMIM 313 200), are all dominantly 
inherited. No other mutation in the gene has been found to cause the disease. The 
expanded allele is transcribed and translated and encodes a protein of unknown 
function. The CAG repeat encodes a polyglutamine tract in the protein. There is a 
critical threshold repeat size, below which the repeat is non-pathogenic and above 
which it causes disease. When the polyglutamine tract exceeds the threshold 
length the protein aggregates, forming an inclusion body, which apparently kills 
the cell (Kim and Tanzi 1998). The larger the repeat, above the threshold, the 
earlier is the age of onset (on average, predictions cannot be made for individual 
patients, but there is a clear statistical correlation). The androgen receptor 
mutation in Kennedy disease provides clear evidence that CAG-repeat diseases 
involve a speciﬁc gain-of-function. Loss-of-function mutations in this gene are 
well known and cause androgen insensitivity or testicular feminization syndrome 
(OMIM 300068), a failure of male sexual differentiation. The different clinical 
features of each disease reﬂect the killing of different cells, presumably because of 
interactions with other cell-speciﬁc proteins. The mechanisms and their general 
signiﬁcance remain to be discovered. 
Minisatellites have also been implicated as regulators of gene expression 
(for example, at levels of transcription, alternative splicing, or imprint control) or 
as part of bona ﬁde open reading frames (reviewed by Bois and Jeffreys 1999). In 
Fragile-X syndrome and Friedreich’s ataxia (Table 1), an enormously expanded 
repeat causes a loss-of-function by abolishing transcription. The same is true for 
the expanding 12-, 15-, or 18-mer in juvenile myoclonus epilepsy. In each case, the 
disease is occasionally caused by different, more conventional, loss-of-function 
mutations in the gene. Such mutations produce an identical clinical phenotype 
as expansions, apart from (presumably) not showing anticipation. 
The minisatellite repeats have also been envisaged as possible protein-
binding sites and in some cases, protein binding at the RNA level has also 
been suggested to contribute to pathogenesis, notably in dystrophia myotonica 
(Philips et al. 1998). No other mutations have ever been found in dystrophia 
myotonica patients, so there must be something quite speciﬁc about the action 
of the CTG repeat. It may affect processing (splicing) of the primary transcript 
in a speciﬁc way, or it may affect expression of a whole series of genes by altering 
the chromatin structure in this gene-rich chromosomal region. The site of the 
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expansion reduces expression of the adjacent gene. SCA8 may have a similar 
mechanism (Koob et al. 1999).
The non-random clustering of chromosome deletion breakpoints with the 
CCG repeats has given reason to assume that they may play an important role in 
a common mechanism of chromosome breakage. This has been shown, e.g., in the 
fragile 11B site causing the Jacobsen (11q-) syndrome (Jones et al. 2000). Other 
highly expanded shorter repeats, such as FRA16A (an expanded CCG repeat) 
(Nancarrow et al. 1994, 1995) or FRA16B (an expanded 33 or 35 bp minisatellite) 
(Yu et al. 1997; Yamauchi et al. 2000) are non-pathogenic, presumably because 
no important gene is located nearby.  
There is evidence that certain minisatellite mutations can regulate or 
modify the transcription of adjacent genes and therefore they might be at the 
origin of the associated pathologies. This has been shown to occur with the 
insulin gene, the cystatin B gene and HRAS oncogene. The insulin minisatellite 
(INS VNTR OMIM 147510) located 596 bp upstream of the human insulin gene 
translation-initiation site, has attracted widespread interest because of its 
associations with a range of phenotypes, including susceptibility to type 1 diabetes 
(Bennett et al. 1995; Bennett and Todd 1996), insulin dependent diabetes mellitus 
type 2 (IDDM2) (Bell et al. 1984), polycystic ovary syndrome (Wa-terworth et 
al. 1997), variation in birth size (Dunger et al. 1998), and obesity (Le Stunff et 
al. 2001). In IDDM2, repeat alleles of different length have been shown to affect 
transcriptional regulation of insulin (INS) gene expression, with short alleles 
resulting mainly in increased insulin expression and susceptibility to IDDM2 
(Bell et al. 1984; Bennett et al. 1995; Kennedy et al. 1995; Lucassen et al. 1995). 
In the case of the cystatin B, the expansion of the dodecamer repeat located in 
the proximal promoter of the cystatin B gene severely disrupts the function of 
the promoter and thus reduces transcription (Pennacchio et al. 1996; Lalioti et 
al. 1997; Virtaneva et al. 1997; Alakurtti et al. 2000). HRAS oncogene associated 
minisatellites have shown to act as risk factors for spontaneous abortion (Kiaris et 
al. 1995) and various cancers (Trepicchio and Krontiris 1992; Green and Krontiris 
1993; Krontiris et al. 1993; Phelan et al. 1996; Gosse-Brun et al. 1999; Lindstedt 
et al. 1999; Rosell et al. 1999; Weitzel et al. 2000). However, the link between the 
HRAS minisatellite and cancer remains uncertain as in many studies the cancer 
association could not be seen (Thein et al. 1986; Sutherland et al. 1986; Ishikawa 
et al. 1987; Gerhard et al. 1987; Firgaira et al. 1999). Langdon and Armour (2003) 
explained this discrepancy by the possibility that earlier studies showing cancer 
association could have been incapable of distinguishing small length differences 
at the HRAS minisatellite because these studies were conducted using Southern 
blot hybridization compared with more recent PCR-based studies. 
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2.2.1.6 Exploitation of minisatellite polymorphisms
Minisatellites were originally utilized as highly informative hypervariable 
markers for linkage analysis (Lander and Schork 1994), but rapidly swept to 
prominence with the realization that they provided a powerful new method for 
individual identiﬁcation. Thus a major application of minisatellites has been 
in DNA ﬁngerprinting. Minisatellite DNA ﬁngerprinting has been exploited 
in paternity and immigration disputes, forensic studies, zygosity testing, and 
monitoring bone marrow transplants. Minisatellites are efﬁcient markers for 
gene mapping and loss of heterotsygosity (LOH) studies. Single locus probes are 
used in pedigree analysis and mutation screening, where signiﬁcant changes 
can be detected with smaller sample sizes. Minisatellites are nowadays widely 
used also in identiﬁcation of different strains of bacteria and in molecular 
epidemiology. When mycobacterial interspersed repetitive units (MIRUs) in 12 
human minisatellite-like regions were studied in Mycobacterium tuberculosis 
genome, >16 . 106 different combinations were found. This has been utilized in 
MIRU-VNTR identiﬁcation of tuberculosis (Mazars et al. 2001).
2.2.2 Microsatellites
In addition to minisatellites, the other type of multiallelic polymorphic loci 
in the human genome consists of microsatellite markers (Litt and Luty 1989; 
Weber and May 1989) or short tandem repeats (STRs). Microsatellites are 
composed of 1–4 bp repeating units. Repeat units of (AT)n are the most common 
ones in humans and (AC)n in rats (Beckman and Weber 1992). Microsatellite 
cluster length is usually <150 bp, but some STRs involved in diseases have 
thousands of repeats. Microsatellite markers account for about 0.5% of the 
human genome and they occur relatively evenly spaced throughout the genome 
approximately once in every 30 kb (Strachan and Read 1999). Thus, the 
potential number of microsatellite loci in the human genome is >105, out of 
which about 104 microsatellites have already been discovered. Microsatellites 
are spread throughout the human genome and are located mostly in introns 
and untranslated regions. Many of them are polymorphic (i.e., variable from 
individual to individual) in copy number in human populations due to the high 
spontaneous mutation rates estimated to be in the range of 10-2 to 10-4/locus/
gamete/generation (Ellegren 2000). Microsatellite mutations are 5–6 times more 
frequent in the human male germline than in the female germline (Brinkmann 
et al. 1998). Large-scale pedigree studies have shown that more than 90% of 
microsatellite mutations result from the expansion or contraction of alleles by a 
single repeat unit. Repeat length and base composition affect the microsatellite 
mutation rate; dinucleotide repeats mutate faster than trinucleotide repeats 
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and sequences with high AT content mutate faster than sequences with high 
CG content. In addition, the number of repeats, the presence of interruptions 
within the sequence, and the rate of intracellular processes such as replication, 
transcription, DNA repair, and recombination may contribute to the mutational 
dynamics of microsatellite DNA (Schlötterer 2000). Experiments in bacteria, 
yeast, and mammalian systems suggest that an elevated frequency of length 
changes (expansions and deletions) is caused by their propensity to form unusual 
secondary structures (McMurray 1999). Unstable DNA structures such as left-
handed Z-DNA, cruciforms, slipped-stranded DNA, triplexes, and tetraplexes 
may form due to their palindromic nature, under physiological conditions as well 
as in vivo (Jaworski et al. 1987; Sen and Gilbert 1988; Parniewski et al. 1990; 
Pearson and Sinden 1996). Such structures may be potentially hazardous for 
genome stability if not removed by repair mechanisms. 
Microsatellite mutations are selectively neutral and so they are compatible 
with the assumptions of most population genetic theory. There are many 
microsatellites with 5–10 different length alleles, and a few with even more. 
Therefore, they are highly informative and provide a rich source of markers 
that are widely used in studies of the human genome. PCR ampliﬁcation of 
microsatellite markers is utilized in personal identiﬁcation (e.g., forensic and 
paternal analysis), quantitative analysis of chimerism after allogenic stem cell 
transplantation (recently reviewed by Acquaviva et al. 2003), genetic mapping, 
and linkage analysis in association with disease susceptibility genes. One form 
of microsatellites, unstable trinucleotide repeats, in 5’ and 3’ untranslated 
regions and coding regions are known to be associated with several inherited 
neurological disorders (Ashley and Warren 1995; Warren 1996). Altogether, 20 
Mendelian diseases have been shown to be associated with trinucleotide repeat 
expansions (Table 1). In general, there is an inverse relationship between the age 
of onset and the size of repeat and a direct relationship between expansion size 
and disease severity. The length of the expanded trinucleotide repeat sequence in 
afﬂicted families may vary from as much as tens of triplet repeats to thousands 
of repeats. 
2.2.3 Single nucleotide polymorphism
Apart from micro-and minisatellites, all other types of human polymorphisms are 
mostly biallelic. The most widespread class of variation in the human genome is 
single nucleotide polymorphism (SNP) (Kruglyak 1997; Wang et al. 1998). SNPs 
are simple base-substitutional variants in DNA sequence that comprise a large 
part of human diversity. They are very frequent, occurring once per 1250 bp on 
average but there is marked heterogeneity in the level of SNP polymorphism 
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across the human genome (Venter et al. 2001). More than 5 million SNPs with 
a minor-allele frequency greater than 10% are expected to exist in the human 
genome (Kruglyak and Nickerson 2001). A recent analysis (Reich et al. 2003) 
indicated that over half (2.7 million) of SNPs with frequency of >10% are already 
presented in available databases and thus can be utilized. The public (TSC and 
BAC overlap) and Celera databases contain approximately 4 million candidate 
SNPs in the human genome (Sachidanandam et al. 2001; Marth et al. 2001; 
Venter et al. 2001). However, at present the databases contain limited information 
about the population frequency of SNPs. The frequency of base-substitutional 
polymorphism depends on local sequence context. The dinucleotide CG, in which 
the cytosine is generally methylated in human DNA, has a relatively high 
mutation rate to TG or CA. As a result, CG dinucleotides are preferential sites 
of polymorphism as well as of disease-causing mutations in genes. As each SNP 
has usually only two alleles, SNP typing is easily automated and widely used 
in mapping disease associations. Less than 1% of all SNPs result in variation in 
proteins, but the task of determining which SNPs have functional consequences 
is an open challenge. Studies have revealed SNP variation in and around genes 
of medical importance and it has been suggested that their inheritance may alter 
susceptibility to diseases (Lander 1996; Risch and Merikangas 1996; Collins et 
al. 1997). SNPs may have effects (e.g., individual susceptibility to cancer) that 
are not recognised, but which may be yet important in future human genetics. 
2.3. Mutations in the human genome
In a living cell, DNA undergoes frequent chemical change, especially when it 
is replicated (in S phase of the eukaryotic cell cycle). The DNA of the human 
genome is subject to a variety of different types of hereditary change (mutation). 
A mutation is a change in the nucleotide sequence of a genome. Mutations result 
either from errors in DNA replication and repair (spontaneous or endogenous 
mutations) or from the damaging effects of mutagens such as radiation and 
chemicals that react with DNA (induced or exogenous mutations). Most DNA 
damage in humans is spontaneous and caused by thermodynamic decay 
processes and by reactive free radicals formed by the oxygen metabolism. Each 
mammalian cell suffers millions of spontaneous DNA-damaging events/year. 
Thus, all cells have effective DNA repair systems that attempt to identify and 
correct abnormalities in the DNA sequence in order to minimise the number of 
mutations. The ultimate source of all variation in the human genome is de novo 
mutation in the germline, resulting in sequence alterations that can range from 
simple base substitutions through deletion, duplication, and transposition to 
turnover at tandem repeat loci.
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2.3.1. Molecular nature of mutations
The clinical effects of various changes in a given gene can be observed in humans. 
Many different mutations are known for most inherited diseases where the 
responsible gene has already been identiﬁed. On September 9, 2004, The Human 
Gene Mutation Database (HGMD) (http://archive.uwcm.ac.uk/uwcm/mg/docs/
hahaha.html) contained 42 521 mutations in 1 657 human genes (Table 2). 
Currently 1 364 different mutations have been described in the cystic ﬁbrosis 
(CF) (OMIM 219 700) gene (http://www.genet.sickkids.on.ca/cftr) and 390 in the 
haemoglobin beta (HBB) (OMIM 141 900) gene (http://archive.uwcm.ac.uk/uwcm/
mg/hgmd/search/119297.html). 
A comparatively common type of human mutations consists of point 
mutations (single-base substitutions), which replace one nucleotide with another. 
Point mutations include transitions and transversions. In a transition, one purine 
is substituted by another purine (A«G) or one pyrimidine is substituted by 
another pyrimidine (C«T). In a transversion, a purine is replaced by a pyrimidine 
(A®T, A®C, G®T, or G®C) or a pyrimidine is replaced by a purine (C®A, C®G, 
T®A, or T®G). Missense mutations alter the codon so that it speciﬁes a different 
amino acid. Often this has no signiﬁcant effect on the biological activity of the 
protein. In nonsense mutations, a codon for an amino acid is changed into a 
terminating (STOP) codon (UAA, UAG, or UGA in nuclear mRNA; UAA, UAG, 
AGA, or AGG in mitochondrial mRNA). Therefore, translation of the mRNA 
transcribed from this mutant gene will stop prematurely, resulting in a shortened 
or absent protein. However, nonsense mutations often trigger mRNA instability 
rather than cause production of a truncated protein. Missense/nonsense mutations 
constitute 57% of the over 42 521 human mutations that have been collected in the 
Human Gene Mutation Database (HGMD) (Table 2). Silent substitutions result 
in a new codon specifying the same amino acid. They usually cause no change in 
their product and can be detected only by sequencing the gene (or it is mRNA). 
Silent mutations also include virtually all those that occur in extragenic DNA 
and in the noncoding components of genes and generelated sequences (Figure 
1). Consequently, 98.9% of the human genome can be usually mutated without 
signiﬁcant effect. Mutations in the coding regions of the genes are much more 
important. Multiple base substitutions (gene conversion-like events) are rare 
except at certain tandemly repeated loci or clustered repeats. Base substitutions 
in coding sequences may be pathogenic because splice site mutations create or 
destroy signals for exon-intron splicing. They may also destroy an embedded 
signal (e.g., a nuclear localization signal). 
In addition to point mutations and multiple base substitutions, human 
mutations also contain insertions, duplications, and deletions. In insertions, one 
or more nucleotides are inserted into a DNA sequence. Insertions of one or a few 
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Repeat number 
            
Disease 
OMIM 
number25
Mode 
of 
inherit- 
ance 
Location 
of the 
gene 
Repeat 
sequence 
Location 
of repeat 
Normal Disease 
DM1 160 900 AD26 19q13.3 CTG  3’UTR30 5-37  50- 4 000 
DM22 602 668 AD 3q13.3- q24 CCTG intron 1 75- -11 000 
DRPLA3 125 370 AD 12p13.31 CAG coding 3-35 49-93  
EPM14 254 800 AR27 21q22.3 CCCCG- CCCCGCG promoter 2-3 30-80 
FRAXA5 309 550 X28 Xq27.3 CGG 5’UTR  5-54 200-    >1 000 
FRAXE6 309 548 X Xq28 CCG promoter 6-25 200-750 
FRA 11B/ 
Jacobsen 600 651 mf
29 11q23.3 CGG 5’ UTR 11 100- 1 000 
FRDA8 229 300 AR 9q13,   9p23-p11 GAA intron 1 7-22 
120- 
1 700 
HD9 143 100 AD 4p16.3 CAG coding 6-35 36-121 
HRS10 140 340 AD 12p13.31 CAG coding 3-13 63-68 
IDDM211 125 852 mf 11p15.5 ACAGGGG- TGTGGGG 5’UTR 138-210 26-63 
OPMD12 164 300 AD  14q11.2- q13 GCG coding 6 8-13  
OPMD13 257 950 AR 14q11.2- q13 GCG coding 6 7 
1 Dystrophia myotonica. One form of dystrophia myotonica has been found to be caused by a CTG expansion near the 
dystrophia myotonica protein kinase gene (DMPK, OMIM 605377) (Brook et al. 1992; Mahadevan et al. 1992). 
2 Dystrophia myotonica 2 is caused by expansion of a CCTG repeat in intron 1 of zinc finger protein9 (ZNF9, OMIM 
116955) (Liquori et al. 2001).
3 Dentatorubral-pallidoluysian atrophy is caused by the same expanded CAG repeat as HRS (Burke et al. 1994; Koide et al. 
1994; Ikeuchi et al. 1995; Takiyama et al. 1999; Shimojo et al. 2001). 
4 Progressive myoclonus epilepsy is caused by 12 bp expansions in the promoter region of the cystatin B gene (CSTB, 
OMIM 601145). In addition, 15bp and 18 bp repeated units have been shown to cause EPM1 (Pennacchio et al. 1996; 
Lalioti et al. 1997, 1998; Virtaneva et al. 1997). 
5 Fragile-X site (Oberlé et al. 1991; Verkerk et al. 1991; Yu et al. 1991; Bates and Lehrach 1994). 
6 Fragile-X site E (Knight et al. 1994). 
7 Fragile site 11B locates 5’ prime end of the CBL2 oncogene (OMIM 165360) which includes a CCG trinucleotide repeat. 
Fragile site 11B causes predisposition toward Jacobsen syndrome which is a chromosomal aberration (11q-), and many 
genes are involved in the phenotype of the offspring (Jones et al. 1995, 2000). 
8 Friedreich’s ataxia. One form of Friedreich’s ataxia is caused by mutation in the FRDA gene (OMIM 606829), which has 
been mapped to 9q. Another locus for the disorder has been mapped to 9p (OMIM 601992) (Campuzano et al. 1996; Dürr 
et al. 1996a; Filla et al. 1996; Delatycki et al. 1999, 2000). 
9 Huntington’s disease (MacDonald et al. 1993; Ambrose et al. 1994; Nasir et al.1996). 
10 Haw River syndrome is caused by the same expanded CAG repeat as DRPLA (Burke et al. 1994).  
11Insulin-dependent diabetes mellitus type 2 is caused by minisatellite expansion (INS VNTR, OMIM 147510) located 596 
bp upstream of the insulin gene (INS, OMIM 176730) translation initiation site (Bell et al. 1982, 1984; Owerbach and 
Gabbay 1993; Bennett et al. 1995; Kennedy et al. 1995; Lucassen et al. 1995; Lew et al. 2000).
12, 13Oculopharyngeal muscular dystrophy is caused by mutation in the gene encoding poly(A) – binding protein-2 (PABP2, 
OMIM 602279) (Fried et al. 1975; Brais et al. 1998; Becher et al. 2001). Mode of the inheritance of the disease depends 
on the length of the GCG repeat. 
Table 1. Human diseases known to be caused by micro- or minisatellite tandem 
repeats.
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Table 1. continues.
Repeat number 
            
Disease 
OMIM-
number25 
Mode 
of 
inherit- 
ance 
Location 
of the 
gene 
Repeat 
sequence 
Location 
of repeat 
Normal Disease 
SBMA14 313 200 XR Xq11-q12 CAG coding 6-35  36-72  
SCA115 164 400 AD 6p23 CAG coding 6-44  39-83 
SCA216 183 090 AD 12q24 CAG coding 13-33 32-77 
SCA3/ 
MJD17 109 150 AD 14q32.1 CAG coding 12-47  54-89 
SCA618 183 086 AD 19p13 CAG coding 4-18  20-33 
SCA719 164 500 AD 3p12- p13 CAG coding 4-35 36-306  
SCA820 603 680 AD 13q21 CTG 3’UTR  14-92 100-250 
SCA1021 603 516 AD 22q13 - qter ATTCT intron 9 10-28  29-4500 
SCA1222 604 326 AD 5q31- q33 CAG 5’UTR 7-45 55-78 
SCA1723 607 136 AD 6q27 CAG coding 25-42 44-63 
SPD24 186 000 AD 2q31 GCG coding 15 22-29 
14Spinal and bulbar muscular atrophy (Kennedy disease) is caused by mutation in one part of the androgen receptor gene 
(AR, OMIM 313700) (Doyu et al. 1992; La Spada et al. 1992; Amato et al. 1993; Ferlini et al. 1995). 
15Spinocerebellar ataxia type 1 (Orr et al. 1993; Banfi et al. 1994; Schöls et al. 1995).  
16Spinocerebellar ataxia type 2 is caused by an expansion of a CAG repeat in the coding region of 1 isoform of the alpha-
1A calcium channel subunit (CACNA1A, OMIM 601011) (Pulst et al. 1993, 1996; Imbert et al. 1996; Sanpei et al. 1996; 
Riess et al. 1997).  
17Spinocerebellar ataxia type 3/Machado-Joseph disease (Kawaguchi et al. 1994; Giunti et al. 1995; Maruyama et al.1995; 
Schöls et al. 1995; Twist et al. 1995; Dürr et al. 1996b).  
18Spinocerebellar ataxia type 6 is associated with CAG expansion in the �1A-voltage-dependent calcium channel gene 
(CACNL1A4, OMIM 601011) (Matsuyama et al. 1997; Zhuchenko et al. 1997; Takiyama et al. 1998; Ishikawa et al. 1999; 
Mariotti et al. 2001). 
19Spinocerebellar ataxia type 7 (David et al. 1997; Gouw et al.1998; Stevanin et al. 1998; Giunti et al. 1999; Michalik et al. 
1999; Jonasson et al. 2000). 
20Spinocerebellar ataxia type 8 has been shown to be caused by a CTG expansion (Koob et al. 1999; Moseley et al. 2000; 
Silveira et al. 2000; Stevanin et al. 2000; Vincent et al. 2000; Cellini et al. 2001; Topisirovic et al. 2002), but this expansion 
has also been shown not to be confined to patients with SCA8 (Worth et al. 2000; Sobrido et al. 2001).  
21Spinocerebellar ataxia type 10 (Matsuura et al. 2000, 2002; Grewal et al. 2002; Potaman et al. 2003). 
22Spinocerebellar ataxia type 12 is caused by an expansion of a CAG repeat in a brain-specific regulatory subunit of the 
protein phosphatase PP2A (PPP2R2B, OMIM 604325) (Holmes et al. 1999; Cholfin et al. 2001; Fujigasaki et al. 2001; 
Srivastava et al. 2001).  
23 Spinocerebellar ataxia type 17 is caused by an expansion of a CAG repeat in a TATA box-binding protein (TBP, OMIM 
600075) (Koide et al. 1999; Nakamura et al. 2001; Zühlke et al 2001; Silveira et al. 2002). 
24Synpolydactyly phenotype is caused by mutation in the homeo box D13 gene (HOXD13, OMIM 142989). However, this 
does not seem to be an unstable expanding repeat. The expansion is probably the result of unequal crossing over, and at 
least in one family it has been stable for 7 generations (Akarsu et al. 1996; Kjaer et al. 2002). 
25On-Line Mendelian Inheritance in Man (OMIM) (McKusick 2001); http://www3.ncbi.nlm.nih.gov/Omim/searchomim.html 
26Autosomal dominant mode of inheritance. 
27Autosomal recessive mode of inheritance. 
28X-chromosomal mode of inheritance. 
29Multifactorial disease. 
30Untranslated region. 
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nucleotides are very common in noncoding DNA but rare in coding DNA, where 
they produce frameshift (see below). Occasionally large-scale tandem duplications 
and insertions of transposable elements are found. In deletions one or more 
nucleotides are eliminated from the DNA sequence. The deletion size varies 
from 1 bp to megabases. Deletions of one or a few nucleotides are very common 
in noncoding DNA but are rare in coding DNA, where they produce frameshifts. 
Larger deletions are rare, but often occur in regions containing tandem repeats or 
between interspersed repeats. Insertions and deletions are particularly prevalent 
in short repeated sequences (e.g., microsatellites) because such sequences can 
induce replication slippage. In replication slippage, the template strand and its 
copy shift their relative positions so that part of the template is either copied 
twice or missed out. The result is that the new polynucleotide has a larger or 
smaller number of the repeat units. Microsatellite sequences are hypervariable, 
as replication slippage occasionally generates a new length variant and adds it 
to the collection of alleles already present in the population (see below: dynamic 
mutations). Insertions, deletions, or splicing errors result in frameshift mutations. 
If the number of bases inserted or deleted is not a multiple of three base pairs, 
the reading frame is changed (frame shift mutation) since the genetic code is read 
in non-overlapping triplets. This leads to the situation where the entire amino 
acid sequence of the protein is altered beyond the site of the mutation, causing 
loss-of-function of the protein. 
A further class of human mutations contains large-scale chromosome 
abnormalities that involve loss or gain of chromosomes or the breakage and 
rejoining of chromatids. Numerical and structural chromosomal abnormalities 
are rarer as constitutional mutations because they are often lethal and end up 
in spontaneous abortion. They are far more common as somatic mutations and 
are often found in tumour cells. 
The most recently found class of human mutations (dynamic mutations) 
arise as a result of non-traditional mechanisms. Dynamic mutations are unlike 
conventional mutations, because the expanded repeats can undergo further 
change (usually continued expansion) with each subsequent generation. For those 
expansions that result in an altered phenotype, the subsequent expansion of the 
repeat in descending generations can lead to non-Mendelian inheritance patterns 
due to incomplete penetrance and/or variable expressivity, which can generally 
be directly correlated with the parental repeat length. With the discovery that 
one form of microsatellites, an expanded CGG repeat, is the mutation causing 
Fragile-X mental retardation (Oberle et al. 1991; Yu et al. 1991), trinucleotide re-
peat expansions were recognised as an important and novel mutation mechanism 
in human genetic disease. Trinucleotide repeat expansions are rare but they can 
change tandem repeat sequences in coding or untranslated regions of genes and 
cause various human diseases (Table 1). 
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Table 2. Number of entries by mutation type in Human Gene Mutation Database 
(HGMD) statistics (September 9, 2004) (http://archive.uwcm.ac.uk/uwcm/mg/docs/
hahaha.html).
Mutation type Number 
Micro-lesions  
Missense/nonsense 24 364 
Splicing 4 055 
Regulatory 449 
Small deletions 7 089 
Small insertions 2 810 
Small indels1 400 
Gross lesions  
Repeat variations 88 
Gross insertions and duplications 390 
Complex rearrangements (including inversions) 500 
Gross deletions 2 376 
Total 42 521 
1 Small insertion or deletion. 
These different kinds of human mutations can be detected in various parts 
of the human genome. In addition to coding sequences, mutations have also been 
found in regulatory regions, promoter regions, splice junctions, within introns, 
and in polyadenylation sites. They may interfere with any stage in the pathway 
of expression, from the gene to the protein product. Point mutations causing a 
defect in mRNA splicing can cause a reduction in the amount of mRNA generated, 
production of an aberrant mRNA, and non-recognition by the cellular machinery 
of an exon or exons following the lesion. The non-recognised exons are excluded 
from the mature RNA transcript, a process called exon skipping. Most mutations, 
including all silent ones as well as many in coding regions, will still not change 
the phenotype of the organism in any signiﬁcant way. Those having an effect can 
be divided into loss-of-function and gain-of-function mutations. Usually recessive 
loss-of-function mutations reduce or abolish a protein activity. One example of 
an exceptional dominant loss-of-function mutation is haploinsufﬁciency, where 
the organism is unable to fully tolerate the approximately 50% reduction in 
protein activity suffered by the heterotzygote (e.g., Marfan syndrome in humans). 
Proteins that require all homomers to be intact are another example of dominant 
loss-of-function mutations (e.g., ALDH2 functions as a homotetramer, and in 
heterozygotes only 1/16 of the availabe combinations are fully functional). Gain-
of-function mutations confer an abnormal activity of a protein and are usually 
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dominant. Many gain-of-function mutations are in regulatory sequences rather 
than in coding regions. Therefore, they can have a number of consequences. For 
example, one or more genes can be expressed in wrong tissues, whereby these 
tissues gain functions that they normally lack. In other situations one or more 
cell cycle control genes are over expressed, thus leading to uncontrolled cell 
division and hence to cancer.
The above-mentioned different types of human mutations (except dynamic 
mutations) arise usually as new mutations in single individuals in somatic cells 
or in the germline. For the estimation of hereditary risks of radiation, the most 
important mutations are germline mutations as the individuals who inherit 
these mutations have them present in every cell of the body and they can be 
transmitted to the next generation. 
2.3.2 Molecular techniques used for screening unknown mutations
As shown above, various types of human mutations can arise spontaneously 
or they may be induced by, e.g., radiation or chemicals. The great majority of 
mutations are not associated with disease but they occur within noncoding DNA 
sequences. During the last decades various molecular techniques have been 
developed for screening unknown mutations. 
Traditionally used Southern blot hybridization (Southern 1975) uses 
restriction enzyme digestion of studied DNA samples. Digested DNA samples 
are fractionated by gel electrophoresis, blotted and hybridised to probes derived 
from the polymorphic locus. Studied polymorphic loci may be restriction fragment 
length polymorphisms (RFLPs) (Botstein et al. 1980) or a variable number of 
tandem repeats (VNTRs) (Jeffreys et al. 1985; Nakamura et al. 1987; Wong et al. 
1987a). Unlike traditional point mutation RFLPs, minisatellites are caused by 
(and reﬂect) changes in the actual size of the locus itself. The analysis of VNTRs 
at a single-locus site results in the detection of two DNA fragments differing 
in length as long as the paternal and maternal alleles are not identical by 
coincidence. As the Southern hybridization method contains gel electrophoresis, 
it is laborious, relatively slow, and expensive. A further disadvantage of this 
method is the demand for quite large samples because it requires several µg 
of DNA. Conventionally run agarose gels will resolve fragments 500 bp–20 kb 
in size and therefore Southern blotting can only detect rearrangements in 
this size range. Rearrangements outside the size range detected by Southern 
blotting can be analysed using pulsed ﬁeld gel electrophoresis (PFGE) (Collier 
et al. 1989). PFGE involves the restriction digestion of genomic DNA using rare-
cutting enzymes, resulting in large restriction fragments. The extraction and 
digestion of the DNA is done in agarose blocks, which are then loaded directly 
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into the wells of the gel. Large restriction fragments are separated with a 
specialised electrophoresis system in which the direction of the electric ﬁeld is 
changed/pulsed regularly. As in Southern blotting, rearrangements are detected 
as abnormally sized fragments upon hybridisation with a probe corresponding to 
the gene of interest. The RNA equivalent of Southern blotting is called Northern 
blotting. If the gene rearrangement signiﬁcantly alters the length of the RNA 
transcript, it should be detectable by Northern blotting. Northern and Southern 
blotting can detect only a very small proportion of unknown mutations but they 
are useful as a preliminary mutation screen and they are the only way to detect 
large deletions, insertions, and duplications.
Formerly Southern blot–based mutation screening was revolutionised by 
the invention of the polymerase chain reaction (PCR) (Mullis et al. 1986; Saiki 
et al. 1988). PCR is usually designed to selectively amplify a speciﬁc target DNA 
sequence(s) within a heterogeneous collection of DNA sequences (e.g., total 
genomic DNA or a complex cDNA population). PCR is a rapid and simple method 
requiring minute amounts of DNA or cDNA and it is most suitable for sequences 
less than 300 bp in length. PCR is ideal for providing numerous DNA templates 
for mutation screening. Nowadays, minisatellites can also be typed by PCR less 
laboriously than by using Southern hybridization. The small pool polymerase 
chain reaction (SP-PCR) (Jeffreys et al. 1994) technique was developed to detect 
mutations at the DNA level directly in sperm cells thus avoiding the need to 
measure mutations arising in offspring. A minisatellite locus is ampliﬁed in 
multiple reactions, each containing a DNA equivalent to that from a number 
of sperm cells (usually <200), under conditions that are sensitive enough to 
detect the PCR product from a single DNA molecule. SP-PCR has been proven 
very efﬁcient, remarkably free of PCR artefacts, and it can be used to measure 
mutation rates as low as 10–3/cell. This method can overcome the small sample 
size limitation in pedigree analysis because there are millions of sperm in an 
average ejaculate and numerous PCR reactions can be run simultaneously. 
Mutation frequencies can be determined in individuals by SP-PCR, whereas 
pedigree analysis only gives an average from the population. A modiﬁcation of 
SP-PCR, a single-molecule PCR, has been used to quantify the in vivo frequency 
of spontaneous and radiation-induced mutations in somatic and germ cells at 
mouse tandem repeat locus (Ms6-hm) (Yauk et al. 2002). 
Unknown mutations can also be screened by the chemical cleavage of 
mismatches (CCM) (Moser and Dervan 1987; Cotton et al. 1988; Grompe et al. 
1989). This method detects mismatches, variations in the DNA sequence, by 
a series of chemical reactions. Heteroduplexes formed between wild-type and 
variant DNAs are treated with the single-strand-speciﬁc S1 nuclease to cleave 
the DNA at the point of mismatched bases (Shenk et al. 1975). The differential 
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mobility of native and denaturated DNA-DNA heteroduplexes coupled with their 
differential melting temperature has been exploited by Myers et al. (1985a). 
CCM is a highly sensitive method that shows the position of the mutation by 
the size of the fragments generated. Quite large fragments (over 1 kb) can 
be analyzed. However, this method is experimentally difﬁcult and since the 
necessary reagents are toxic, the usage of CCM is inconvenient. In the RNase 
mismatch cleavage method (Myers et al. 1985b; Winter et al. 1985) mismatches 
in RNA-DNA heteroduplexes are cleaved by RNase. This method does not reliably 
detect all mutations (Gibbs and Caskey 1987). However, nearly all single-base-
pair mismatches can be detected by using sense and antisense probes (Myers et 
al. 1985c). Thus, this method may be used to identify the mutated base and its 
position in a heteroduplex. No toxic reagents are needed, but the disadvantage 
of this method is the poor quality of the results. 
In addition to above mentioned mutation screening methods, single-strand 
conformational polymorphism (SSCP) analysis (Orita et al. 1989a, b) has also 
been widely used in mutation screening. It is based on a tendency of single-
stranded DNA to fold up according to the DNA sequence in a non-denaturing gel. 
Any variation in DNA sequence (conformation) is seen in the gel as a mobility 
shift. SSCP analysis is suitable for relatively short PCR fragments, the optimal 
fragment size being approximately 150 bp (Hayashi 1992). To maximise the 
differential migration of DNA fragments in SSCP it is crucial to optimise the 
experimental conditions. Thus, the sensitivity of SSCP for mutation detection 
has been reported to vary from 30% to 100% (Michaud et al. 1992; Sarkar et al. 
1992a; Claustres et al. 1993; Shefﬁeld et al. 1993). SSCP analysis has proven to 
be a simple, cheap, and effective technique for detecting single base substitutions. 
However, it does not reveal the nature or position of any mutation detected. 
Dideoxy ﬁngerprinting (ddF) (Sarkar et al. 1992b) is a hybrid technique that 
combines aspects of SSCP and dideoxy sequencing. Dideoxy ﬁngerprinting 
analyses each band in a sequencing ladder by SSCP. It is based on changes in 
denatured nucleic acid size/mobility and it can detect the presence of single 
base and other sequence changes in PCR-ampliﬁed segments. Moreover, the 
point of the mutation can be estimated from the ddF pattern and samples with 
different mutations have different ﬁngerprints. This method has been used to 
screen fragments of about 250 bp with virtually 100% sensitivity (Sarkar et al. 
1992b), but it is complicated to interpret.
An even more efﬁcient mutation detecting method than SSCP has turned 
out to be denaturing gradient gel electrophoresis (DGGE) (Fischer and Lerman 
1980, 1983; Myers et al. 1987; Shefﬁeld et al. 1989, 1992; Cariello and Skopek 
1993). This method separates DNA molecules based on their sequence on a 
denaturant or a temperature gradient (Wartell et al. 1990) gel. Migration of DNA 
39
STUK-A208
continues until the DNA duplexes reach a gel position where the DNA strands 
melt and separate. After this, the denatured DNA does not migrate much further. 
The melting temperature of the fragment is determined by its DNA sequence. 
DGGE is often used in conjunction with PCR to determine if a given DNA 
fragment contains a mutation. In DGGE, the choice of the primers is critical for 
mutation detection. Primers with long stretches of Gs and Cs (GC-clamps) are 
used to maximise the sensitivity of the method for mutation detection (Myers 
et al. 1985d; Shefﬁeld et al. 1989). DGGE has been shown to detect differences 
in the denaturing behaviour of small DNA fragments (200–700bp) that differ 
by as little as one base pair. Using optimized conditions, 100% of single-base 
substitutions, frameshifts, and deletions less than about 10 bp can be resolved 
from the wild-type sequence. However, GC-clamps in the primers make DGGE 
an expensive procedure and another disadvantage of the DGGE method is 
that it does not reveal the position of the mutation. An adaptation of DGGE, 
called constant denaturant gel electrophoresis (CDGE) (Hovig et al. 1991), is 
based on the electrophoretic runs of perpendicular gels (the electrical ﬁeld is 
perpendicular to the linear gradient of the denaturing chemicals). In CDGE, a 
speciﬁc concentration of the denaturing chemicals is selected to give maximum 
separation between the wild type and mutant sequences of DNA fragments. 
In addition to DGGE, heteroduplex analysis (Keen et al. 1991; White et 
al. 1992) can also observe single base pair mismatches. The heteroduplex gel 
mobility method is based on change in native nucleic acid conformation/mobility 
on nondenaturing gels following PCR. This method is very simple and cheap. 
However, its disadvantage is that it is applicable only to sequences <200 bp long 
and its sensitivity is limited. Heteroduplex analysis does not reveal the position 
of the change. 
As in heteroduplex analysis, PCR products are also examined for mutations 
in denaturing high-performance liquid chromatography (D-HPLC) analysis 
(Oefner and Underhill 1995; Underhill et al. 1996). It is a form of reverse-phase 
ion-pair high-performance liquid chromatography. D-HPLC is used after PCR to 
divide heteroduplexes from homoduplexes in mixtures of wild type and mutated 
sequences. This method is based on change in native nucleic acid size/mobility. 
Instead of polyacrylamide gel matrix used in conventional heteroduplex analysis 
to separate homo and heteroduplex species in a non-denaturing environment, 
D-HPLC uses partially denaturing conditions to exaggerate the difference 
between the two species. D-HPLC is very efﬁcient, accurate (100% of cystic 
ﬁbrosis transmembrane conductance regulator gene mutations, Le Maréchal et 
al. 2001), and rapid as it can be automated. The disadvantages of this method are 
the need for expensive equipment and modiﬁcation of PCR conditions because 
optimisation for each segment is required for full sensitivity of the method.
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Among mutation screening methods, the protein truncation test (PTT) (van 
der Luijt et al. 1994) is a speciﬁc test for frameshifts, splice site, or nonsense 
mutations that truncate a protein product. This test is based on the size/mobility 
of the protein generated in vitro and it is highly speciﬁc, revealing the approximate 
location of any mutation. Large genomic regions can be tested using genomic 
DNA rather than RT-PCR. Several variants have been developed to give cleaner 
results, usually by incorporating an immunoprecipitation step. However, this 
method is expensive, experimentally difﬁcult, usually needs RNA, and can detect 
only chain terminating mutations.
Mutation detection has become much more efﬁcient with the development of 
a DNA microarray (DNA chip) (Cheung et al. 1999). Many different oligonucleotides 
are located in a DNA chip. The DNA microarray technologies employ a reverse 
nucleic acid hybridization approach. The probes consist of unlabeled DNA ﬁxed 
to a solid support (the arrays of DNA or oligonucleotides) and the target is 
labelled and in solution. Many SNPs as well as mutations within these repeats 
can therefore be scored in a single experiment (Wang et al. 1998). Minisequencing 
can also be used in this mutation detection method. Oligonucleotide arrays are 
quick, have a high throughput, and they might detect and deﬁne all mutations. 
However, the equipment is expensive and only a limited number of genes can 
be analysed with these arrays.
As automated ﬂuorescence sequencers have become standard items of 
laboratory equipments during the past few years, direct sequencing (Wong et 
al. 1987b) has become more common as a means of primary mutation screening. 
Sequencing detects all changes and the mutations will be fully characterized. 
However, sequencing is expensive and the sequences may be hard to interpret. 
Much time can be wasted investigating artefacts, especially if the sequencing 
template is not of the highest quality. Capillary electrophoresis (Simpson et 
al. 1998) is a powerful technique for DNA sequencing and fragment analysis 
especially when it is combined with confocal ﬂuorescence detection, whereby 
it yields excellent sensitivity together with high speed and high-throughput, 
even fully automated separations. Using a four-colour detection system, DNA 
sequencing of 500 bp can be performed with 99% in less than 10 minutes. 
However, a limitation of this method is its resolution, thus making it only useful 
for the analysis of large fragments.  
One of the most efﬁcient mutation screening methods is mass spectrometry 
(MALDI-TOF MS) (Pieles et al. 1993). It is a strategy for analysing STR loci 
in the order of seconds per sample, with the advantage that it is not necessary 
to use allelic ladders. As part of the process, the products for analyses are co-
crystallised with a small organic compound, the matrix. Irradiation with a short 
laser causes the spontaneous volatilisation of matrix molecules. Along with these 
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matrix molecules, DNA molecules are ionised and desorbed into the gas-phase, 
where they are subjected to an electric ﬁeld. Determination of the molecular 
weight of the DNA is achieved by measuring the time-of-ﬂight towards a detector, 
which is proportional to the mass. The main disadvantages of this method are 
the expensive equipment and the limitation in the size since only fragments of 
<100 bp can be analysed.
2.3.3 Equilibrium theory
Mutation and selection are the two basic forces in evolution. The equilibrium 
theory assumes that the population is in balance between spontaneous mutations 
and selection. Spontaneous mutations arise in every generation producing a new 
variation to the gene pool, and selection eliminates some of these mutations, 
depending on their effects on reproduction (= ﬁtness). The effects of mutations on 
ﬁtness vary. Some mutations cause death before reproduction and are therefore 
eliminated in one generation. Other mutations allow reproduction and can thus 
persist in the population for varying periods of time. 
Radiation exposure can disturb the balance between mutation and selection 
by introducing new mutations into the gene pool of the population. Furthermore, 
these new, induced mutations are subject to selection. If the population is 
exposed to radiation in one generation only, there will be a transient increase 
in the mutation frequency in the ﬁrst generation after irradiation followed by a 
progressive decline to the old equilibrium. If the mutation rate is increased as a 
result of radiation in every generation, the population will attain a new balance 
between mutation and selection at a higher mutation frequency. The time and 
the rate at which the new equilibrium is reached depend on the induced mu-
tation rate and selection coefﬁcients. 
2.4 Mammalian gametogenesis
In the mammalian gametogenesis, primordial germ cells migrate into the 
embryonic gonad and engage in repeated rounds of mitosis (many more in males 
than in females, which may be a signiﬁcant factor in explaining sex differences in 
mutation rates) to form oogonia in females and spermatogonia in males. Further 
growth and differentation produce primary oocytes in the ovary and primary 
spermatocytes in the testis. These specialized diploid cells can undergo meiosis. 
Meiosis involves two cell divisions but only one round of DNA replication, so the 
products are haploid. 
In the mammalian male germline, stem cell spermatogonia are present 
throughout life. They recycle and produce later spermatogonial stages. 
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Spermatogenesis is a continuous process of mitotic and meiotic cell divisions, 
occurring from the beginning of sexual maturity. Male meiosis takes place 
only a few weeks before germ cell maturation producing four spermatozoa. In 
testes on adult males, all germ cell stages are present: stem cell spermatogonia 
and differentiating spermatogonia (pre-meiotic stages), spermatocytes (meiotic 
cells), and spermatids and spermatozoa (post-meiotic cells) (Searle 1974; Lyon 
1981).  In the male mouse, the number of cell divisions from zygote to sperm 
is of the order of 62 at age 9 months, assuming a 9-month generation (Drost 
and Lee 1995). The duration of spermatogenesis in the mouse is 42 days. From 
this, the time required for stem cell division is 8.5 days. The duration of human 
spermatogenesis is about 74 days (Figure 2). In the human male, there are 30 
male cell divisions from zygote to spermatogonial stem cells at puberty (13 years). 
Six subsequent cell divisions are required for spermatogenesis, but thereafter the 
spermatogenesis cycle occurs approximately every 16 days or 23 cycles/year. This 
means that in human males, the number of cell divisions required to produce 
sperm is age-dependent. If an average age of 20 is taken as the male reproductive 
age, then the total number of cell divisions prior to sperm production is about 
30 + [23 × (20-13)] + 6  » 200, increasing to » 430 at age 30, » 660 at age 40 and 
» 890 at age 50 (Vogel and Motulsky 1997).
In the mammalian female germline, oocytes are already formed in late 
embryogenesis and remain arrested until the onset of sexual maturity. In females 
the cytoplasm divides unequally at each stage: the products of the ﬁrst meiotic 
division are a large secondary oocyte and a small cell (polar body) and the 
secondary oocyte then gives rise to the large mature egg cell and a second polar 
body. The estimate for the number of germ cell divisions (from zygote to mature 
egg)/generation is 25 for mouse females (Drost and Lee 1995). In humans, primary 
oocytes enter meiosis I during fetal life but then arrest at the prophase stage 
right through to puberty or later (Vogel and Motulsky 1997). During this time, 
the primary oocytes complete their growth phase, acquiring an outer jelly coat, 
cortical granules, ribosomes, mRNA, yolk, etc. After puberty, one oocyte a month 
completes meiosis only a few hours before ovulation. Crossing-over in the female 
germline also occurs in the late embryonic stages. In human females, the number 
of cell divisions from zygote to fertilized oocyte is constant because all the oocytes 
have been formed by the ﬁfth month of development (about 22 cell divisions) and 
only two further cell divisions are required to produce the zygote, irrespective of 
the age at which fertilisation occurs. The estimate for the number of germ cell 
divisions (from zygote to mature egg)/generation is thus 24 for human females 
(Vogel and Motulsky 1997). 
It is established from studies with the mouse that there are major differences 
in the sensitivity of different germ cell stages in the male to ionising radiation 
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and a number of chemical mutagens when investigated with dominant lethal, 
translocation, speciﬁc-locus, or minisatellite mutation tests. Such sensitivity 
differences may reﬂect the characterictics of the different germ cell stages in 
terms of metabolism, chromosomal condensation, presence or absence of repair 
systems, etc. If the mechanisms of minisatellite mutation in females are similar to 
those in males (see 2.2.1.2), then minisatellite mutation in the maternal germline 
may only occur before birth. Thus, stem cell spermatogonia and immature, 
arrested oocytes are the stages most at risk of accumulating hereditary radiation 
damage (Searle 1987). 
2.5 Molecular biological methods in genetic risk assessment
2.5.1 Methods currently available
The detection of changes in the germline mutation rate in human populations is 
extremely difﬁcult. Traditionally used methods for evaluating the mutational load 
in human populations contain the search for untoward pregnancy outcomes, which 
includes stillbirths, neonatal deaths occurring during the ﬁrst two weeks of life, 
and major congenital malformations.  Malignancies, chromosomal aberrations, 
and electrophoretic protein variants have also been studied. Because of the very 
low frequency of spontaneous mutations at most loci, enormous sample sizes are 
required to detect de novo mutations or increases in mutation rate. 
Spontaneous mutation rates in minisatellite are orders of magnitude 
higher than those of most protein-coding genes (see 2.2.1.3), and thus mutation 
rates can be studied by using reasonable sample sizes. The calculations use the 
number of rare events (mutations) in the control and exposed groups. Based 
on the Poisson distribution, the variance should be equal to the mean value. 
According to Poisson distribution the main statistics is:
 R = (E – C) /  ,             (1)
   where:  E = number of mutations in exposed group
    C = number of mutations in control group
For a statistically signiﬁcant difference between the two groups, this ratio 
should exceed a cut-point value derived from the Student distribution. For the 
reason of simplicity, R = 2 would roughly correspond to 95% probability. Thus, 
assuming the Poisson approximation, the sample size N needed for detection of 
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Figure 2. Human spermatogenesis (modiﬁed from Vogel and Motulsky 1997). 
1Dark-staining A-type spermatogonia, 2Pale-staining A-type spermatogonia.The number of cell 
divisions needed to produce a sperm cell = ~ 30 + [ 23 × (age in years-13)] + 6.
Primordial male germ cell
1.2 · 109 cells are formed in 30 cell divisions at the age of puberty (13 years) 
Ad spermatogonia1
 Ad spermatogonia division every 16 days 
Ad spermatogonia1
Ap spermatogonia2
16 days
9 days
B spermatogia 
9 days 
Primary spermatocytes 
Meiosis I, 19 days 
Secondary spermatocytes 
Meiosis II, 21 days 
Spermatid
Spermatozoa 
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a statistically signiﬁcant difference (p <0.05) in the mutation rate between the 
two groups using the equation (1) can be calculated by the formula:
 (E – C) /  = 2 ,
   where:  E = k × N × s × m0
    C = N × s × m0
    k = expected increase in mutation rate
    N = sample size (number of offspring)
    s = number of studied loci
    m0 = mean spontaneous mutation rate
 , then N = [4 (k+1)] / [(k-1)2 × s × m0].           (2)
When the expected increase in the mutation rate (k) is 2 (2-fold increase 
of the mutations), then according to Eq. (2):  
 N = 12 / s × m0              (3)
Therefore, the sample size (N), which is necessary to detect a doubling 
(= 2-fold increase) of the mutation rate varies considerably (Table 3), depending 
upon  the  mutation  detection method used, from 120 for minisatellite loci to 
1 200 000 for protein-coding genes. According to these calculations minisatellites 
seem to be a superior method for detecting new mutations in the human 
genome.
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Table 3. Minimal sample size (N) for detecting a 2-fold increase in the mutation rate 
[Eq.(3)].
Study system 
Mean spontaneous  
mutation rate/locus 
(m0) 
Minimal  
sample size  
(N)1 
Protein-coding 
genes 
10-5 - 10-6 120 000 - 1 200 000 
Microsatellites 10-3 - 10-4 1 200 - 12 000 
Minisatellites 10-2 120 
In these calculations, s = 20 in each study system. 
1Minimal sample size (N) contains an equal number of studied case and control off-
spring, e.g., 60 case offspring and 60 control offspring in the case of minisatellite loci. 
2.5.2 Future perspectives
New molecular biology methods of revealing genetic damage in exposed human 
populations are needed in genetic risk assessment in the future. There is need for 
the more complete, efﬁcient, and automated genetic screening of offspring. This 
could perhaps be achieved by using automated DNA sequencing or ﬂuorescent 
in situ hybridization (FISH) methods. Since a single ejaculate of semen can 
contain 108 or more sperm, they are ideal monitors for the effects of radiation 
and other mutagens. They provide, in principle, a virtually limitless source of 
new mutant molecules derived from a given donor. Minisatellite mutations have 
already been explored from individual sperm cells using the SP-PCR method 
(see 2.3.2), but application of existing and the further development of individual 
sperm assays is needed. Unfortunately, human oocytes are not readily obtainable 
and thus the possibilities of obtaining genetic information directly from human 
oogonia or oocytes are minimal. Therefore, pedigrees remain the only source of 
maternal mutations. 
Maternal mutations may be studied by minisatellite loci thus minimizing 
the number of offspring to be examined. However, the extensive amount of 
minisatellite (usually noncoding) DNA in eukaryotic genomes is a puzzle for 
molecular evolutionists. Since noncoding DNA has already been shown to affect 
transcription and protein binding at the RNA level, it may have a broad-ranging 
control function that has not yet been discovered. Noncoding DNA must have been 
maintained in evolution because in some (so far unknown) way, it is essential for 
cell survival. A challenge in the future of human genetics is to distinguish neutral 
variation in the human genome from functionally relevant DNA variation that 
inﬂuences individual differences in human biology.
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In addition, further research and new methods are demanded in order 
to reveal the molecular mechanisms and pathways included in minisatellite 
mutagenesis as well as in other radiation-induced genetic damage. The actual 
nature of radiation-induced mutations has been poorly studied. It is known that a 
number of radiation-induced mutations are deletions, but very few loci have been 
investigated so far. Further work is required to examine a number of loci at which 
induced dominant mutations are frequent. They may help to show why some loci 
are highly mutable, while others seem to be completely immutable (Kohn and 
Melvold 1976; Arndt and Hwa 2004). Analyses of the effects of the genes known to 
play important roles in DNA turnover and their inﬂuence on recombination hot-
spots rates and proﬁles using knockout mice should help deﬁning the regulators of 
minisatellite instability. Yeast models have shown to be promising, but ultimately 
a manipulable mammalian model will be needed. Major challenges will be 
to understand the nature of the hypersensitivity of minisatellites to ionising 
radiation as well as the subsequent heritable instability. 
2.6 Ionising radiation
2.6.1 Background
Humans are exposed throughout life to low-level ionising radiation from natural 
sources. This radiation comes from outer space (cosmic rays) and from radioactive 
substances in the earth’s crust, (the most important ones are 238U, 235U, and 232Th). 
In Finland, most natural exposure is due to indoor radon (222Rn), a gas from 
the earth’s crust. Radon gas, however, does not cause exposure of the gonads. 
The human body (muscles, bones, and other tissues) contain trace amounts of 
naturally occurring radioactive isotopes (the most important is 40K). In addition 
to radiation from natural sources, most people receive additional exposure from 
manmade sources. These manmade sources consist mainly of medical radiation, 
but also commercial and industrial activities make their contribution to the 
total radiation exposure of humans. Radiation protection standards assume that 
radiation doses above natural background doses cause additional health risks, 
notably an increase in the induction of cancers. The increase in cancer incidence 
is assumed to be proportional to the additional doses. 
2.6.2 Radiation quantities
The biological effects of ionising radiation are primary due to its ability to ionise 
the material in the cells that make up the body’s tissues. Each discrete photon 
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or particle of ionising radiation has enough energy to knock electrons out of 
atoms and to break chemical bonds in the molecules from which human tissues 
are built. In general, radiation protection evaluates alpha (a)-, beta (b)-, gamma 
(g)-, X-rays, and neutrons. 
For radiation risk assessment, the health effects of a- and b-ray exposure 
appear only when a- or b-emitting materials are ingested or inhaled (i.e., internal 
exposure). Alpha (a) rays consist of posi-tively charged particles formed by two 
protons and two neutrons (= a nucleus of helium). Alpha rays are produced by 
spontaneous decay of certain radioactive isotopes (e.g., 226Ra, 239Pu, 240Pu, 234U, 
235U, 238U, and 222Rn). Because of its large mass and positive charge, a a-ray can 
usually pass only a short distance in water (µms) or air (<40 mm) and thus a 
single piece of paper or human skin can stop a-rays effectively. The beta (b) ray 
is a particle ray consisting of a fast electron (i.e., a negative charge) whose mass 
is about 1/2000 of the mass of a proton or neutron. Beta rays are produced by 
the spontaneous decay of certain radioactive isotopes (e.g., 3H, 14C, 32P, and 90Sr). 
Depending on its energy (= speed), a b-ray can travel between <0.1 mm and <10 
mm (3H and 32P) in water and up to 10 m in air. In general, a few mm thick sheet 
of aluminium will stop b-radiation. 
Much more important than a- and b-rays in assessing the health effects of 
radiation are g- and X-rays as well as neutrons. Gamma (g) rays are electromagnetic 
waves similar to visible light, but the wavelength of g-rays is much shorter (and 
their energy is far higher) than that of ultraviolet light. Gamma rays are produced 
following the spontaneous decay of certain radioactive isotopes (e.g., 60Co and 
137Cs). As a 60Co g-ray can penetrate deeply into the human body, it has been 
widely used for cancer radiotherapy. Gamma rays can be stopped by thick walls 
of concrete or lead. X–rays have the same characteristics as g-rays, although 
they are produced in a different way. When high-speed electrons hit metals, the 
electrons are stopped and energy is released in the form of an electromagnetic 
wave. X-rays consist of a mixture of different wavelengths, whereas g-ray energy 
has a ﬁxed value (or two) characteristic to the radioactive material. Neutron 
particles are released following nuclear ﬁssion (splitting of an atomic nucleus 
producing large amounts of energy) of uranium or plutonium. Neutrons are 
uncharged particles and they do not produce ionisation directly, therefore they 
do not damage cells. However, their interaction with atoms can give rise to 
a-, b-, or g-rays which then produce ionisation. Since the human body contains 
large amounts of hydrogen (70% of human body constitutes of water molecules), 
ionisation can take place when neutrons hit the nucleus of hydrogen, i.e., a proton 
that is positively charged. Neutrons are penetrating and can only be stopped 
by thick masses of concrete, water, or parafﬁn. At equivalent absorbed doses, 
neutrons can cause more severe damage to the body than g-rays. In male mice, 
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ﬁssion neutrons have been shown to be about 23 times more effective mutation 
inducers than g-rays (Batchelor et al. 1966).
Several different dose estimates are needed in the assessment of radiation-
induced risks in humans. The absorbed dose (D) of ionising radiation is the 
amount of energy absorbed/unit mass within the target (cell, tissue, organ, or 
human body). The unit of the absorbed dose is gray (Gy), which is deﬁned as 1 J/kg. 
Even though 1 J/kg is a minor amount of energy, it is a high radiation dose because 
the biological effect of radiation is not based on the heating of tissue but on the 
break-up of important chemical structures. The basic assumption in radiation 
protection is that the harmful effects of ionising radiation are fundamentally 
related to the absorbed dose. The dose rate expresses the absorbed dose in a 
unit of time. The most used unit for a dose rate is Gy/h. The unit of the dose rate 
of the effective dose is Sv/h. The dose rate from natural background radiation 
is 0.04–0.3 µSv/h. Equivalent dose (H) describes the health effects of ionising 
radiation. It depends on the absorbed dose and the quality and energy of the 
radiation. The equivalent dose can be obtained by multiplying the absorbed dose 
with the weighting factor (wR) for a particular radiation type. X-, g-, and b-rays 
have a wR of 1. Depending on their energy, neutrons have wR of 2.5–10 (even 20). 
The highest wR of 20 is used for a-particles. The unit of the equivalent dose is 
sievert (Sv). The concept of effective dose (E) (ICRP 60, 1991) is used to describe 
the total health effects of radiation doses on different organs or tissues. The 
effective dose can be obtained by multiplying the equivalent dose for each organ 
with the weighting factor (wT) for that particular organ. The whole body has wT 
of 1.00. The lowest wT of 0.01 is used for skin and bone surfaces. Human gonads 
have the wT of 0.20. The unit of the effective dose is also the sievert (Sv). The 
doubling dose (DD) is the radiation dose required to produce as many mutations 
as those occurring spontaneously in one generation (see 2.9.2). The genetically 
signiﬁcant dose is the gonadal dose which, if received by every member of the 
population, would be expected to produce the same total genetic effect on the 
population as the individual doses actually received. An acute dose is a large 
radiation dose (>1 Gy) to the whole body delivered during a short period of time 
(few days at most). An acute dose can cause clearly identiﬁable symptoms in 
blood-forming organs and the gastrointestinal tract. A chronic dose is a relatively 
small amount of radiation received over a long period of time. In chronic exposure 
the human body has time to repair damage and therefore, chronic/low-dose-rate 
irradiation is only about one-third as effective in mutation induction as acute/
high-dose-rate exposure. 
Linear energy transfer and relative biological effectiveness are also important 
concepts in radiation risk assessment. Linear energy transfer (LET) indicates the 
energy deposited in matter along the track, i.e., the frequency of ionisations. LET 
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can differ considerably between different radiation types. In general, the larger 
the mass or charge of the particle or amplitude of electromagnetic radiation, the 
greater the LET. The relative biological effectiveness (RBE) can be obtained by 
dividing the dose from reference radiation (e.g., g- or X-rays) by the dose from 
test radiation, which causes the same effect. Thus, RBE gives the ratio of the 
effectiveness/unit dose. RBE describes the ability of a given type of radiation 
to induce different biological endpoints, such as DNA damage, mutations, cell 
death, chromosomal damage, and cancer. The RBE is often different for acute, 
single exposure and for protracted or fractionated exposure. RBE can also vary 
depending on the endpoint chosen for examination.
2.6.3 Biological effects of ionising radiation on humans
The biological effects of ionising radiation are determined in terms of their 
effect on living cells. The target for radiation action is the entire human genome. 
Therefore, different genomic regions have equal initial probabilities of having 
radiation-induced biological effects, e.g., mutations. Radiation-induced biological 
effects are initialized by the random deposition of energy in the cells, causing the 
high-energy ionisation of atoms. Ionisation may affect DNA directly or indirectly 
(BEIR V, 1990). Direct effects arise from energy deposited directly on the DNA 
molecule. Ionising radiation induces base damage, single- and double-strand 
DNA breaks (SSBs and DSBs), and DNA-protein cross-links. Different types of 
mutations (see 2.6.4) might arise, as well as more severe forms of DNA damage, 
which prevent subsequent replication of the genome. In indirect effects, ionisation 
in other molecules (mostly water molecules) leads to the formation of reactive 
molecules (free radicals), which in turn attack the DNA. 
Different defence mechanisms have been developed against these above-
mentioned DNA attacks. The human body has defence mechanisms against 
damage induced by radiation as well as by chemicals. DNA damage is mostly 
efﬁciently repaired by cellular (DNA) repair processes. The ﬁnal yield of mutations 
depends on the types of damage initially induced and on the efﬁciency of DNA 
repair processes. In a harmless situation, cells may be undamaged by the dose. 
However, even low radiation doses can damage or alter the DNA of irradiated 
cells. After the damage, either the damaged cells are repaired correctly and 
operate normally or they are repaired incorrectly and operate abnormally, thus 
resulting in biophysical changes (e.g., cancer). High radiation doses tend to kill 
cells by apoptotic or reproductive death and thus result in no residual damage. 
The biological effects of ionising radiation are of particular concern in the case 
of rapidly dividing embryo/foetus cells causing growth retardation, small head/
brain size, mental retardation, childhood cancer, and even foetal death. Ionising 
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radiation can have different biological effects on humans depending on the type 
and length of radiation exposure. The biological changes may be manifested 
as medical symptoms that can be classiﬁed into deterministic or stochastic 
effects. 
Of these above-mentioned radiation effects, the deterministic effects are 
based on extensive cell death. When only a few cells die, new cells replace them. 
However, when the radiation dose increases, a point will be reached where a 
sufﬁcient number of cells are killed to affect the overall operation of the organ. 
The different types of radiation damage resulting from the loss of organ function 
are known as deterministic effects. Clinically observable deterministic effects, e.g., 
skin reddening and burning, radiation sickness, radiation pneumonitis, sterility 
(temporary or permanent), foetal damage and, cataracts, occur days to months, 
even several years (cataracts) after an acute radiation dose. Deterministic effects 
are most often seen in cases of high doses of radiation delivered over a short 
period of time (i.e., in the case of acute exposure in radiation accidents or radiation 
therapy) and they can always be connected with certain exposure. Deterministic 
effects occur only at doses above a certain threshold dose level. If the radiation 
dose is below this threshold dose level deterministic effects do not occur, but if 
the dose exceeds the threshold, these effects will certainly appear. The severity of 
deterministic effects increases sharply with increasing dose. Moreover, the period 
over which the dose was received has an effect on the severity of deterministic 
effect. If the dose is received over several weeks rather than all at once, the 
threshold dose at which the effect occurs increases considerably (usually by about 
100%) and the deterministic effect will be smaller. The effect of a radiation dose 
on a particular person depends on biological factors (e.g., age and general health) 
as well as on chemical factors (e.g., the amount of oxygen present in tissue). 
Therefore, in any population there will be a range of sensitivity to radiation. 
Hence, the threshold dose in a given tissue will be reached at lower doses in more 
sensitive individuals. However, individual sensitivity has only limited impact on 
deterministic effects. As the dose increases more individuals will show the effect, 
up to a dose above which all exposed people will show the effect. 
Not all radiation effects are deterministic effects as sometimes the radiation 
does not kill the cell but alters it in some way. In most cases, this alteration will 
not affect the cell signiﬁcantly and there will be no observable effect. However, 
the cell may lose its ability to reproduce or there is a possibility that the injury 
might affect the control system of the cell. The effects of ionising radiation, which 
rely on chance, are called stochastic effects. These may be somatic (e.g., cancer) 
or hereditary effects (see 2.8.). They are based on DNA damage occurring after 
a long latency period (usually between 5-20 years) following radiation exposure. 
Hereditary effects and the development of cancer are the primary health concerns 
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attributed to radiation exposure. Any amount of radiation may pose a risk of 
causing cancer and hereditary effects. This risk is higher for higher radiation 
exposure. A linear-no-threshold (LNT) dose response relationship is used to 
describe the relationship between a radiation dose and the occurrence of cancer. 
This dose response model suggests that any increase in dose, no matter how small, 
results in an increase in risk. The likelihood of cancer occurring after radiation 
exposure is greater than a hereditary effect. For low levels of radiation exposure, 
the biological effects are so small that they may not be detected. For instance, 
it is not known how many cases of cancer are caused by natural background 
radiation. Stochastic effects are statistical effects based on genetic change in 
one exposed, surviving cell. Unlike deterministic effects, the amount of radiation 
exposure does not change the severity of the stochastic effect, but it does alter 
the chance of getting it. Thus, low radiation doses are also capable of inducing 
stochastic effects and the probability of stochastic effects is assumed to be linearly 
proportional to the dose without a minimum threshold dose. The total risk to an 
individual is determined by the cumulative radiation dose received during his/
her whole lifetime and thus stochastic effects cannot usually be connected with 
a certain radiation exposure. 
Currently, the human health risks associated with radiation exposure 
are based primarily on the assumption that the detrimental effects of radiation 
occur in irradiated cells and the biological effects of ionising radiation have been 
explained by the target theory. According to this theory, the critical target of 
radiation is the DNA molecule in the exposed cell. DNA damage occurs during 
or very shortly after irradiation of the nuclei in target cells. The radiation-
induced changes are thought to be ﬁxed already in the ﬁrst cell division following 
the radiation exposure and the health effects are considered to result as a 
consequence of the clonal proliferation of cells carrying mutations in speciﬁc 
genes, causing hereditary effects (see 2.8.) or cancer. 
These basic assumptions have recently been challenged by a growing 
research area based on the assumption that DNA is not the only target of 
radiation exposure. These radiation-induced non-targeted and delayed effects 
do not require direct radiation exposure and are particularly signiﬁcant at 
low radiation doses. These effects include genomic instability and bystander 
effects. 
In genomic instability (Kadhim et al. 1992; Morgan et al. 1996; Ullrich and 
Ponnaiya 1998; Wright 1998; Little 2000; Morgan 2003a, b), it has been observed 
that the progeny of irradiated cells show the occurrence of new mutations and/or 
new chromosomal aberrations or other genomic damage for many generations. 
The affected progeny also demonstrate a high level of lethal mutation, which 
may be measured as delayed reproductive cell death and/or delayed apoptosis. 
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These non-clonal, delayed effects occur in cells that were not exposed to radiation. 
Even very low doses of radiation are capable of inducing genomic instability 
and there is no linear dose response or dose rate effect. Genomic instability is 
induced both by high-LET and low-LET radiation, but not all cell lines show 
this effect. Animal studies indicate that some mouse strains are genetically 
more susceptible to the induction of genomic instability than others are. These 
mouse strains also show a higher susceptibility to radiation-induced malignancy. 
Genomic defects in the progeny are too common to result from a mutation in one 
gene and existing data suggests that stable non-mutational changes, epigenetic 
mechanisms and increased oxidative stress may play a role in radiation-induced 
genomic instability.
Moreover, in the bystander effect (Nagasawa and Little 1992; Prise et al. 
1998; Belyakov et al. 2001; Bonner 2003; Morgan 2003a, b), mutations, changes 
in gene expression, and apoptosis are seen in cells that were not directly hit 
by radiation but were nearby. A bystander effect can be induced in unexposed 
neighbour cells by irradiated single cells through cell-to-cell communication 
(inhibition of cell communication prevents bystander effect) or via a culture 
medium in which irradiated cells have been grown earlier (‘clastogenic factors’). 
The irradiation of cellular cytoplasm with either a single or an exact number of 
alpha particles has been shown to result in gene mutation in the nucleus of the 
cell. The induced mutations are point mutations instead of deletions, which is 
the form of damage usually seen after radiation exposure (see 2.6.4). It has been 
proposed that the bystander response is the initiating event in radiation-induced 
genomic instability (Morgan 2003c). It is likely that bystander effect is the 
main, but not necessarily the only, trigger of genomic instability. The bystander 
effect and genomic instability may be important modiﬁers of radiation response 
in the low dose region. Radiation-induced genomic instability and bystander 
effects may be inﬂammatory-type responses to radiation and they pose new 
challenges to evaluating the risk(s) associated with radiation exposure. The 
genomic instability and bystander endpoints are both transmissible (mutational) 
and non-transmissible (lethal). The balance of these in different cellular systems 
may lead either to an increased or decreased risk. Some scientists indeed argue 
that these non-targeted radiation effects are in fact part of the adaptive response 
to ionising radiation.
2.6.4 Radiation induced mutations
Ionising radiation can penetrate cells and create ions in the cell contents. These, 
in turn, can cause permanent alterations (mutations) in DNA. These are ‘direct’ 
mutations that have a linear dose response (Figure 3). Radiation-induced genomic 
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instability and bystander effects may cause ‘indirect’ mutations with no linear 
dose response (Figure 3). It has been speculated that these ‘indirect’ mutations are 
most important at very low doses of radiation exposure. In addition to radiation 
dose also the nature of the radiation exposure has an impact on the radiation 
mutagenesis. In the mouse, at the experimental doses used, it has been shown 
that chronic radiation is only about 1/3 as effective in producing mutations as 
acutely delivered radiation (Russell 1963). 
          Number of mutations 
                  ‘direct’ mutations 
                  ‘indirect’ mutations 
            
                          Radiation dose 
Figure 3. Radiation-induced mutations.
It has long been known that ionising radiation induces both somatic and 
germinal mutations, and several mammalian cell mutational systems have been 
developed for studying chemical and radiation mutagenesis (Hsie et al. 1979; 
Moore et al. 1987). These include the endogenous hypoxanthine-guanine phosph
oribosyltransferase (hprt), adenine phosphoribosyl transferase (aprt), thymidine 
kinase (tk), and the transgenic xanthine guanine phosphoribosyl transferase 
(gpt) genes. Various types of radiation-induced changes are broadly similar 
to those occurring naturally, e.g., point mutations, small and large deletions, 
complex rearrangements, etc. However, in well-studied experimental systems, 
most (e.g., 70-90% at hprt in CHO cells, Sankaranarayanan 1991a) radiation-
induced mutations are recessive and due to DNA deletions. Radiation-induced 
mutations are often deletions that include not only a single gene, but also adjacent 
genomic regions, i.e., they are multilocus deletions (Sankaranarayanan 1991a, b; 
Thacker 1992). It can be presumed that they almost invariably cause loss-of-
function which, in the case of dominant genes, occurs through haploinsufﬁciency 
(see 2.3.1.). The conclusions from molecular studies into the nature of radiation-
induced mutations in mammalian (including human) somatic cells are also the 
same since most radiation-induced mutations are DNA deletions or due to other 
gross changes. However, the actual proportion of these mutations may vary with 
the test system and the locus under consideration.
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Induction and recovery of these radiation-induced deletions can be 
interpreted on the basis of the current knowledge about DNA organization and 
functions in cells. Gene deletions require the occurrence of two DSBs in the 
DNA. There is evidence that the break points of radiation-induced deletions in 
the hprt gene of hamster cells are clustered (Morgan et al. 1990; Thacker et al. 
1990). There are also hotspots for radiation-induced breaks in the chromosomes of 
blood lymphocytes of radiotherapy patients (Barrios et al. 1989; Holmquist 1992). 
These hotspots are in T-bands, which are very rich in both GC and Alu sequences 
(Holmquist 1992), suggesting that at least some radiation-induced deletions may 
arise by mechanisms similar to those inferred for naturally-occurring deletions 
mediated by Alu sequences. However, there are few mechanistic similarities 
between spontaneous and radiation-induced mutations, particularly for deletions. 
This is not unexpected, since ionising radiation produces mutations by the 
random deposition of energy in the cell, whereas spontaneous mutations arise 
through speciﬁc mechanisms. 
Among radiation-induced mutations, point mutations constitute a small 
minority group with the exception of the bystander effect where the induced 
mutations constitute of point mutations. The low proportion of point mutations 
in the radiation-induced mutations is not easily explained. Using cultured 
mammalian cells it was shown that base substitutions are induced by ionising 
radiation, although multilocus deletions tend to predominate over point mutations 
in late cell generations. The detected base substitutions are usually those resulting 
in an inactive protein. Particularly in classic mouse studies, many substitutions 
remain undetected. These are likely to have effects that are more subtle than 
simple loss-of-function. 
If human germ cell responses are similar as in the experimental studies, 
recessive deletion mutations will accumulate in the gene pool because they can 
be eliminated only when they are homozygous. As close inbreeding is exceptional 
in human populations nowadays, homozygosity for induced recessives is rare. 
Therefore, an assessment of the overall adverse health effects of induced recessives 
in the heterozygous condition is needed.
2.7 Naturally occurring hereditary diseases in man
2.7.1 Background 
Naturally occurring hereditary diseases have been classically divided into 
Mendelian (or single gene) diseases, chromosomal diseases, and multifactorial 
diseases. The Human Genome Project has provided knowledge of the molecular 
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aspects of naturally occurring human hereditary diseases and the mechanisms 
of their origin. The identiﬁcation of radiation-induced hereditary abnormalities 
in the human population is complicated by the quite high normal (background) 
incidence of such abnormalities. Various genetic and environmental factors 
underlie naturally occurring human diseases and the relative importance of these 
factors in the pathogenesis of different human diseases varies. Genetic factors 
dominate in Mendelian diseases and constitutional chromosomal anomalies; 
on the other end of the disease spectrum, environmental factors dominate 
in infectious diseases. Both genetic and environmental factors have a strong 
impact on the multifactorial diseases. Besides these classical disease types, 
new mechanisms of gene regulation and hereditary diseases have lately been 
detected. These new mechanisms include genomic imprinting, uniparental 
disomy, sytoplasmic inheritance, expansion of alleles, and mosaicism (UNSCEAR 
2001). The effect of radiation on these new mechanisms is insufﬁciently known 
and thus they are not yet included in the assessment of radiation-induced 
hereditary risks.
2.7.2 Mendelian diseases
Mendelian diseases are also called single gene diseases because they are due to 
mutations in single genes showing predictable pattern of inheritance. There are ﬁve 
types of Mendelian pedigree patterns: autosomal dominant, autosomal recessive, 
X-linked dominant, X-linked recessive, and Y-linked. A disease is dominant if it 
manifests in the heterozygote and recessive if it manifests only in the homozygote. 
In addition to Mendelian diseases, genetic diseases in humans may be due to 
mitochondrial inheritance, which gives rise to a recognizable matrilinear pedigree 
pattern. Current estimates indicate that about 2.4% of children born alive are 
afﬂicted by one or another Mendelian disease (Sankaranarayanan 1998). Over 
15 600 Mendelian disease genes or phenotypes have been established in the 
On-Line Mendelian Inheritance in Man (OMIM) Statistics (McKusick 2001) 
(Table 4). For many of these genes, extensive information is available, including 
sequence organization, the nature and function of the gene product, and the 
diseases associated with mutations in them.
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Table 4. Number of entries in On-Line Mendelian Inheritance in Man (OMIM) statistics 
(McKusick 2001) (November 11, 2004) (http://www3.ncbi.nlm.nih.gov/Omim/mimstats.
html).
 
Gene with known sequence 9 397 416  48  37    9 895 
 
Gene with known sequence   358  38   0   0      396 
and phenotype 
 
Phenotype description, 1 483 136   1  26    1 646 
molecular basis known 
 
Mendelian phenotype or locus, 1 297 132   4   0    1 433 
molecular basis unknown 
 
Other, mainly phenotypes with  2 173 154   2   0    2 329 
suspected Mendelian basis 
Total                                                    14 704             876                  55                     63                  15 704 
 
            Auto-               somal 
    X- 
     linked 
   Y- 
    linked 
Mito- 
chondrial Total 
When Mendelian genes and their function became better known, the 
classical ‘One mutation, one disease’ concept turned out to be too simplistic. Not 
all individuals carrying the mutant gene always express the mutant phenotype 
(variable penetrance) or are affected to the same degree (variable expressivity). 
Even in simple Mendelian diseases, mutations in the same gene may cause 
different phenotypes (allelic heterogeneity) (e.g., Charcot-Marie-Tooth disease 
and cystic ﬁbrosis). Mutations in different genes can result in the same or 
nearly the same phenotypes (non-allelic heterogeneity or genetic heterogeneity) 
(e.g., Osteogenesis imperfecta and Ehlers-Danlos syndrome type VII). Identical 
mutations have also been reported to cause large differences in clinical severity 
(e.g., sickle-cell anaemia and cystic ﬁbrosis).
2.7.3 Chromosomal diseases
Chromosomal diseases are caused by structural or numerical chromosomal 
abnormalities [e.g., partial deletion of 5p: cri-du-chat -syndrome (OMIM 123 450); 
trisomy for chromosome 21: Down syndrome (OMIM 190 685)]. Chromosome 
mutations, such as deletions and translocations, will usually lead to early 
fetal loss if they are unbalanced. Various chromosomal diseases are known 
in the human population and about 0.4% of children born alive are afﬂicted 
with detectable chromosomal diseases (UNSCEAR 2001). The microdeletion 
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syndromes (contiguous deletion syndromes) are conditions resulting from 
deletions of multiple, often functionally unrelated, yet physically contiguous loci. 
True microdeletion syndromes are caused by the haploinsufﬁciency of several 
loci. These loci are compatible with viability in heterozygous condition. They are 
identiﬁed clinically through a characteristic association of unusual appearance 
and defective organ development (e.g., Langer-Giedion syndrome, OMIM 150230). 
Mental and growth retardation are often prominent features. 
2.7.4 Multifactorial diseases
Multifactorial diseases are common conditions (e.g., cleft lip, cleft palate, and 
neural tube defects) caused by complex interactions between genetic and 
environmental factors. They have a genetic component and they tend to cluster 
in families, but the inheritance pattern is not a simple Mendelian one. Most of 
the common diseases with onset predominantly in adults (e.g., diabetes mellitus, 
coronary hearth disease, allergy, asthma, most cancers, etc.) are also multifactorial 
diseases. The multifactorial diseases constitute the predominant load of genetic 
diseases, as at least 71% of children born alive will have multifactorial diseases 
[i.e., 6% congenital abnormalities (Czeizel and Sankaranarayanan 1984) and 
65% common chronic diseases (Czeizel et al. 1988)]. Because of their high 
prevalence, they contribute very substantially to morbidity and mortality in 
human populations.
In multifactorial diseases the risk to ﬁrst-degree relatives is much less than 
what is known for Mendelian diseases. In the multifactorial threshold model, it 
is assumed that all genetic and environmental causes can be combined into a 
single continuous variable called liability. Numerous genetic and environmental 
factors act additively, each contributing a small amount of liability and thus, its 
distribution is normal (Gaussian). Affected individuals are those whose liability 
exceeds a certain threshold. This threshold is exceeded by a larger proportion 
of population consisting of relatives of affected individuals than of the general 
population, i.e., the disease prevalence is higher among relatives of affected 
individuals than in the general population
2.7.5 Spontaneous mutation rates in humans
Mutagenic products of metabolism and the intrinsic instability of DNA (e.g., 
deamination, depurination, depyrimination, endogenous methylation, oxygen 
metabolism) can cause spontaneous damage to DNA. This leads in some cases to 
various types of spontaneous mutation (see 2.3.1) through errors in DNA repair, 
replication, and recombination processes (Ames 1989, Smith 1992). In general, the 
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mutation rate of a given gene is a function of the size and organization of the gene, 
the mechanisms involved, and the number of mutational sites. Most spontaneous 
mutations arise as a consequence of DNA replication errors. Therefore, the male 
germline has a higher mutation rate than the female germline due to continual 
post-pubertal mitotic processes in the male (Hurst and Ellegren 1998) (see 2.4). 
The likelihood of germinal mutations increases in older males (paternal age 
effect) (Crow 1993, 1997, 1999; Vogel and Motulsky 1997). 
New mutations arise spontaneously in every generation. The frequency 
of diseases in the population is nevertheless believed to remain stable from one 
generation to the next (the equilibrium theory, see 2.3.3). In general, selection 
against autosomal dominant diseases is strong and thus they occur at similar 
frequencies in most populations. Most of them are due to new mutations. In 
autosomal recessive diseases selection pressures are much less efﬁcient. Most of 
the mutant genes are carried by asymptomatic heterotzygotes, and these diseases 
can appear at high frequencies in some isolated populations. 
Based on population studies, Vogel and Motulsky (1997) estimated that 
mutation rates for human genes vary from 10-4 to 10-6/gamete/generation. However, 
the spontaneous mutation rates of tandem repeat sequences are much higher 
than in human regular genes. Minisatellites have a spontaneous mutation rate 
of 10-1–10-2/locus/gamete/generation (Buard et al. 1998), and microsatellites 
have a spontaneous mutation rate of 10-2–10-4/locus/gamete/generation (Ellegren 
2000). 
2.8 Hereditary effects of radiation
2.8.1 Background
Hereditary effects of radiation are those effects observed in offspring born after 
one or both parents have been exposed to radiation before the child was conceived. 
Hereditary effects are the result of a mutation and chromosome structural 
changes produced in the reproductive cells of an exposed individual. They should 
not be confused with the possible harmful effects due to exposure of the mother 
during a pregnancy. Radiation exposure of the parents can lead to lethality, 
malformations, and genetic diseases in future generations. Hereditary effects 
may appear in the exposed person’s direct offspring, or several generations later, 
depending on whether the altered genes are dominant or recessive. Hereditary 
effects must be compatible with germ cell survival and division for transmission 
to the next generation, unless they are induced in non-dividing forms such as 
spermatozoa. As these effects can be caused only when ionising radiation reaches 
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the germ cells; penetrating X- or g-rays (see 2.6.2) can induce germline mutations 
from outside the body, but a- or b-particles of short track-length must be present in 
the gonads and very close to the nuclei of germ cells in order to have a hereditary 
effect. The cells of special concern in heredity risk assessment for radiation are 
those most at risk of accumulating genetic damage, namely spermatogonial stem 
cells and resting oocytes (Searle 1987). 
It has been shown that radiation increases the mutation rate in different 
organisms, including humans. However, many mechanisms (e.g., DNA repair, 
mutation ﬁxation, transmission of mutant-bearing germ cells, as well as 
zygotic, embryonic, and postnatal survival of mutants) inﬂuence the frequency 
of mutations observed. Hereditary mutations range from harmful to beneﬁcial. 
Humans evolved to the present state by utilizing beneﬁcial mutations. Mutations 
with damaging effects are gradually eliminated from a population by natural 
means, since affected individuals are less likely to have offspring than normal 
individuals are. The more severe the damage produced by a given mutation, 
the more rapidly it will be eliminated. Mildly damaging mutations may require 
several generations before they gradually disappear. As mutations in persons 
without offspring have no genetic effects, the genetically signiﬁcant dose of 
radiation to a population is markedly less than the total dose. The risk of 
hereditary effects caused by radiation is smaller (1.3%/Sv) than the risk of a 
lethal, radiation-induced cancer (10%/Sv in high, acute dose or 5%/Sv in low, 
chronic dose) (ICRP 1990). Therefore, the risk of a hereditary defect in humans 
has been estimated as 15/million births for a radiation dose of 1 mSv (UNSCEAR 
2001). This is small ﬁgure compared with the risk of a spontaneous hereditary 
defect in humans from all causes that is of the order of several percent (see 
2.7). As experimental data is not feasible for humans, results from mammalian 
mutagenesis experiments provide the most precise estimate of the induced 
mutation rate in germ cells of humans (UNSCEAR 2001). Thus, mammalian 
mutagenesis results have been used in an extrapolation of the genetic effects of 
radiation exposure in humans.
2.8.2 Mouse studies
The genetic effects of radiation have been extensively studied in a wide spectrum 
of biological systems (Sankaranarayanan 1982; DeMarini et al. 1989). The main 
purpose of mammalian mutagenesis experiments has been to elucidate those 
factors important in mutation induction in the germ cells of mammals as a model 
for humans. It is clear that the successful mutation test systems (e.g., 7-locus 
system and minisatellites) have been those in which the studied genes and their 
genomic loci were not essential for survival. In these cases, induced mutations 
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can be recovered and studied. Even viability-compatible changes may occur in 
regions that cannot be detected, so their phenotypes remain unknown. The least 
successful test systems, the histocompatibility (H)-loci in the mouse (Bailey and 
Kohn 1965; Kohn and Melvod 1976; Kohn et al. 1976) and ouabain resistance 
in mammalian somatic cells (Arlett et al. 1975; Thacker et al. 1978), are those 
in which the genes themselves are essential for survival and/or are located in 
gene-rich regions of the genome and for that reason cannot tolerate induced 
deletions. All the methods are effective in screening for mutations, although the 
differences in the number of offspring needed for screening reﬂect the relative 
ease with which offspring may be examined for different genetic endpoints. The 
7-locus test and minisatellites require the least investment of time and resources, 
followed by the dominant cataract test, the enzyme-activity assay, and ﬁnally 
the protein-charge assay.
2.8.2.1 Traditional studies
The traditional mouse study method, the speciﬁc-locus (7-locus) method was 
developed by Russell (1951). It is the most efﬁcient method of screening for 
transmitted germ cell mutations. It has provided virtually all experimental data 
on factors affecting the mutation rate in the germ cells of mam-mals. Brieﬂy, 
the method involves mating homozygous wild type treated or control mice with 
untreated tester stock mice, homozygous recessive at 7 marker loci: a (non-
agouti), b (brown), cch (chincilla), p (pink-eyed), d (dilute), s (piebald-spotting), 
and se (short ear), located in chromosomes 2, 4, 7, 7, 9, 14, and 9. Six of these 
loci control coat colour and the se locus affect the size of the external ear. 
The 7-locus method and its results in the mouse have been discussed in detail 
(Searle 1974; Selby 1981; Ehling and Favor 1984). Over a million animals were 
needed (over decades) to obtain meaningful results in the 7-locus method, 
nevertheless the results were difﬁcult to interpret. It was shown that different 
types of mutations differed widely in their sensitivity to radiation. Even among 
the small number (n = 7) of genes studied, there is more than a 30-fold difference 
in their observed radiation mutabilities, with the s locus being the most mutable 
and the a locus the least mutable (Russell and Russel 1959; Russell 1965). 
Doubling of the natural background mutation rate required radiation doses of 
0.1–2 Gy. Homozygosity tests uncovered the existence of recessive mutations or 
deletions in developmental genes, i.e., heterozygotes do not manifest the abnormal 
developmental phenotype (Rinchik and Russell 1990). Radiation dose, dose rate, 
dose fractionation, dose-fractionation interval, radiation quality, and germ cell 
stage affected the radiation-induced mutation rate. The consequences were 
minimised by allowing some time to elapse between irradiation and conception. 
Doses spread over a period of time (fractionated dose) produced a smaller effect 
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than if they were delivered all at once. The effects for a given dose were greater 
for the offspring of the irradiated male.
In addition to 7-locus test, a number of procedures have been developed to 
screen for induced dominant mutations in germ cells of the mouse. These include 
congenital malformations (Searle 1974; Kirk and Lyon 1982, 1984; Lyon and 
Renshaw 1988; Favor 1989), skeletal abnormalities (Ehling 1965, 1966, 1985; 
Selby and Selby 1977, 1978), cataracts (Kratochvilova and Ehling 1979), and 
growth retardation (Cattanach et al. 1993, 1996) as well as mutations that affect 
quantitative traits and ﬁtness (Green 1968). Procedures have also been developed 
to screen for protein-charge (Soares 1979; Johnson and Lewis 1981; Pretsch et 
al. 1982; Peters et al. 1986) or enzyme-activity mutations (Bishop and Feuers 
1982; Feuers et al. 1982) and thus provide methods to recover mutations with 
direct homology to human genes that can be characterised through biochemical 
methods. Mouse data support the view that radiation-induced, predominantly 
multi-locus deletions in different chromosomal regions are associated with growth 
retardation and dysmorphic features. Most of the mutational events scored are of 
the recessive loss-of-function type, involving the marker and several neighbour-
ing genes. Thus, induced mutations could be identiﬁed through the phenotype 
of the marker genes and recovered for further studies.
The mutability as determined by the various genetic endpoints differed. 
The mutation rates for recessive 7-locus alleles and enzyme-activity alleles 
were similar and greater than the mutation rates to dominant cataract and 
protein-charge alleles. The type of mutation event scored by a particular test 
can determine the mutability of the genetic endpoint screened. When the loss of 
a functional gene product can be scored in a particular mutation test, as in the 
recessive 7-locus and enzyme-activity tests, a wide spectrum of DNA alterations 
may result in a loss and a higher mutation rate is observed.
2.8.2.2 Minisatellite studies
Minisatellites (see 2.2.1) have been identiﬁed and characterized in various 
genomes. In particular, systematic isolation has identiﬁed minisatellites in the 
mouse, rat, and pig genomes. Unstable mouse minisatellites originally identiﬁed by 
DNA ﬁngerprinting are now known to consist of long arrays (0.5–16 kb in length) 
of short (4-6 bp) repeat units that are almost exclusively sequence-homogeneous 
with the longer arrays exhibiting the highest mutation rates (Kelly et al. 1991; 
Gibbs et al. 1993b; Bois et al. 1998, 2001). These properties distinguish these loci 
from true mouse minisatellites (0.5–10 kb, repeat size of 14–47 bp) (Kelly et al. 
1989), and therefore these shorter mouse repeat sequences have been renamed 
expanded simple tandem-repeat arrays (ESTRs) (Bois et al. 1998). Differing 
from human minisatellites, mouse ESTRs are not preferentially associated with 
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centromeres or telomeres. Rather they are mainly found at interstitial sites 
(Jeffreys et al. 1987). ESTRs are the most hypermutable sequences isolated in 
the mouse genome, with germline mutation rates as high as 13%/locus (Yauk et 
al. 2002). However, in sharp contrast to human minisatellite loci, most mouse 
minisatellite loci mutate at a rate below 10-3/gamete/generation and mainly by 
simple and intra-allelic mutation events, similar to those observed in human 
peripheral blood DNA (Bois et al. 2002). Unlike unstable human minisatellites, 
which mutate almost exclusively in the germline, mouse ESTRs show repeat 
instability in both germinal and somatic DNA. Therefore, there seems to be a 
fundamental difference between humans and mice in the turnover mechanisms 
at minisatellite loci and ionising radiation appears to induce instability at various 
types of hypermutable tandem-repeat arrays.
The hereditary effects of radiation have been studied experimentally using 
the mouse ESTRs. The probable selective neutrality of ESTR mutants should 
ensure that mutants are not lost prenatally. Several studies have shown that 
ionising radiation causes a signiﬁcant increase in the germline mutation rate at 
the mouse ESTR loci (Dubrova et al. 1993, 1998a, b, 2000; Sadamoto et al. 1994; 
Fan et al. 1995; Niwa et al. 1996; Niwa and Kominami 2001; Barber et al. 2002; 
Dubrova and Plumb 2002). Attempts to transfer minisatellite instability to mice 
using large transgenic constructs (~30 kb) containing human hypermutable loci 
have failed to recapitulate the complex recombination-based germline instability 
observed in humans (Bois et al. 1997; Buard et al. 2000). It is possible that the 
transgenic constructs used failed to provide the correct chromatin environment 
needed for human minisatellites associated with the ﬂanking recombination 
hotspots. However, more promising result has been obtained with microsatellite 
expansion of CGG repeat causing human fragile X syndrome. Baskaran et al. 
(2002) have generated transgenic mice lines that show a dramatic increase from 
26 to >300 repeats in three generations. Their results support a postzygotic 
mechanism for CGG expansion that is independent of a genomic imprinting 
effect.
In mouse minisatellite studies, results concerning the relative 
radiosensitivity of different stages of spermatogenesis have varied depending on 
the study design. Dubrova et al. (1993) conducted a pilot study to determine the 
inducibility of ESTR mutations in mouse germ cells by radiation. Male (101/
HY x C3H/SnY) F1-hybrid mice were given an acute exposure of 0.5 or 1 Gy of g-
radiation using 60Co and mated to untreated F1 females six weeks later. Paternal 
ESTR mutations at loci 33.6 and 33.15 appeared to be induced in spermatogonia 
and stem cells by low doses of ionising radiation, with an estimated doubling 
dose of 0.5 Gy. However, the frequency of observed mutations did not appear 
to increase linearly with radiation dose because the mutation frequencies in 
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exposed mice in relation to controls were 1.9 and 1.6 for mice irradiated with 
0.5 and 1 Gy. 
Conﬂicting results were obtained by Sadamoto et al. (1994) who investigated 
60Co gamma radiation-induced germline mutations at ESTR loci. In this study, 
male mice (C3H/HeN) were exposed to 3 Gy of g-rays and mated to female mice of 
strain C57BL/6N. The males were mated again with unirradiated female mice at 
different time intervals after irradiation to score minisatellite mutations at locus 
Ms6-hm (Pc-1) in different stages of spermatogenesis. Post-meiotic spermatids 
seemed to be much more sensitive to radiation-induced ESTR mutations than, 
e.g., spermatogonia and spermatozoa (paternal mutation frequencies were 28%, 
15%, and 13%, respectively). The induced mutation frequencies were too high 
to be accounted for by the direct action of radiation on the locus and therefore, 
no reliable relationship between radiation dose and mutation frequency was 
seen. The authors described a small but statistically signiﬁcant increase in the 
maternally derived Ms6-hm allele in addition to the paternally derived allele.
The experimental design of Sadamoto et al. (1994) was essentially repeated 
by Fan et al. (1995). They exposed male C3H/HeN mice to various doses (1, 2, 
or 3 Gy) of 60Co g-rays and mated them to unirradiated C57BL/6N female mice. 
The matings were done immediately, 3 weeks, or 11 weeks after irradiation for 
analysis of radiation effects on the spermatozoa, spermatid or spermatogonia 
stage germ cells. The spermatid stage was detected most sensitive to radiation 
and a statistically signiﬁcant dose response was observed. The mutation frequency 
of the paternal allele increased linearly up to 2 Gy where the curve reached a 
plateau. The doubling doses of the paternal allele of Ms6-hm were 6, 0.79, and 
6 Gy for the spermatozoa, spermatid and spermatogonia stages, respectively. 
Also these authors detected a small but statistically signiﬁcant increase in 
the maternally derived Ms6-hm (Pc-1) allele in addition to paternally derived 
allele.
As in the two previous studies, spermatid stage germ cells were observed 
to be the most sensitive to radiation also by Niwa et al. (1996). Male C3H/HeN 
mice were exposed to 252Cf radiation (35% g-rays and 65% neutrons) and mated 
to unirradiated C57BL/6N females immediately, 2 weeks, or 10 weeks after 
irradiation corresponding irradiation of spermatozoa, spermatid, or spermatogonia 
stage germ cells, respectively. Paternal mutations at minisatellite locus Ms6-hm 
increased to 18%, 26%, and 24% when spermatids were irradiated by 0.35, 0.7, 
and 1.02 Gy of 252Cf radiation, respectively.
Dubrova et al. (1998a) studied germline mutation induction at minisatellite 
loci MMS10, 33.15, Ms6-hm, and Hm-2. Male CBA/H mice were given whole-body 
acute X-ray irradiation of 0.5 and 1 Gy. Males were mated to untreated CBA/H 
females 3, 6, and 10 weeks after irradiation, corresponding induction of mutations 
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at these ESTR loci in pre- and post-meiotic stages of mouse spermatogenesis. 
The results showed a linear dose-effect relationship for mutations in pre-meiotic 
spermatogonia and stem cells, with a doubling dose of 0.33 Gy. There was no 
evidence for induced mutations in post-meiotic spermatids. The results could 
also be interpreted in such a way that the mutations result from damage 
accumulated in germ cells prior to meiosis. This does not necessarily indicate that 
the mutational events themselves occur pre-meiotically rather than later, e.g., in 
meiosis. Since meiotic stages were not included in this study, no ﬁrm conclusions 
could be drawn. Paternal irradiation did not affect the maternal mutation rate. 
These results were later repeated by using the mouse minisatellite loci Ms6-hm 
and Hm-2 (Dubrova et al. 1998b).
In their following mouse study Dubrova et al. (2000) gave a total whole-
body low-LET chronic g-irradiation of 0.5 and 1 Gy using a 60Co source. Also, 
whole-body high-LET chronic irradiation (0.125, 0.25, or 0.5 Gy) was performed 
using a 252Cf source (67% neutrons and 33% g-radiation). After irradiation 
male CBA/H mice were mated to untreated females of the same mouse strain 
10 weeks post-irradiation. The F1 mice generated were therefore conceived with 
sperm derived from irradiated stem cells. Radiation-inducted minisatellite 
mutations were scored at minisatellite loci MMS10, Ms6-hm, and Hm-2. Both 
types of radiation produced linear dose response curves for mutation of the 
paternal allele. The authors estimated the relative biological effectiveness 
(RBE) of neutrons as 3.36 (95% CI 1.30-5.41). They concluded that minisatellite 
mutation induction patterns were similar for both irradiations, indicating that 
the elevated mutation rate was independent of the ability of the cell to repair 
damage induced immediately or over a period of up to 100 hours. The paternal 
exposure had no effect on mutation rates of the maternal allele.
However, results by Niwa and Kominami (2001) revealed a hereditary 
risk to the maternally derived genome due to the paternal radiation exposure. 
They demonstrated a statistically signiﬁcant increase (from 9.8% to 20%) in 
the maternal allelic mutation rate in F1 mice born to at the spermatozoa stage 
irradiated male parents was demonstrated by Niwa and Kominami (2001). Partial 
body irradiation to the testicular portion was performed on male C3H/HeN 
mice. A total of 6 Gy of g-rays was delivered using a 60Co source. The irradiated 
males were mated to unirradiated females (C57BL/6N) immediately or 15-20 
weeks after exposure to assess the effect of spermatozoa or spermatogonial stem 
cell irradiation. Paternal minisatellite mutations at the Ms6-hm (Pc-1) locus 
increased from 8.4% to 22% and 19% when spermatozoa and spermatogonia 
stages were irradiated. The authors concluded that as a consequence of male 
(sperm) irradiation, genomic instability is triggered in zygotes and in embryos 
of subsequent developmental stages, which then induces untargeted mutations 
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at the paternally derived allele in cis and the maternally derived unirradiated 
allele in trans. 
More recently, both pre-and post-meiotic exposures were reported to 
increase mutation yield in two generations (Barber et al. 2002), suggesting that 
strains of mice may differ in stage susceptibility. Male CBA/H and C57BL/6 mice 
were given a 0.4 Gy whole-body chronic irradiation of ﬁssion neutrons by using a 
252Cf source. In addition, whole-body acute 2 and 1 Gy irradiation of X-rays was 
given to other CBA/H and BALB/c males. All males were mated to unirradiated 
females of the same inbred mouse strain; CBA/H males 3 and 6 weeks after 
irradiation and C57Bl and BALB/c males 6 weeks postirradiation. Minisatellite 
mutation rates were examined among F2 and F3 offspring at loci Ms6-hm and 
Hm-2. The authors demonstrated that rates of spontaneous mutations as well 
as radiation-induced trans-generational instability varied between three mouse 
strains examined (BALB/c >CBA/H >C57BL/6). Higher mutation rates did not 
correlate with allele length and they were possibly due to functional differences 
at cyclin-dependent kinase inhibitor 2a (Cdkn2a, OMIM 600 160) and DNA-
dependent protein kinase catalytic subunit (Prkdc, OMIM 600 899) genes in 
BALB/c. Barber et al. (2002) concluded that the persistence of elevated mutation 
rates in the germline of two consecutive generations excluded the possibility that 
transgenerational effects were caused by radiation-induced mutations at any 
speciﬁc set of genes (e.g., DNA-repair genes) in the exposed F0 male mice. The 
authors stated that signiﬁcantly increased mutation rates in the germline of both 
generations clearly implicated an epigenetic mechanism for the transgenerational 
minisatellite instability.
The frequency of induced mutation appear to be signiﬁcantly greater than 
the predicted frequency of radiation-induced DNA damage at a given minisatellite 
locus. The above-mentioned doubling (= 2-fold increase) of the minisatellite 
mutation rates at 0.5 Gy dose (Dubrova et al. 1993) is in discordance with the fact 
that at a 0.5 Gy dose only 50 double strand breaks (DSBs) have been shown to be 
generated/cell (Frankenberg-Schwager 1990). It is improbable that most of these 
breaks would have occurred in the few tandem repeats analysed since damage 
caused by ionising radiation appears random. Later estimation of doubling 
dose of 0.33 Gy by the same authors (Dubrova et al. 1998a, b) creates an even 
more unrealistic situation. This has led many investigators to conclude that the 
increased mutation rates observed at these ESTR loci are not necessarily the 
result of directly induced DNA damage at the speciﬁc loci but rather result from 
radiation-induced damage elsewhere in the genome or cell (Sadamoto et al. 1994; 
Fan et al. 1995; Dubrova et al. 1993, 1998a, b, 2000; Niwa and Kominami 2001; 
Barber et al. 2002; Yauk et al. 2002). The mechanism by which the repair of DSBs 
generates speciﬁc increases in tandem repeat instability can only be speculated. 
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Bois (2003) has described three possible effects, two in cis, and one in trans. 
One possibility is that DSBs generated in meiotic cells are by strand conversion 
quickly turned into Holliday junctions, which could then generate DSBs in the 
vicinity of, or within, tandem arrays. A second possibility could be that tandem 
repeats are particularly sensitive to long-range chromatin modiﬁcations such as 
change in DNA tension or relaxation subsequent to ionising radiation exposure. 
A third possibility is an effect in trans in which DSBs activate genomic defence 
mechanisms that could indirectly increase minisatellite instability. If ESTR 
mutations are non-targeted events, then there appears to be an indirect induction 
mechanism whereby radiation is sensed and in some way transduced into a signal 
that somehow destabilises tandem repeat loci. If correct, this would represent a 
completely novel mechanism for radiation mutagenesis.
2.8.3 Human studies
In a variety of experimental systems, the phenotypes of radiation-induced 
mutations in the speciﬁc genes were similar to those of spontaneous mutations. 
Even though animal studies have clearly shown a relationship between radiation 
exposure and hereditary effects, the real quantity of the hereditary effects in 
humans is so far unknown. Assessment of radiation-induced hereditary risks 
is a formidable task in the human population. Each of the human 30 000 genes 
can mutate in the germ
line and give rise to hereditary effects. Therefore, the spectrum of the possible 
effects is wide. The type and severity of radiation-induced hereditary effects 
can be highly different and there are still many open questions concerning 
hereditary effects of ionising radiation. Neither the extent to which a certain 
radiation dose increases the mutation frequency in the human population nor 
the health effects of this increase on the future generations are known. No direct 
evidence of radiation-induced hereditary effects has been detected in human 
populations – not even among the offspring of survivors of the atomic bombing 
of Hiroshima and Nagasaki (Neel et al. 1990, 1998; Otake et al. 1990; Byrne et 
al. 1998). Thus, radiation risk assessment is based on the general knowledge 
of human he-redity and on animal studies. It seems that humans are not as 
sensitive to hereditary effects as laboratory animals are (Neel et al. 1990). This 
may be due to strong negative selection in the critical periods during embryo 
and foetal development. 
In contrast to animal studies, most of the human genes in which induced 
mutations have been examined, do not seem to be non-essential for survival. 
Thus, the failure to ﬁnd induced germline mutations in humans is not due to 
the resistance of human genes to induced mutations but due to the structural 
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and functional constraints associated with their recoverability in live births 
(UNSCEAR 2001). It is difﬁcult to measure changes in the human mutation rate 
because the majority of mutations will not express themselves in an individual 
as they are in a heterozygous state. Moreover, most of the mutations that occur 
are minor (e.g., a less efﬁcient digestive system or a predisposition to a given 
disease) and therefore difﬁcult to measure. The situation becomes even more 
complicated by the fact that they are often also impossible to distinguish from 
conditions caused by other inﬂuences. Recent studies of minisatellite loci (see 
below) are conducted in non-essential genes, but they are difﬁcult to interpret 
because these mutations are perhaps induced by some indirect effects of radiation 
on these genes.
2.8.3.1 Hiroshima and Nagasaki
The most comprehensive study of heritable genetic effects following 
preconception irradiation in humans is that of the Japanese atomic bomb 
survivors. The main source of data is the Life Span Study (begun in 1950) of 
the survivors (n ~ 120 000) of the atomic bombings at Hiroshima and Nagasaki 
in Japan 1945. The atomic bomb survivors had a range of radiation doses of 
acute gamma and neutron irradiation. Their germinal doses varied between 360 
and 600 mSv (average ~ 400 mSv), and 1 500 parents had doses greater than 
1 Sv (Yoshimoto et al. 1990). However, nowadays the mean dose estimation of 
<200 mSv is used for this cohort (Pierce et al. 1996). The atomic bomb survivors 
showed a pattern of increasing mortality with an increasing dose for leukaemia 
and most solid cancers, with a signiﬁcant increase following acute doses in the 
range of 200–500 mSv. Signiﬁcantly increased cancer risk and a signiﬁcant dose 
response has been seen at low doses (<100 mSv) (Pierce et al. 1996). In addition, 
the incidence of myocardial infarctions has been shown to increase among 
younger, heavily exposed persons (Wong et al. 1993; Shimizu et al. 1999). 
The Hiroshima and Nagasaki cohort is ideal for studying hereditary risks 
at low radiation doses. To date those exposed to radiation during the bombings 
have had more than 80 000 children and tens of thousands of grandchildren and 
great grandchildren. The main focus has been direct assessment of the hereditary 
risks of exposure to the atomic bombs in the offspring of the survivors (Neel et al. 
1990, 1998; Otake et al. 1990; Yoshimoto et al. 1990; Little 1991, 1992). Neel et al. 
(1990) studied untoward pregnancy outcomes, deﬁned as a pregnancy terminating 
in a child with a major congenital malformation, stillborn, or neonatal deaths 
occurring during the ﬁrst two weeks of life. In addition, malignancies in the F1 
children with onset before the age of 20 years as well as mortality of live born 
infants exclusive of those resulting from malignant tumours through 26 years 
of age were examined. The frequency of sex-chromosomal aneuploids and the 
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balanced structural rearrangements of chromosomes were also studied among 
the offspring. Sex ratio shifts (indicative of damage to X-chromosome) were looked 
for among children of exposed mothers. The growth and development of the F1 
children as well as the frequency of mutations altering protein charge or function 
(electrophoretic variants due to point mutations) were examined. Untoward 
pregnancy outcomes, F1 mortality, and cancers are multifactorial traits and their 
responsiveness to an increase in mutation rate (as a result of radiation exposure) 
will depend on the magnitude of the genetic component. Neel et al. (1990) pointed 
out that the genetic component is quite small. Therefore the rates of induced 
genetic damage underlying these traits are expected to be small, and increases 
will be undetectable at the low radiation doses (<200 mSv) sustained by most of 
the survivors. The reason for the lack of signiﬁcant effects in sex-chromosomal 
aneuploidy is clear, as mouse studies have revealed that radiation is incapable of 
inducing chromosomal nondisjunction which is the principal basis for the origin 
of sex-chromosomal aneuploidy. Otake et al. (1990) detected that the frequency 
of untoward pregnancy outcomes increased unsigniﬁcantly with the combined 
(summed) parental dose. The authors estimated that the untoward pregnancy 
outcomes increased 0.00354 (±0.00343)/Sv.
Yoshimoto et al. (1990) determined cancer incidence prior to age 20 years 
for children born to atomic bomb survivors and a control group. Altogether, 43 
malignant tumours were ascertained in the 31 150 children whose one or both 
parents were exposed to >10 mSv of radiation (average conjoint gonadal exposure 
was 430 mSv). In a control groups consisting of total of 41 066 children, 49 
tumours were detected. Therefore, no increase in the malignancy of the children 
of exposed parents could be detected. Little (1991) did not detect an increased 
risk of childhood leukaemia among the children of atomic bomb survivors.
Studies of the rare electrophoretic variants of 30 proteins of blood plasma 
and erythrocytes and of deﬁciency variants of 11 erythrocyte enzymes showed no 
signiﬁcant differences between children of exposed parents and controls (Satoh 
et al. 1983). In 667 404 tests of children of exposed parents and in 466 881 tests 
of children of control parents, only 3 probable mutations were found in both 
groups. Null-enzyme mutants would be expected to be induced but unlikely to 
be found at the dose level received by most of the A-bomb survivors.
Medical studies of the offspring of Japanese atomic bomb survivors failed 
to demonstrate a clear excess of genetic diseases. No statistically demonstrable 
adverse effects of parental radiation exposure have been found among the 
offspring of survivors of the atomic bombing. However, this does not mean that 
the gonadal mutation frequency cannot be increased. It may be increased, but so 
slightly that it cannot be demonstrated with the methods used in a population 
of this size. 
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2.8.3.2 Chernobyl
The catastrophic explosion of reactor 4 at the Chernobyl nuclear power station 
on 26 April 1986 led to the accidental release of some 5 × 107 Ci of assorted 
radionuclides, which resulted in widespread pollution, particularly in areas of 
the former Soviet Union. The immediate health risk to the general population 
was from the emission of 1 × 107 Ci of short-lived 131I, resulting in a signiﬁcant 
thyroid dosage whose consequence was a substantial increase in the incidence of 
thyroid cancer among people exposed in childhood (Kazakov et al. 1992; Likhtarev 
et al. 1995; Stsjazhko et al. 1995; Astakhova et al. 1998). The dose response 
seemed to be linear and a signiﬁcant increase was seen even in children with 
an average dose of 50 mGy (Jacob et al. 1999). Long-term exposure has arisen 
mainly from environmental pollution with 137Cs, which has a half-life of 30 years. 
137Cs caused persistent ground contamination as well as entered the food chain. 
The biological consequences of chronic environmental 137Cs contamination for 
humans, including the effects of germline mutation, are unknown. A search for 
genetic effects associated with exposure from the Chernobyl fallout was conducted 
in the areas of the highest contamination (i.e., Belarus and Ukraine) and in a 
number of European countries. The study concentrated on congenital anomalies 
and other adverse reproduction outcomes. 
An increased frequency of Down syndrome was reported in West Berlin in 
January 1987 (Sperling et al. 1994). However, a causal relationship to Chernobyl 
radioactivity was later excluded, because the associated cumulative dose was 
so low in comparison with natural background (Burkart et al. 1997). In the 
Lothian region of Scotland there was a signiﬁcantly higher than expected 
incidence of Down syndroma cases in 1987 (Ramsay et al. 1991). However, this 
increase in Down syndroma cases could not be associated with the low levels 
of radioactive fallout (total deposition of 137Cs of 0.1–1.0 kBq/m2) reported in 
Lothian in May 1986. No evidence was seen for the incidence clustering chro-
mosomal syndromes registered in 19 birth defect registries in Europe from 
January 1986 to March 1987 (De Wals et al. 1988). There was no difference in 
the Down syndrome frequency between the study and control groups in Finland 
(Harjulehto et al. 1989; Harjulehto-Mervaala et al. 1992) and even a decreasing 
trend was revealed in Norway (Lie et al. 199). The analysis of selected anomalies 
(predominantly autosomal dominant and X-linked diseases of childhood onset 
and Down syndrome) did not reveal any measurable germinal mutagenic effects 
of the Chernobyl accident in Hungary (Czeizel et al. 1991). An alleged increase in 
the frequency of neural tube defects and anencephaly in several small hospital-
based series in Turkey (Mocan et al. 1990) was not conﬁrmed in larger and more 
representative series (Mocan et al. 1992). 
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A statistically signiﬁcant increase in spontaneous abortions with a dose of 
radiation was observed in Finland (Auvinen et al. 2001). However, the authors 
stated that the effect on spontaneous abortion should be interpreted with caution 
because of potential bias of confounding and because the effects of very low 
doses of radiation on the outcome of pregnancy are poorly known. The authors 
thought that the decrease in the live birth rate was probably not a biological 
effect of radiation, but more likely related to the public concerns of the fallout. 
No major effects on the outcome of pregnancy were seen in Sweden (Ericson 
and Källen 1994) or in Austria (Haeusler et al. 1992). A striking deviation 
from the linear model in early mortality rates was detected in West Germany 
immediately after the Chernobyl accident (Luning et al. 1989). A comprehensive 
review of Chernobyl studies stated that there was no consistent evidence for an 
increase in miscarriages, perinatal mortality, low birth weight, sex ratio shifts, 
or multiple births (Little 1993). However, there was evidence for an increase in 
induced abortions due to anxieties substantial enough to show a reduction in 
the total number of births. 
The results of these Chernobyl studies are inconsistent, clearly illustrating 
that the analysis of mortality and genetic diseases among the offspring of parents 
exposed to radiation is not a sensitive method for monitoring radiation-induced 
germline mutations in humans. Therefore, minisatellite loci have been considered 
to offer a new experimental approach to the evaluation of germline mutation 
induction in humans.
2.8.3.3 Minisatellite studies
The hereditary effects of the Chernobyl accident have been studied in several 
exposed populations. Minisatellite analysis was chosen for study objects in these 
Chernobyl studies as well as in some studies of the Hiroshima and Nagasaki 
atomic bomb survivor cohort as it is thus far the most promising method for 
detecting genetic effects in humans. This is because minisatellites are non-
essential for survival, have high spontaneous mutation frequencies, and are easy 
to detect. However, as it seems that radiation has no direct effect on minisatellite 
loci (effects are mediated by other systems that are themselves induced by 
the DNA damage) and as the biological signiﬁcance of these repeats is mostly 
unknown, the interpretation of minisatellite results is complicated. Conﬂicting 
results obtained in the studies of radiation-induced minisatellite mutations in 
humans (Table 5) do not make the interpretation any easier.
The ﬁrst human minisatellite studies were conducted among the offspring 
of atomic bomb survivors in Hiroshima and Nagasaki (Kodaira et al. 1995; Satoh 
et al. 1996) (Table 5). The authors sampled families in which at least one parent 
had been externally exposed to high doses of acute radiation.  The majority of the 
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children studied were born more than 10 years following the exposure and derived 
from families in which mainly one parent had been exposed to radiation. No 
increase in minisatellite mutation rates was observed as minisatellite mutations 
were found in 1.5% of children derived from the irradiated gametes of atomic 
bomb survivors and in 2.0% of the control children. The later expansion of this 
study (Satoh and Kodaira 1996) using a multilocus minisatellite probe was also 
unable to show any signiﬁcant difference in mutation frequencies between the 
children of the exposed parents and the control children despite the quite high 
median gonadal doses (1.9 Sv) of the exposed parents. However, because the 
children were born more than 10 years after the radiation exposure of their 
parents, these studies were unable to detect any short term effects of exposure 
on minisatellite mutation rate. 
However, positive results were obtained by Dubrova et al. (1996, 1997) who 
studied minisatellite mutations in Belarus after the Chernobyl accident (Table 
5). In these studies both parents of the examined children were continuously 
living in the contaminated area and therefore they were exposed chronically to 
internal and external sources of radiation. The monitoring system used revealed 
a nearly 2-fold increase (using all loci, 1.5-fold increase using single loci) in the 
mutation rates in the offspring of parents exposed to 137Cs (>1 Cikm-2) compared 
with unexposed control families from the United Kingdom. In the expansion 
of the study (1997), the authors showed that mutation rates in families with 
higher exposure (>20 mSv) to radiation were more elevated than in families with 
the lower exposure (<20 mSv), suggesting that radiation was the source of the 
induced mutations. This represented the ﬁrst indication of a systematic genome-
wide shift in the mutation rate between two different human populations, but 
it did not necessarily implicate environmental radiation as the inducer. The use 
of a control group from the United Kingdom made these data methodologically 
controversial and difﬁcult to interpret. There were several possible confounding 
factors such as ethnicity, health status, smoking, absence of calculated dose to 
the parents, environmental contamination to chemical pollutants other than 
137Cs exposure, and inability to eliminate them (Neel 1999a).
In their further study Dubrova et al. (2002a) (Table 5) studied three-
generation families in the Semipalatinsk nuclear test site in Kazakhstan. In 
the Semipalatinsk region of the former Soviet Union, the parents received 
presumably relatively high doses of radiation (>1 Sv) as a consequence of nuclear 
bomb tests from 1949 to 1989, including both surface and underground explosions. 
A signiﬁcant 1.8-fold increase in minisatellite mutation rate was found in the 
ﬁrst generation and a 1.5-fold increase in the next generation. The authors 
stated that the decrease in minisatellite mutation rate in the second generation 
was a direct result of their lower exposure. Furthermore, there was a negative 
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correlation between parental year of birth and mutation rates, providing evidence 
for decreasing mutation rate with the decay of radionuclides in Kazakhstan. 
There was uncertainty on the actual doses received but the increased mutation 
rate observed in the ﬁrst generation was broadly consistent with the genetic 
doubling dose of 1 Sv used by the ICRP (1990) and UNSCEAR (2001) to make 
estimates of hereditary risks in humans after radiation exposure. However, the 
radiation dose estimate achieved by using FISH translocation analysis did not 
conﬁrm the dose estimate of 1 Sv (Salomaa et al. 2002, see 2.8.3.6).
In their latest study Dubrova et al. (2002b) studied minisatellite mutations 
in Ukraine. In Ukraine, the whole-body doses from external sources for the 
period of time from 1986 to 2002 did not exceed 50 mSv (Dubrova et al. 2002b). 
These doses were well below all known estimates of the doubling dose of 1 Sv. 
However, the authors detected a 1.6-fold increase in minisatellite mutation rate 
using the same eight minisatellite loci as in their previous studies (Dubrova 
et al. 1997, 2002a) (Table 5). Dubrova (2003) explained their results by using 
other estimates of the mean doses when dose estimates ranging up to 0.5 Gy 
could lead to the detected 1.6-fold increase in minisatellite mutation rates. Even 
though the dose estimates are uncertain, the studies by Dubrova et al. (2002a, b) 
provide the most convincing evidence to date of hereditary mutations in humans 
following parental exposure to ionising radiation. However, the signiﬁcance of 
these mutations to the health of their carriers and the following generations 
remains to be clariﬁed in the future.
Unlike the studies described above, only the fathers were exposed to 
radiation in the studies by Livshits et al. (1999, 2001) (Table 5). They examined 
minisatellite mutation rates in Ukrainian Chernobyl cleanup workers exposed 
externally to relatively uniform levels of radiation, with a minor contribution from 
the intake of radionuclides. The cleanup workers received repeated small daily 
doses (average doses <150 mSv) of radiation over the cleanup period. Livshits 
and colleagues detected no increase in minisatellite mutation frequencies in 
children born after the Chernobyl accident to Chernobyl cleanup workers in the 
Ukraine compared with other Ukrainian families. The established mutation rate 
ratio of the exposed to control families was 0.9.
Deviating from all other human minisatellite studies as much as a 7-fold 
increase in minisatellite mutation rates has been documented in Chernobyl 
cleanup workers in the Ukraine and Israel (Weinberg et al. 1997, 1999, 2001). 
However, these studies have been judged unreliable because of the method used 
to detect the mutations (mainly RAPD-PCR, where DNA is ampliﬁed with short 
random-sequence PCR primers). The claimed minisatellite ‘mutations’ detected 
by the authors were not validated and had no obvious molecular basis. They 
may have arisen as PCR artefacts or through non-paternity or sample mix-up 
(Jeffreys and Dubrova 2001).
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No clear evidence of an increase in the minisatellite mutation rate has 
been observed between pre-and post-irradiation in human sperm following 
radiotherapy (May et al. 2000). The study included three patients who had 
received hemipelvic radiotherapy. Patients received a total testicular X-ray dose 
between 0.38 and 0.82 Gy over a three week period. Minisatellite loci B6.7 and 
CEB1 mutations were examined by using small pool PCR (SP-PCR) to analyze 
patient sperm samples in the pre-meiotic, meiotic, and post-meiotic cells. The 
authors found no evidence for mutation induction in any of the studied patients 
even though they were able to detect a change as low as 1.4-fold. However, the 
resolution in SP-PCR is conservative as very small gains or losses in repeat units 
may go unnoticed by this technique.
Differences in the above mentioned minisatellite studies may be explained 
by the obvious interpretation that there may be different biological consequences 
of a single acute external radiation dose received from atomic bombing compared 
with chronic external and internal environmental exposure received by people 
living in the contaminated areas and with the small, fractionated external dose 
to which Chernobyl cleanup workers were exposed. The evidence for mutation 
induction at minisatellite loci in humans remains controversial. However, all the 
above-mentioned data in radiation-induced minisatellites were derived from a 
relatively small number of families. Therefore, additional studies are needed in 
order to evaluate the mechanisms of mutation induction at human minisatellite 
loci and the possible role of radiation in it.
Although the evidence available is limited, it seems most likely that the 
vast majority of minisatellite mutations are genetically neutral and very few 
of these loci are associated with heritable diseases (Bridges 2001; UNSCEAR 
2001). Those associations made for speciﬁc minisatellite loci refer largely to 
complex multifactorial conditions (diabetes, cancer, and spontaneous abortion) 
involving multiple genes and their interaction with variable environmental and 
lifestyle factors. According to current knowledge, the incidence of multifactorial 
disease in a given population is only poorly responsive to an increase in mutation 
rate (UNSCEAR 2001). Thus, the absolute increase in minisatellite mutations 
recorded by Dubrova et al. (2002a, b) will not relate directly to the incidence 
of genetic diseases. Minisatellites may be very sensitive to radiation-induced 
germline mutation in both mice and humans. In both cases, the scale of induction 
implies some so far unknown mechanisms whereby radiation indirectly results 
in mutation at tandem repeat loci. It is not possible to extrapolate these ﬁndings 
to other, more biologically relevant classes of mutation in the human genome, or 
to infer any adverse health consequences to descendants of the post-Chernobyl 
population. However, the current data raise questions about the mechanisms 
of radiation mutagenesis and consequences of environmental radiation to the 
future generations.
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2.8.3.4 Sellaﬁeld
The hereditary effects of human radiation exposure have also been studied 
among nuclear power plant workers. Gardner et al. (1990) reported a statistical 
association between low total cumulative paternal radiation doses (³100 mSv 
before conception or ³10 mSv in the 6 months prior to conception) and a 6-8-
fold increase in the risk of leukaemia/non-Hodgkin’s lymphoma in children of 
male workers at the Sellaﬁeld nuclear fuel reprocessing plant. This hypothesis 
was based on only 10 affected children and in spite of a recent study (Dickinson 
and Parker 2002) repeating the conclusions, the results cannot be considered 
independently repeated since the recent study included the same cases previously 
studied by Gardner et al. (1990). The median dose in the Sellaﬁeld cohort was 
only 29 mSv and no worker received doses greater than about 900 mSv (Parker 
et al. 1999; Dickinson et al. 2002). Therefore, the leukaemia of the studied 
children cannot be explained by the radiation exposure of the fathers and no 
other explanation has been found. Chance based on small number of leukaemia 
cases is one possible explanation as well as viral aetiology. The study by Gardner 
et al. (1990) prompted many other studies of nuclear power plant workers, but 
these studies could not conﬁrm the possibility that radiation exposure received 
by a father before conception could be the cause for childhood cancer (Kinlen et 
al. 1993; McLaughlin et al. 1993; Doll et al. 1994; Little et al. 1995; Tawn 1995; 
Siffel et al. 1996; Draper et al. 1997; Neel 1999a; Wakeford 2000). 
A statistical association was also reported between paternal preconception 
radiation exposure at the Sellaﬁeld nuclear power plant and stillbirth (Parker 
et al. 1999). However, the data from atomic bomb survivors (Otake et al. 1990; 
Little 1999) and a larger study of 13 600 nuclear industry workers in the 
United Kingdom (Doyle et al. 2000) did not support this ﬁnding. In addition, 
no correlation between preconception doses and congenital malformations was 
detected among children of Canadian nuclear power industry workers (Green 
et al. 1997).
2.8.3.5 Medical radiation exposure studies
Survivors of cancer therapy are exposed to high doses of ionising radiation 
before reproduction and offer a unique possibility to study the hereditary effects 
of radiation. The mutational analysis of this group is very complicated because 
radiotherapy is normally administered with chemotherapy, which itself may also 
be mutagenic. However, studies of the hereditary effects of radiation on patients 
given medical radiation are largely negative.
In spite of high radiation doses, signiﬁcant genetic effects in genetic 
diseases attributable to parental exposure to radiation have not been found in the 
offspring of cancer survivors who have received radiotherapy (Byrne et al. 1998; 
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Sankila et al. 1998). Boice et al. (2003) conducted a large study into the hereditary 
effects of radiotherapy among survivors of childhood cancer. This study included 
>25 000 survivors whose gonadal doses were reconstructed from radiotherapy 
records to be >100 mSv in 46% and >1 Sv in 16% of them. In this study, the 
material was from the United States, 4 214 children were born to survivors of 
childhood cancer among whom genetic diseases were reported in 3.7% in contrast 
to 4.1% among 2 339 children born to sibling controls. The same study also 
included 1 345 children of cancer survivors and 4 225 children of sibling controls 
from Denmark. These children had birth defects in 6.1% and 5.0%. In addition 
to prior studies, this study provided reassurance that cancer radiotherapy did 
not carry much if any risk for hereditary diseases in offspring conceived after 
radiation exposure. Boice et al. (2003) concluded that although damage to the 
germ cells clearly occurs during radiotherapy, the complex biological processes of 
fertilisation, implantation, and foetal development may ﬁlter out those deleterious 
insults that lead to birth defects, cancer, or other serious outcomes.
In addition, hereditary effects of radiation were studied in another type 
of medical radiation exposure in a cohort of women who were exposed to X-rays 
in the therapy of scoliosis. These women were followed up for the association 
between radiation exposure and subsequent adverse reproductive outcomes in 
adulthood (Goldberg et al. 1998). Among these females, the risk of spontaneous 
abortions was slightly increased (OR 1.35, 95% CI 1.06-1.73), but linear dose 
response to radiation could not be detected. In addition, a statistically non-
signiﬁcant increase (OR 1.20, 95% CI 0.78-1.84) in congenital malformations in 
their offspring was observed. 
Another type of medical radiation exposure was studied by Källen et al. 
(1998) who conducted a detailed analysis of the possible impact of early gonadal 
irradiation with b particles, g-rays, and X-rays. They studied 19 494 infants born 
to 10 237 women who had been irradiated for skin haemangioma at the age 
of 18 months or less in Sweden. The mean ovarian dose was 0.06 Gy and the 
maximum, 8.55 Gy. An excess of perinatal deaths (RR 1.21, 95% CI 1.06–1.39) 
was evident as well as a slight increase in the rate of malformation (RR 1.08, 
95% CI 1.02–1.15), but neither was related to the radiation dose received by the 
mother. No increase in the rate of Down syndrome or in childhood malignancies 
was detected. 
2.8.3.6 Cytogenetic studies
The most thoroughly studied structural change that can be induced in germ 
cells by radiation is reciprocal translocation. It can arise in any type of germ 
cell and it can generally be transmitted. A signiﬁcant increase in the frequency 
of translocation conﬁgurations has been found after spermatogonial irradiation 
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of human testes (Brewen and Preston 1975). However, no ﬁrm ﬁgure can be 
given for the risk after the low-level exposure of female germ cells, in which the 
induction of translocations has not been conﬁrmed, because relevant work has 
not been carried out at low dose rates. 
Translocation analysis using ﬂuorescence in situ hybridization (FISH) 
chromosome painting was performed in two generations among the human 
population living close to the Semipalatinsk nuclear test site in Kazakhstan 
(Salomaa et al. 2002). Similar translocation frequencies were observed in persons 
living in either the Semipalatinsk area or a noncontaminated area. These ﬁndings 
indicate that, on average, the magnitude of exposure of this cohort has been 
considerably smaller than that (1–4.5 Gy) reported in the literature. 
Cytogenetic studies of A-bomb exposed populations have recently been 
reviewed by Awa (2003). One part of these studies was a long-term cytogenetic 
study of the children (n = 8 322) of A-bomb survivors conducted in 1967–1984. 
Among these children, 19 had sex chromosome anomalies, 23 had structural 
chromosome rearrangements, and 1 child had trisomy. The corresponding values 
in the control group (n = 7 976) were 24, 27, and 9. Therefore, no statistically 
signiﬁcant differences in the frequencies of children with abnormal karyotypes 
were detected in the exposed and control groups.
Cytogenetic analysis performed 4-13 years after the Chernobyl accident 
showed an elevated frequency of acentrics, dicentrics, rings, and chromatid 
exchanges among Chernobyl cleanup workers compared to the control group 
(Neronova et al. 2003). All these detected changes could not be attributed to 
radiation exposure because the frequency of acentrics was correlated with the 
age of the workers and the amount of chromatid exchanges increased according 
to the amount of smoking. However, the number of dicentrics and rings suggested 
a genotoxic effect of ionising radiation that was still present over 13 years after 
the Chernobyl accident and radiation exposure due to their cleanup activities 
there. 
2.9 Parameters used in estimating hereditary risks of 
radiation 
2.9.1 Background
The radiation exposure of human populations can cause an increase in the 
frequency of germ cell mutations which can induce genetic diseases in the 
descendants of those exposed. There is a clear need for methods to estimate 
the genetic risks associated with human radiation exposure. Both the mutant 
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genetic risks associated with human radiation exposure. Both the mutant 
frequency and the molecular spectrum of gene mutations need to be considered 
in the assessment of radiation-induced genetic risk. Data on mouse germ cell 
mutation rate following spermatogonial exposure to high dose rate irradiation 
have been presented as the most relevant experimental results upon which to 
extrapolate the expected genetic risk in humans (UNSCEAR 2001). However, 
caution must be exercised when extrapolating from the animal studies to 
the human situation, as the mouse strain used and even different colonies 
of the same mouse strain in different laboratories have their inﬂuence on 
the observed effects. High radiation doses have been used in mice studies 
but the question of low-dose extrapolation is of utmost importance when 
estimating the genetic risk from radiation in humans. There has been a general 
international consensus that it would be prudent to assume linearity at low 
doses (<0.1–0.2 Gy) in the absence of convincing data to the contrary. Most 
mutations, such as deletions, that are conventionally considered to constitute a 
genetic risk arise from complex DNA lesions that are produced linearly with dose 
at low doses (Goodhead 1994). However, if mutations were to arise from indirect 
processes (e.g., minisatellite mutation, genomic instability, bystander effect), then 
the biophysical argument would collapse, since the nature of the lesions that 
trigger such responses is not known. Thus far it is unknow if these phenomena 
reﬂect lesions in DNA or the relationship between indirect responses and initial 
damage. The following parameters are traditionally used in the assessment of 
radiation-induced hereditary risks in humans. 
2.9.2 Doubling dose
Radiation-induced hereditary effects are often measured by using the indirect or 
doubling dose method (see 2.10.3). Doubling dose (DD) is the gonadal radiation 
dose required to produce as many mutations as those occurring spontaneously in 
a generation, i.e., doubling (= 2-fold increase) of the mutation rate of the control 
population. It is estimated as a ratio of the average spontaneous mutation rate 
of a given set of genes relative to the average rate of induction of mutations 
by radiation in the same set of genes (Sankaranarayanan and Chakraborty 
2000a):
 DD = 
 
,       (4)
 where: m = average spontaneous mutation rate 
  Dm = average increase in the mutation rate/unit dose.
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Genes that mutate at high rates spontaneously are assumed to behave 
similarly after irradiation. However, this assumption is open to criticism. A high 
spontaneous rate depends, among other factors, on the size and sequence of the 
genes in question and of the types of mutational mechanisms involved. A high 
induction rate is more dependent on whether a random change in the gene can 
give rise to the phenotypes being observed. 
 Risk / unit dose = P ×  ,      (5)
  where:   P = baseline (equilibrium) incidence 
    1/DD = relative mutation risk/unit dose.
The population genetic theory that underlies the equation (5) is the 
equilibrium theory (see 2.3.3). The P in the equation (5) represents the equilibrium 
incidence, which is directly proportional to the mutation rate. If the mutation 
rate is increased as a result of radiation in every generation, the prediction is 
that the population will attain a new balance (over a number of generations) 
between mutation and selection. 
It would have been ideal to base DD estimates on human spontaneous 
and induced rates of mutations. However, as human data on radiation-induced 
germ cell mutations is still lacking, a less ideal approach of using human data on 
spontaneous mutation rates and mouse data on induced rates have to be used. 
Several mouse mutation systems have been used for this purpose (Table 6). 
The doubling dose (DD) of 1 Gy based on mouse data has been used in 
humans at least during the past 20 years. Based on the results of mice studies, 
Selby (1998 a) suggested that it would be reasonable to raise the doubling dose 
from 1 Gy to 5 Gy for low-dose-rate exposure to X- and g-irradiation. Doing so 
would reduce the risk estimates made by the DD method ﬁvefold. An even higher 
estimate of the DD as the computer stimulation of control experiments involving 
57.4 million offspring in mice showed that the total frequency of spontaneous 
mutations/generation is much higher than thought because of gonadal mosaicism. 
Therefore, the estimate of the DD could be increased to as much as 7.7 Gy (Selby 
1998b). However, Russell and Russell (1959) have pointed out the fallacy of 
comparing DD estimates for mutations that were induced at different stages of 
gametogenesis, in different sexes, or under different dose rates. It has also to be 
born in mind that spontaneous mutation rates in humans and mice are dissimilar. 
Unlike in mouse, the mutation rate in humans differs between the two sexes 
(higher in males than in females) and increases with paternal age. Germinal 
mosaic mutations in mice, which result in clusters of identical mutations in the 
following generations, compose another source of uncertainty. 
81
STUK-A208
Table 6. Estimates of the gonadal doubling dose for acute radiation of spermatogonia 
in mice.
System 
Spontaneous 
mutation 
rate 
Total tested1 Exposure (Gy) 
Doubling dose (Gy) 
(95% CI)2 
Russell 7-locus3-4 7.95 · 10-6 1 051 869 3, 6, 6.7 0.34 (0.22-0.50) 
Dominant visibles4                            8.11 · 10-6 225 017 6, 12 0.17 (0.00-0.59) 
Dominant cataract5 (30 loci)    7.38 · 10-7 84 750 6 0.38 (-0.14-3.75) 
Enzyme activity6 (12 loci)       2.85 · 10-6 36 422 6 0.44 (-0.09-2.68) 
Skeletal malformations4                2.88 · 10-4 2 493 6 0.27 (-0.07-1.67) 
Semi-sterility4                                       1.04 · 10-3 2 124 12 0.31 (0.03-0.95) 
Minisatellites7 5.56 · 10-2 252 0.5, 1 0.33 (0.06-0.75) 
Mean for 7 systems - - - 0.35 (0.20-0.95) 
1Including offspring from the control and irradiated parents, 2Confidence limits computed from the Poisson distribution, 
3Russell and Kelly 1982, 4Lüning and Searle 1971, 5Favor 1989, 6Pretsch et al. 1994, 7Dubrova et al. 1998a, b.  
From the Hiroshima and Nagasaki data it has been estimated that the 
doubling dose (DD) in humans is 2 Sv for acute exposure and about 4 Sv for 
chronic exposure (zygotic rather than gametic DD) (Neel 1998, 1999b). The data 
did not exclude estimates of the zygotic DD of acute radiation as high as 3, 4, or 
5 Sv equivalents. Using human data on spontaneous mutation rates (estimate 
of 2.95 ± 0.64 × 10-6/locus/generation) and mice data on induced rates (estimate 
of 3.6 ± 0.10 × 10-6/locus/Gy), UNSCEAR (2001) yields a DD estimate of 0.82 Gy. 
Using the variance of 0.0834 and standard error of 0.29, the currently revised DD 
of 0.82 ± 0.29 Gy is not signiﬁcantly different from 1 Gy. Therefore, UNSCEAR 
(2001) concluded that the round ﬁgure of 1 Gy for chronic, low-dose, low-LET 
radiation exposure can also be used in risk estimation for for DD for both sexes 
in the future. 
2.9.3 Mutation component
The mutation component (MC) is a measure of the proportion of the impact of a 
genetic condition that is attributable to recurrent mutation (Crow and Denniston 
1981). MC predicts the extent to which the frequencies of a given class of diseases 
increase as a result of, e.g., radiation exposure, i.e., MC is the fraction of the 
disease incidence that is proportional to mutation rate. 
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The formal deﬁnition of the mutation component (MC) is:
 MC =  /  ,      (6)
 
 where:  P = disease incidence before radiation
  (baseline incidence)
  DP = change in P due to new induced mutations
  m = spontaneous mutation rate
  Dm = change in mutation rate as a result of radiation.
In the ﬁrst generation the empirical mouse data on induced developmental 
abnormalities can be used. For the second and later post-radiation generations, 
knowledge of MC (which is dictated by the magnitude of the selection coefﬁcient, s) 
is required:
 Risk / unit dose = P ×  × MC,    (7)
 where:  P = baseline incidence
  1/DD = relative mutation risk/unit dose
  MC = mutation component.
The mutation rate of a hypothetical autosomal dominant mutation in a 
population under equilibrium becomes twice that of the spontaneous rate as a 
result of radiation exposure. This doubling of the mutation rate occurs in either 
one generation or generation after generation. For a one-time (burst, subscript b) 
increase in the mutation rate in any generation is (Chakraborty et al. 1998):
 MCb (t) = s (1 - s)t-1 , (8)
 where:  t = time
  s = selection coefﬁcient.
For a permanent (subscript p) increase in the mutation rate (Chakraborty 
et al. 1998):
 MCp (t) = 1 - (1 - s)t , (9)
 where:  t = time
  s = selection coefﬁcient.
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A one-time or a permanent increase in the mutation rate has the same 
impact in the ﬁrst generation following the increase, namely, MCb = MCp = s. With 
no irradiation in subsequent generations, the mutation component will gradually 
decay to zero at a rate of (1-s)/generation. With a permanent increase in the 
mutation rate, the mutation component will continue to increase in subsequent 
generations to attain a value of 1 at the new equilibrium.
The mutation component (MC) can be applied to Mendelian diseases 
(Chakraborty et al. 1998) and multifactorial diseases (Denniston et al. 1998). 
An estimate of the average selection coefﬁcient, s, for autosomal dominant and 
X-linked diseases is of the order of ~ 0.3. It is a value that deﬁnes the ﬁrst 
generation MC. Therefore, the value of MC = 0.3 can be used for computing the 
risk for autosomal dominant and X-linked diseases for the ﬁrst post-irradiation 
generation. In autosomal recessive diseases the mutation component is close 
to zero in the ﬁrst few generations. For multifactorial diseases as a whole, MC 
can vary between 0.05 and 0.5; MC = 0.02 can be used for the ﬁrst several post-
irradiation generations when there is radiation exposure in every generation. 
For all induced developmental defects considered overall, s may be in the range 
of 0.2 to 0.5 for the second post-irradiation generation (meaning that 20% to 50% 
of the abnormal progeny may transmit the damage to the second generation).
2.9.4 Potential recoverability correction factor
The potential recoverability correction factor (PRCF) (Sankaranarayanan and 
Chakraborty 2000b) deﬁnes the recoverability of radiation-induced mutations 
in human live births. PRCFs are disease-class speciﬁc. As PRCFs are based on 
the known difference (in nature, type, and mechanisms) between spontaneous 
disease-causing mutations in humans and radiation-induced mutations in mice, 
they bridge the gap between radiation-induced mutations determined in mouse 
studies and the risk of inducible genetic diseases in human live births. The 
criteria for assessing the potential recoverability of radiation-induced mutations 
were developed on the basis of recovered mutations in mouse experiments. 
They were applied to human genes of interest from the disease point of view. 
Recoverability of radiation-induced deletions in live births in humans seems 
to be dependent on whether the loss of gene/genomic region is compatible with 
viability in heterozygotes. Human gene size, location, normal function, known 
mutational mechanisms, the spectrum of naturally occurring mutations, gene-
richness of the region, etc. are considered in the assessment.
Sankaranarayanan and Chakraborty (2000b) state that the potential 
recoverability of an induced deletion of a gene/genome region can be judged as 
potentially recoverable if rearrangements (e.g., translocations or inversions) 
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are known to occur with breakpoints in the gene/genomic region of interest and 
produce the disease phenotype. These gene/genomic regions are non-essential 
for viability of the heterozygotes and large, whole gene and multi-locus deletions 
are known to occur in these regions. Potential recoverability can be judged as 
uncertain when the genomic context information of the gene is insufﬁcient and 
large intragenic and multilocus deletions of the gene are rare (presumably 
because of the lethality of heterozygotes). Uncertain potential recoverability 
is also attached to large genes coding for a structural protein and genes where 
known genetic changes are missense and nonsense mutations or small intragenic 
deletions or insertions (causing frameshifts and predicted to result in truncated 
proteins). Potential recoverability can be judged unlikely when mutations in the 
gene/genomic region are speciﬁc point mutations or speciﬁc tandem duplications 
causing gain-of-function. Recoverabilited gene/genome regions where mutations 
are point mutations or small speciﬁc intragenic deletions causing loss-of-function 
due to dominant negative mechanisms are also unlikely. In addition, when a gene 
is in expansion of trinucleotide repeats its potential recoverability is unlikely.
The PRCF varies between 0.15 and 0.30 for autosomal dominant and X-
linked diseases. There is no need to estimate the PRCF for autosomal recessive 
disorders, since the mutation component is close to zero. For multifactorial 
diseases, the PRCF range of 0.02 to 0.09 is used. For congenital abnormalities, 
PRCF calculations are unnecessary, since the available empirical mouse data on 
developmental abnormalities can be used to obtain an approximate estimate of 
risk without recourse to the DD method. The range for PRCF reﬂects biological 
and not statistical uncertainties. 
2.10 Methods for hereditary risk estimation 
2.10.1 Background
The aim of hereditary risk estimation is to predict the impact of a small radiation 
dose on disease incidence in the population. It is assumed that any small dose of 
radiation causes an increase in the mutation rate. Two extrapolation procedures, 
based on experimental data from mice, are available to estimate the genetic risk 
in humans. They are termed the direct and indirect or doubling dose method. 
2.10.2 Direct method
In estimating hereditary risk it is assumed that the 7-loci in mice constitute 
a suitable basis for extrapolation to genetic disease in humans, and that 
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mutations are increasing linearly with dose (at least at low doses) within the 
gene. Recent evidence on the mutability of repeat sequences suggests that both 
these assumptions are wrong and consequently, the direct method has now been 
abandoned (UNSCEAR 2001). However, the data on skeletal abnormalities 
and cataracts used with the direct method (along with those on congenital 
abnormalities diagnosed in utero) now provide the basis for estimating the risk 
of developmental abnormalities as a whole. It is no longer considered necessary 
to make separate estimates of the risk of chromosomal diseases since these are 
already assumed to be included with developmental abnormalities.
2.10.3 The indirect or doubling dose method
The doubling dose (DD) method estimates the hereditary risk in terms of the 
additional number of cases of genetic diseases due to radiation exposure relative 
to the prevalence of those occurring naturally in the population. The DD is 
estimated in mice and the spontaneous mutation rate is estimated in humans. 
Such an extrapolation from mouse data to the risk of genetic diseases is valid 
only if the average rates of inducible mutations in human genes of interest and 
the average rates of induced mutations in mice are similar (Sankaranarayanan 
and Chakraborty 2000b). The advantages of this method include the fact that 
estimates of spontaneous mutation rates in humans (usually presented as 
sex-averaged rates) automatically include sex differences and paternal age-
effects. Moreover, if clusters of mutations have occurred, they are included in 
the mutation rate calculations as all human mutations are counted irrespective 
of whether they are part of a cluster or not. The DD was found to be four times 
higher in the dominant cataract test than the 7-locus test in mice. These results 
indicate that to extrapolate to genetic risks in humans using the DD method, the 
extrapolation must be based on the experimental mutation rate results for the 
same genetic endpoint (Sankaranarayanan and Chakraborty 2000b). 
Since the risk due to radiation is conventionally expressed as the expected 
number of cases of genetic disease (over and above the baseline incidence) for 
autosomal dominant diseases, the risk is estimated as:
 Risk / unit dose = P ×  × MC × PRCF ,   (10)
 where:  P = baseline frequency (incidence) of the genetic disease under  
  consideration
  DD = doubling dose (see 2.9.2.)
  1/DD = relative mutation risk/unit dose (see 2.9.2)
  MC = mutation component (see 2.9.3)
  PRCF = potential recoverability correction factor (see 2.9.4).
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From epidemiological studies, P can be estimated to be 2.4% for Mendelian 
diseases, 0.4% for chromosomal diseases, and 71% for multifactorial disease 
(Czeizel and Sankaranarayanan 1984; Czeizel et al. 1988). For autosomal 
dominant diseases, if there is an x% increase in the mutation rate, it will be 
reﬂected as an x% increase in disease at the new equilibrium. The population 
genetic theory of equilibrium (see 2.3.3) between mutation and selection underlies 
the use of the DD method. The equilibrium theory predicts that under conditions 
of a permanent increase in mutation rate, the MC will reach a value of 1 at the 
new equilibrium for both Mendelian and multifactorial diseases. For all classes 
of genetic diseases, the time it takes to reach the new equilibrium is critically 
dependent on the magnitude of selection. For congenital abnormalities, an 
estimate of risk at the new equilibrium is very difﬁcult to obtain in view of the 
fact that a progressive increase in genetic damage in the genome over time may 
dramatically increase the magnitude of selection, such that individuals affected 
with these developmental abnormalities may not survive to reproductive age 
to transmit the damage. Radiation risk estimates calculated using the indirect 
(DD) method and the equation (10) are seen in Table 7. These risk estimates 
are valid if the whole radiation dose is genetically signiﬁcant and is applicable 
to a reproductive population. The genetically signiﬁcant dose for the whole 
population will be markedly lower than the total dose received over a lifetime, 
as damage in the germ cells of individuals with no offspring produce no risk. In 
the future, computation modelling will be needed to estimate radiation risks in 
heterogeneous human populations.
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Table 7. Radiation risk estimates using the indirect (doubling dose) method [ based on 
the Eq. (10), Sankaranarayanan and Chakraborty 2000c and UNSCEAR 2001].
Risk/Gy of parental irradiation (cases/million live born)4 
Radiation exposure in one 
generation 
Radiation exposure in every generation 
Disease 
1st gen. 
progeny 
2nd gen. 
progeny 
1st gen. 
progeny 
2nd gen. 
progeny 
at new 
equilibrium 
AD1 � 750-1 5005 � 500-1 0006 � 750-1 5005 � 1 300-2 5007 � 2 500-5 0008 
AR2 09 09 09 09 � 1 100-2 20010 
X-linked � 750-1 5005 � 500-1 0006 � 750-1 5005 � 1 300-2 5007 � 2 500-5 0008 
mf 3 � 250-1 20011 � 250-1 20011 � 250-1 20011 � 250-1 20011 � 13 000-58 50012 
dev.abn. 2 00013 400-1 00014 2 00013 2 400-3 00015  
cong. abn. 016 016 016 016  
total %17 0.41-0.64   0.53-0.9118  
1Autosomal dominant disease, 2Autosomal recessive disease, 3Multifactorial disease, 4Risk/Gy = P · (1/DD) · MC · PRCF 
(eq. 10) (at new equilibrium additional cases/million), 5(16 500 · 10-6) · 1 · 0.3 · (0.15-0.30), 6(16 500 · 10-6) · 1 · (0.3 · 0.7) · 
(0.15-0.30), 7(16 500 · 10-6) · 1 · [1 - (1 - 0.3)2] · (0.15-0.30), 8(16 500 · 10-6) · 1 · 1 · (0.15-0.30), 9MC � 0, 10(7 500 · 10-6) · 1 · 
1 · (0.15-0.30) (if the PRCF estimated for autosomal dominant and X-linked diseases are also assumed to be applicable to 
recessive diseases), 11(650 000 · 10-6) · 1 · 0.02 · (0.02-0.09), 12(650 000 · 10-6) · 1 · 1 · (0.02-0.09), 13based on mouse data 
on skeletal abnormalities, cataracts and congenital abnormalities scored in utero, 14s = 0.2-0.5, 15[(0.2-0.5) · 2 000] + 2 000, 
16for congenital abnormalities, complete selection has been assumed (i.e., none is transmitted, s = 1) and consequently all 
cases are new, 17of the baseline frequency of these diseases (738 000/million) in the population, 18includes the risk to the 
first generation as well. 
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3 Aims of the present study
The general purpose of the present study was to evaluate the applicability of 
the minisatellite mutation screening method for assessing radiation-induced 
hereditary risks in humans.
The speciﬁc aims of the study were:
1.   To test the usability of PCR-based minisatellite mutation screening 
methods in family studies.
2.   To determine the rate of heritable minisatellite mutations in the radiation 
exposed population of Estonian Chernobyl cleanup workers.
3.   To examine if the minisatellite mutation rate increased due to father’s 
exposure to radiation while working at Chernobyl.
4.   To determine if there is a correlation between the minisatellite mutation 
rate and the father’s radiation dose.
5.   To test if the paternal age effect can be seen in the minisatellite mutation 
rate.
6.   To determine the effect of a father’s spermatogonial stage during the 
radiation exposure in the minisatellite mutation rate
7.   To determine the applicability of the linear dose response to this 
material.
8.   To examine if the doubling dose can be established based on the material 
used. 
9.   To compare paternal and maternal minisatellite mutation rates.
10.   To determine minisatellite mutation rates in other Estonian control 
families.
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4 Materials and methods
4.1 Subjects
The reactor accident at Chernobyl at the 26th April 1986 necessitated a massive 
environmental cleanup that involved over 600 000 workers from all 15 republics 
of the former Soviet Union. The cohort of Estonian cleanup workers consisted of 
4 832 men. They participated, mostly at ages 20–39 years, in cleanup activities 
at Chernobyl over a median period of three months between 1986 (60.4% of 
workers) and 1991. Their mean radiation dose was estimated to be 109 mSv 
(SE ± 63 mSv). Less than 1.4% of the cohort received more than 250 mSv. The 
estimate of the men’s individual radiation dose was obtained from the database 
of the Estonian Study of Chernobyl Cleanup Workers (Inskip et al. 1997; Rahu 
et al. 1997; Tekkel et al. 1997). This dose was a physical dose based primarily 
(70% of the men) on thermoluminescence dosimeter (TLD) readings, which are an 
estimate of the external whole-body dose from gamma irradiation. The estimated 
radiation dose was considered to represent external radiation exposure, reﬂecting 
the gonadal dose. Studies using biological dosimetry (GPA assay, chromosome 
analysis, FISH) yielded comparable estimates of average dose (Salassidis et al. 
1994; Granath et al. 1996; Bigbee et al. 1997; Littleﬁeld et al. 1998).
4.2 Samples and dna extraction 
Within the cohort, men with children born both prior to and after the accident 
were identiﬁed from questionnaires (Tekkel et al. 1997) and those with a child 
conceived within 33 months of return from Chernobyl were selected for the study 
(n = 208). Of them, 192 gave consent and blood samples were collected from 
742 persons from 192 Estonian families (192 fathers, 187 mothers, 198 post-
Chernobyl children, 165 pre-Chernobyl children). Approximately 20 ml of blood 
from each donor was collected into sterile Vacutainers and maintained at ambient 
temperature until delivery to STUK within 24 hours after venipuncture. The 
blood samples were coded by family study number with the code F for father, M 
for mother and C1, C2, or C3 arbitrarily (not in order of age) given for children, 
thus blinding later analyses (analyses were conducted without the knowledge 
of whether the children belonged to the pre- or post-Chernobyl group). Genomic 
DNA was extracted from freshly isolated blood lymphocytes using QIAamp Tissue 
Kit (QIAGEN, Valencia, USA) according to the manufacturer’s instructions. The 
DNAs were stored in 1 x TE buffer in -20°C. 
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After excluding incomplete families and families with non-paternity using 
PCR-based methods (see 5.1.), DNA samples from 597 persons from 147 families 
of Estonian Chernobyl cleanup workers composed the ﬁnal study material. The 
“exposed” children (n = 155) were conceived within 33 months of the father’s 
return from Chernobyl. Their siblings (n = 148) born prior to the accident formed 
the reference group. This design allowed us to use an optimal reference group, 
with matching for inter-individual variability in, e.g., genetic factors. Thus, we 
were able to maximise the comparability of genetic and other factors. To have an 
estimate of the time of conception, and thus of the stage of the spermatogenesis 
during irradiation, the gestation age of the children at birth was assumed to be 
40 weeks.
Blood samples were also collected from 144 persons from 48 Estonian 
families (father, mother, and child) where the father had not been exposed to 
radiation (neither at Chernobyl nor occupationally). These blood samples were 
sent to STUK, coded, and handled identically to other blood samples. This 
additional control group was collected to provide an external reference rate for 
the assessment of generalizability (selection). After excluding families with non-
paternity, 44 families composed the ﬁnal additional control group.
4.3 Polymerase chain reaction-based analyses 
The biological paternity of all children was ascertained by the polymerase chain 
reaction (PCR)-based analysis of ﬁve minisatellite loci. Minisatellite loci APOB, 
HRAS, MCOB19, MCT118, and YNZ-22 were chosen for paternity testing because 
of their reliability due to their relative low spontaneous mutation frequency. 
Some basic features of the used loci are seen in Table 8.
Table 8. Minisatellite loci studied by PCR-based analyses.
Minisatellite 
locus 
Locus 
symbol 
Map  
location 
Repeat 
unit (bp) 
Number 
of alleles Allele size 
Heterozygosity 
(%) 
APOB APOB 2p24-p23 13-15 25 500-1 000 75-77 
HRAS HRAS 11p15.5 28 30 1 000-3 000 72 
MCOB19 D19S20 19p13.3 33 18 200-4 000 70-79 
MCT118 D1S80 1p36-p35 16 21 430-750 79 
YNZ-22 D17S5 17p13.3 70 14 170-1 070 85-88 
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Following ﬂanking primers were used for PCR-based minisatellite analyses: 
 APOB F 5´-ATGGAAACGGAGAAATTATG-3´
  APOB R 5´-CCTTCTCACTTGGCAAATAC-3´
 HRAS F 5´-TTGGGGGAGAGCTAGCAGGG-3´
 HRAS R 5´-CCTCCTGCACAGGGTCACCT-3´
 MCOB19 F 5´-AGATGCCTTACTGAGAAGCGGGAG-3´
 MCOB19 R 5´-TTGTCCACGGGTATTTATCATACGG-3´
 MCT118 F 5´-GAAACTGGCCTCCAAACACTGCCCGCCG-3´  
 MCT118 R 5´-GTCTTGTTGGAGATGCACGTGCCCCTTGC-3´
 YNZ-22 F 5´-TCGAAGAGTGAAGTGCACAGGAGGGCAAG-3´
 YNZ-22 R 5´-GGGTCTGCTGTGCCCACAGTCTTTATTCT-3´
In each primer pair the forward primer was labelled with a ﬂuorescent 
dye, thus the ampliﬁcation products of APOB and YNZ-22 carried green (HEX), 
HRAS and MCOB19 blue (6-FAM), and MCT118 yellow (TAMRA) ﬂuorescence. 
All the used primers have been published earlier (APOB: Boerwinkle et al. 1989; 
HRAS: Ugozzoli et al. 1991; MCOB19, MCT118 and YNZ-22: Tully et al. 1993).
PCR-conditions (Table 9) and programs were optimized for each ampliﬁed 
minisatellite locus in a total volume of 50 ml. The initial denaturation at +94°C for 
5 minutes and the ﬁnal cooling to +4°C was included in each program. APOB was 
ampliﬁed using a diphasic PCR-program at +94°C for 30 seconds for denaturation 
and +58°C for 6 minutes for annealing and extension, which was repeated for 26 
cycles. The ﬁnal extension at +58°C for 7 minutes completed the ampliﬁed APOB 
fragments. PCR-programs consisting of three phases were used for all other 
minisatellite loci. The PCR-program for HRAS contained 25 cycles repeating 
denaturation at +94°C for 20 seconds, annealing at +64°C for 30 seconds, and 
extension at +68°C for 3 minutes. The ﬁnal extension at +68°C for 7 minutes 
ﬁnished the program. A polymerase designed for amplifying longer alleles (Table 
9) was used in amplifying HRAS because large alleles were frequent in this 
minisatellite locus. The MCT118 locus was ampliﬁed using a PCR-program at 
+94°C for 30 seconds, +62°C for 30 seconds, and +72°C for 1.5 minutes repeated 
27 times for denaturation, annealing, and extension. This PCR-program was 
ﬁnalised with the extension at +72°C for 7 minutes. The same PCR-program 
was used for amplifying MCOB19 and YNZ-22 minisatellite loci. This program 
consisted of denaturation at +94°C for 30 seconds, annealing at +62°C for 30 
seconds, and extension at +72°C for 3 minutes. Denaturation, annealing, and 
extension were repeated for 30 cycles. The ﬁnal extension at +72°C for 7 minutes 
completed the PCR-program. 
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The result of the PCR-ampliﬁcation was checked by electrophoresing a 
10 ml aliquot of each PCR-product through 0.8% (HRAS) or 1.8% (all other loci) 
(w/v) agarose gels (Agarose NA, Pharmacia, Sweden). The gels were run with 80 V 
for 2 hours in 1 x TBE buffer (89 mM Tris-borate, pH 8.3, 2 mM EDTA). When 
minisatellite loci MCOB19 and YNZ-22 were studied, some families had large 
alleles, which were ampliﬁed inefﬁciently. Therefore, PCR-based minisatellite 
analysis was repeated in these families using other PCR-conditions (Table 9) 
optimised for especially long alleles using a polymerase designed speciﬁcally for 
amplifying long PCR-fragments (DyNAzyme EXT DNA polymerase, Finnzymes, 
Espoo, Finland). These especially long alleles were ampliﬁed by 30 cycles at +94°C 
for 20 seconds for denaturation, +62°C for 30 seconds for annealing, and +68°C for 
3 minutes for extending. A ﬁnal extension at +68°C for 7 minutes completed the 
extension of the ampliﬁed fragments. The PCR machine was programmed to keep 
the samples at 4°C for an unspeciﬁed time (¥) after the PCR was completed. 
Table 9. Optimized PCR-conditions used in minisatellite analyses.
Locus DNA (ng) 
Primers 
(µM) 
dNTPs 
(mM) 
MgCl2 
(mM) 
KCl 
(mM) 
Triton 
X–100 
(%) 
Tris-HCl  
(pH 8.8) 
(mM) 
(NH4)2SO4 
(mM) 
Poly-
merase 
(U) 
APOB 100 1.5 0.20 1.50 50.0 0.1 10.0 - 3.01 
          
HRAS 250 0.4 0.36 1.75 50.0 0.1 - 15.0 2.02 
          
MCOB19 250 0.2 0.20 1.50 50.0 0.1 10.0 - 2.01 
MCOB193 250 0.2 0.36 1.75 50.0 0.1 - 15.0 2.02 
          
MCT118 100 0.2 0.20 1.50 50.0 0.1 10.0 - 2.01 
          
YNZ-22 100 0.2 0.20 1.50 50.0 0.1 10.0 - 2.01 
YNZ-223 100 0.4 0.36 1.75 50.0 0.1 - 15.0 2.02 
1DyNAzymeTM II DNA polymerase (Finnzymes, Espoo, Finland), 2DyNAzyme EXT DNA polymerase (Finnzymes, Espoo, 
Finland), 3Other PCR-conditions used for especially long alleles. 
Small samples (0.5-2 ml) of successfully ampliﬁed PRC-products from 
complete families were electrophoresed through 4.5% (HRAS) or 6% (all other 
loci) native polyacrylamide (PAGE) (Acryla-mide/Bis 29:1) (Bio-Rad, Hercules, 
USA) gels. Native 6% PAGEs were run with 2500 V and 13 W (~800 V) for 13 
hours using automated ABI PRISM 377 DNA sequencer (Applied Biosystems, 
Fos-ter City, USA). For 4.5% PAGEs 2500 V and 14 W (~800 V) were used for 
a 12-hour electrophoresis. Ampliﬁed PCR-fragments from minisatellite loci 
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MCOB19 and YNZ-22 of one person were run simultaneously on the same lane; 
all other loci were studied individually. The ﬂuorescent bands obtained for each 
family were analysed with the GeneScan program (Perkin-Elmer, Boston, USA). 
Mutations in children were seen as fragments whose size differed from the sizes 
of the parental fragments.
4.4 Southern blot-based analyses 
For the Southern blot–based analysis, 4 mg samples of genomic DNA were digested 
to completion with AluI (Promega, Madison, WI, USA), using reaction conditions 
recommended by the supplier. The samples were electrophoretically separated 
through 25-cm long 0.8% (w/v) agarose gels (Agarose NA, Pharmacia, Sweden) 
for 24 hours in 1 x TBE buffer (89 mM Tris-borate, pH 8.3, 2 mM EDTA). Each 
gel included three lanes carrying l/HindIII fragments (Promega, Madison, WI, 
USA) as molecular weight markers. Separated DNA fragments were transferred 
to a nylon membrane (Hybond N+, Amersham, Buckinghamshire, UK).
Minisatellite loci B6.7, CEB1, CEB15, CEB25, CEB36, MS1, MS31, and 
MS32 were chosen for Southern blot–based minisatellite mutation analysis due 
to their relatively high spontaneous mutation rate (Jeffreys et al. 1988, 1991b; 
Vergnaud et al. 1991; Olaisen et al. 1993; Tamaki et al. 1999; Vergnaud and 
Denoeud 2000). Out of these eight hypervariable single-locus probes (Table 10), 
probe CEB1 for Southern blotting was produced from a PCR fragment. Used 
primers were (Buard and Vergnaud 1994): 
CEB 1F  5´-GGTCTAGAGCTCTGCTGAGTCAGAGTCAGCCAG-3´ 
CEB 1R 5´-AAACTGTAATCTGGAGTTGGTCTGGCGATC-3´.
During the PCR, 500 ng of template DNA was ampliﬁed in a PCR mix 
containing 0.4 mM of each primer, 0.36 mM dNTP, 1.75 mM MgCl2, 2% DMSO, and 
100 ml of Dynawax (Finnzymes, Espoo, Finland). Above the Dynawax was added 
2 U of Dynazyme EXT (Finnzymes, Espoo, Finland) DNA polymerase. The total 
volume of the PCR was 10 ml. Ampliﬁcation of CEB1 alleles was initiated with 
denaturation at 94°C for 2 minutes. Ampliﬁcation was continued with 10 cycles 
at +96°C for 10 seconds for denaturation, +62°C for 30 seconds for annealing, and 
+68°C for 6 minutes for extending. Following that were 20 identical cycles, with 
the exception that the extending temperature (+68°C) lasted 20 seconds longer 
in each cycle. A ﬁnal extension at +68°C for 7 minutes completed the extension 
of the ampliﬁed fragments. The PCR machine was programmed to keep the 
samples at 4°C for an unspeciﬁed time (¥) after the PCR was completed. The 
ampliﬁed PCR fragment was cloned into vector pCR 2.1. The host bacterium used 
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was INValphaF´ with kanamycin selection. The cloning product was digested 
with EcoRI. This digestion gave a 1.2 kb restriction fragment that was used as 
a CEB1 probe in Southern blotting. 
Probes CEB15, CEB25, CEB36, MS32, and B6.7 were received as gifts 
(see acknowledgements). These probes were transformed and cloned using a 
TOPO™TA cloning kit (Invitrogen, Carlsbad, USA) under the conditions speciﬁed 
in Table 11. Probes MS1 and MS31 were commercially purchased (Cellmark 
Diagnostics, Oxfordshire, UK).
Table 10. Minisatellite loci studied by Southern blot-based analyses.
*Spontaneous minisatellite mutation frequencies vary from individual to individual from <0.05% to these figures  
depending on size of the minisatellite allele of the individual 
Mini-
satellite 
locus 
Locus 
symbol 
Map  
location 
Repeat 
unit 
(bp) 
No. of 
alleles 
Allele 
size 
(bp) 
Spont. 
male mut. 
freq.* 
(%/gam.) 
Spont.  
female mut. 
freq.* 
(%/gam.) 
Hetero-
tsygosity 
(%) 
B6.7  20q13.33 34 2 000 204 - 17 000 7.6 3.9 99.9 
CEB1 D2S90 2q37.3 39 109 500 -  12 000 25.0 0.4 93.0 
CEB15 D1S172 1p36.33 18 116 500 -  11 000 2.4 0 94.0 
CEB25 D10S180 10q26.3 52 109 600 -  16 000 3.2 1.9 97.0 
CEB36 D10S473 10q26.3 42 108 500 - 7 000 1.8 1.8 97.0 
MS1 D1S7 1p33-p35 9 132 540 -  20 000 5.4 5.4 99.0 
MS31 D7S21 7p22-pter  20 124 
2 000 - 
13 000 1.0 1.0 98.0 
MS32 D1S8 1q42-q43 29 122 1 000 - 20 000 0.8 0.8 97.5 
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Table 11. Conditions used for cloning minisatellite probes.
Probe Vector Host bacterium 
LB bacteria growing 
medium + selection 
antibiotic (50 µg/ml) 
Restriction  
enzyme(s) 
Length of  
the digestion  
fragment (kb) 
B6.7 cosmid 
pWE15 TOP10 ampicillin 
AluI + HinfI 2.7 
CEB1 pCR 2.1 INV�F' kanamycin EcoRI 1.2 
CEB15 pUC 13 TOP10 ampicillin HinfI 3.8 
CEB25 cosmid 
pWE15 TOP10 kanamycin 
AluI + HaeIII 1.9 
CEB36 pUC13 TOP10 ampicillin AluI + HaeIII + HinfI 2.5 
MS32 pUC13 TOP10 ampicillin BamHI 5.6 
The samples were hybridised to ﬂuorescein-11-dUTP random primed 
labelled probes. The probes were attached to an anti-ﬂuorescein antibody 
conjugate including alkaline phosphatase (all CEB probes, MS32, and B6.7) or 
to commercial, alkaline phosphatase labelled single-stranded oligonucleotide 
NICE™ (probes MS1 and MS31, Cellmark Diagnostics, Oxfordshire, UK). 
Detection was achieved via alkaline phosphatase catalysing the chemiluminescent 
reaction. The CDP-Star™ was a chemiluminescent substrate either by using 
the GeneImages™ CDP-Star™ detection module following the manufacturer’s 
instructions (Amersham Pharmacia Biotech, Buckinghamshire, UK) or by using 
the non-isotopic chemiluminescent enhanced probe system (NICETM) following 
the producer’s instructions.
For visualisation the ﬁlters were placed against Hyperﬁlm (Amersham 
Pharmacia Biotech, Buckinghamshire, UK) at room temperature for 10–60 
minutes. After probing the ﬁlters were stripped with 0.1% SDS and kept moist 
before hybridisation using the other probes. The same blots were hybridised 
with all probes used. Autoradiographs were scored over the well-resolved regions 
(1–23 kb) by eye by two independent assessors. The GelWorks1D Advanced -
computer program (Phoretix International, Newcastle upon Tyne, UK) was 
used to estimate the sizes of the detected alleles on the basis of the sizes of the 
l/HindIII-markers included in all gels. Mutants were identiﬁed as novel DNA 
fragments present in the children that could not be ascribed to either parent. 
The mutations were studied assuming that they were derived from the parental 
allele closer in size. Only mutations identiﬁed in two independent experiments 
(beginning from the DNA) were scored. The samples were decoded only after 
ﬁnishing all the analyses.
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4.5 Statistical analyses 
Conditional logistic regression methods were used in data analysis. The unit 
(stratum) used in the analysis was a family, i.e., a comparison of minisatellite 
mutation frequency was made between siblings born prior to and following 
cleanup work in Chernobyl. Hence, children born to the same mother and 
father were compared with each other. The outcome event was a minisatellite 
mutation, i.e., children with conﬁrmed minisatellite mutations were regarded as 
cases and those without mutations as controls. Explanatory variables included 
exposure status (pre- vs. post-Chernobyl children), father’s age and radiation 
dose, and the sex of the child. Statistical signiﬁcance was evaluated using two-
sided likelihood ratio tests and conﬁdence intervals were likelihood-based. In 
addition, the doubling dose was calculated using unconditional logistic regression 
methods including only the post-Chernobyl children as subjects and continuous 
dose as the explanatory variable. The statistical analyses were carried out using 
the STATA statistical computer program package.
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5 Results and discussion
5.1 The usability of PCR-based minisatellite mutation 
screening method
The usability of PCR-based minisatellite mutation screening methods in family 
studies was tested in 192 families of Estonian Chernobyl cleanup workers and 
in 48 Estonian control families. Altogether 886 individuals were studied using 
ﬁve minisatellite loci (APOB, HRAS, MCOB19, MCT118, and YNZ-22) in PCR-
based analysis. The results obtained revealed children with mutations in several 
of the studied loci. When a child had a minisatellite mutation in three or more of 
the studied loci, paternity was considered excluded. Non-paternity was detected 
in 6.2% (12/192) of the exposed fathers and in 8.3% (4/48) of the non-exposed 
fathers from the additional control group. 
In addition to minisatellite mutations connected with non-paternity, only 
one paternal mutation (APOB: father’s allele + 2 repeats) was detected in the 
PCR-based minisatellite mutation screening.  The father of this child belonged to 
the additional control group and was thus unexposed to radiation. No mutations 
(except those connected with non-paternity) were detected in the exposed families 
with the PCR-based method. As expected, the studied minisatellite loci proved 
unuseful in mutation screening due to their low spontaneous mutation rates, 
which however were the prerequisite for reliable paternity testing.
The use of the PCR-based method was very easy and quick with the short 
alleles but with the longer alleles, other PCR-conditions had to be developed to 
accomplish reliable ampliﬁcation of the DNA samples. Despite using the PCR-
conditions suitable for the longer alleles, the ampliﬁcation of the few very longest 
alleles was difﬁcult and unreliable thus causing many repetitions of the assay. 
However, the PCR-based method revealed non-paternity very efﬁciently and 
it can be used in testing the paternity of children before the actual mutation 
screening takes place, thus avoiding the laborious Southern blot-based analyses 
of families with non-paternity. Therefore, the PCR-based minisatellite mutation 
detection method was not shown to be recommendable for minisatellite mutation 
screening due to several existing long alleles at minisatellite loci most suitable 
for mutation screening (high spontaneous mutation rates), but it was applicable 
to the efﬁcient ascertainment of the paternity of the children. This result is in 
concordance with the most popular use of PCR-based micro- or minisatellite 
loci in paternity or forensic testing, where the aim is to identify an individual, 
not a mutation. 
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5.2 Minisatellite mutation rates among children of Estonian 
Chernobyl cleanup workers
The parental origin and germline length change were determined for 94 de 
novo mutations (52 mutations among 155 exposed children and 42 mutations 
among 148 reference children) found at the eight tested minisatellite loci in 
the 147 studied families of the Estonian Chernobyl cleanup workers (Table 12). 
Only mutations of paternal origin were used as the endpoint in the publication 
(Kiuru et al. 2003). Of the eight single locus probes used, CEB1 had expectably 
the highest mutation rate. The CEB1 mutation rate (~14/100 paternal meioses) 
detected in post-Chernobyl children was comparable with the results found in 
other radiation exposed European populations [11/100 (Dubrova et al. 1997), 
15/100 (Livshits et al. 1999, 2001), and 17/100 (Dubrova et al. 2002b)]. The 
gender of the child had no effect on the minisatellite mutation rates (OR 0.95, 
95% CI 0.50-1.79). However, there was no reason to assume a shift in sex ratio 
because minisatellites are not X-linked lethal mutations shifting the sex ratio 
in favor of female offspring.
Table 12. Paternal minisatellite mutation frequency among pre- and post-Chernobyl 
children.
 
Pre-Chernobyl children Post-Chernobyl children 
Probe No. of  mutations 
No. of 
paternal 
meioses 
Mutation 
frequency 
No. of  
mutations 
No. of 
paternal 
meioses 
Mutation  
frequency 
B6.7 10 146 0.069 9 153 0.059 
CEB1 15 148 0.101 21 155 0.136 
CEB15 4 148 0.027 7 155 0.045 
CEB25 4 148 0.027 4 155 0.026 
CEB36 2 148 0.014 2 155 0.013 
MS1 4 148 0.027 6 155 0.039 
MS31 1 148 0.007 2 155 0.013 
MS32 2 148 0.014 1 155 0.006 
Total 42 1 182 0.036 521 1 238 0.042 
1In addition to these 52 mutations, 8 mutations (2 at B6.7, 4 at CEB1, 1 at CEB15 and 1 at MS1) were detected in post-
Chernobyl children in 22 families, which were excluded from the publication due to the missing pre-Chernobyl children. 
The addition of these mutations to the other mutations of post-Chernobyl children (60/1414 = 0.042) would not have 
changed the detected mutation frequency of 0.042. 
The detected minisatellite mutations were studied further by assuming 
that the progenitor allele was the paternal allele closest in size to the mutant 
allele (Jeffreys et al. 1988). As the same men fathered both groups of the studied 
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children, the sizes of progenitor alleles were identical in both groups, which 
allowed further comparison of mutation spectrum. The distribution of the detected 
gained and lost paternal minisatellite repeats at the studied eight minisatellite 
loci in the pre- and post-Chernobyl children is illustrated in Figure 4. Most 
of the detected minisatellite mutations both in the pre- and post-Chernobyl 
children were small changes in the length of the repeated minisatellite allele. 
A few larger changes in the number of repeats were seen both in pre- and post-
Chernobyl children. The results obtained in the present study are in agreement 
with the results of previous studies analysing spontaneous mutations at these 
minisatellite loci (Jeffreys et al. 1988, 1984; Buard et al. 1998; Tamaki et al. 1999; 
Vergnaud and Denoeud 2000), most mutation events involved the gain or loss of 
only few repeat units. The distribution of length changes was similar between the 
two groups of children. Therefore, we conclude that there is no obvious difference 
in the spectrum of paternal minisatellite mutations between the pre- and post-
Chernobyl children.
Figure 4. Detected lost and gained minisatellite repeats at the studied eight minisatellite 
loci.
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5.3 Effect of the father’s radiation exposure on minisatellite 
mutation rates
When the effect of the father’s exposure to minisatellite mutation rates was 
examined, it was shown that the minisatellite mutation rate was higher in the 
post-Chernobyl than it was in pre-Chernobyl children in six out of eight used 
loci. The largest difference was a two-fold increase of minisatellite mutations at 
locus MS31 (Table 13). However, it may well be a chance ﬁnding, as it resulted 
from one and two mutations in the unexposed and exposed groups (Table 12). 
No single locus showed a statistically signiﬁcant increase in the mutation rate 
among exposed children. There was a small, non-signiﬁcant increase in the 
combined single locus probe mutation frequency among the post-Chernobyl 
children compared with the pre-Chernobyl children (0.042 versus 0.035, Table 
13). In the logistic regression analyses, an odds ratio of 1.3 (95% CI 0.8-2.2) (and 
a rate ratio of 1.2) was obtained. 
Table 13. Paternal minisatellite mutation frequency among pre- and post-Chernobyl 
children with odds ratio (and 95% conﬁdence interval, CI).
 Mutation frequency  
Probe Pre-Chernobyl children Post-Chernobyl children Odds ratio1 (95% CI) 
B6.7 0.069 0.059 1.00 (0.35-2.85) 
CEB1 0.101 0.136 1.38 (0.68-2.80) 
CEB15 0.027 0.045 1.65 (0.48-5.68) 
CEB25 0.027 0.026 1.00 (0.25-4.00) 
CEB36 0.014 0.013 0.84 (0.12-6.12) 
MS1 0.027 0.039 1.41 (0.40-5.02) 
MS31 0.007 0.013 2.00 (0.18-22.1) 
MS32 0.014 0.006 0.50 (0.05-5.51) 
Total 0.036 0.042 1.33 (0.80-2.20) 
1Odds ratios were obtained using conditional logistic regression, i.e., comparison between siblings within a family,  
therefore the odds ratios need not correspond to group frequencies.  
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The lack of a statistically signiﬁcant increase in the minisatellite mutation 
frequencies could be due to too small sample size. However, if the total number of 
persons (N) needed for the detection of a 2-fold increase in minisatellite mutation 
rate is calculated by Eq. (3) using m0 of 10-2 (from Table 3) (detected minisatellite 
mutation frequencies from Table 10 cannot be used here because they are 
maximum frequencies, not mean rates), then N = 12/(8 × 10-2) = 12/0.08 = 150. This 
result indicates that a 2-fold increase in the minisatellite mutation rate could 
have been detected by studying 150 case and 150 control children. Therefore, 
the 155 case and 148 control children studied in the present study should form 
an adequate sample for detecting a 2-fold increase in the minisatellite mutation 
rates. In addition, according to power calculations, the studied material and the 
minisatellite loci used in the present study were sufﬁcient for detecting a 1.5-fold 
increase in the mutation rate in the eposed group with 95% probability. Therefore, 
it seems that the used material and minisatellite loci should have detected a 
2-fold, even a 1.5-fold increase in minisatellite mutation frequencies. However, 
the fathers studied were exposed to so low doses of radiation that only a 1.3-
fold increase in paternal minisatellite rates was detected. Such a small increase 
in the mutation frequency may be under the detection limit of the used study 
design and either a bigger sample or higher radiation exposure would have been 
needed in order to reach statistical signiﬁcance.
In this study, the failure to detect a signiﬁcant increase in the mutation 
frequency in men receiving 109 mSv of radiation is consistent with the absence 
of an increase in minisatellite mutations in the offspring of persons exposed 
to radiation from atomic bombs (Kodaira et al. 1995; Satoh and Kodaira 1996; 
Satoh et al. 1996) and in the Ukrainian population exposed by the Chernobyl 
disaster (Livshits et al. 1999, 2001) as well as with the failure to detect increases 
in mutations by SP-PCR in the sperm of men receiving radiotherapy (May et al. 
2000), mutagenic therapy (Armour et al. 1999), or cancer chemotherapy (Zheng 
et al. 2000). However, an increase in minisatellite mutations has been found 
in the Belarusian (Dubrova et al. 1996, 1997) and Ukrainian (Dubrova et al. 
2002b) populations exposed to the Chernobyl radioactive fallout as well as in 
the population living around the Semipalatinsk nuclear test site in Kazakhstan 
(Dubrova et al. 2002a), where 1.5-, 1.6-, and 1.8-fold increases in minisatellite 
mutation rates have been detected (respectively) (Table 5). 
It is not possible at present to explain the differences between these human 
studies, but it should be noted that all data on minisatellite mutation induction in 
humans are derived from a relatively small number of people exposed to different 
sources of ionising radiation. This variety of sources currently prevents any 
reliable comparisons between most of the results of these studies. However, the 
source of ionising radiation is comparable in the present study and in the study 
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by Livshits et al. (2001) because the Chernobyl cleanup workers were exposed to 
repeated small daily doses of ionising radiation. The results of these studies are 
in concordance as Livshits et al. (2001) detected a 0.9-fold paternal minisatellite 
mutation rate and the corresponding value was 1.3 in the present study. Previous 
studies in male mice have clearly shown that the yield of germline mutations 
after a repeated external fractionated radiation exposure was less than when 
the same dose was given in a single exposure (Lyon et al. 1972). Given that he 
maximum reported dose to the Chernobyl cleanup workers of  250 mGy is below 
any known estimates of the doubling dose for mice (Dubrova et al. 1998a, b; 
Sankaranarayanan and Chakraborty 2000a) and assuming the dose-fracionation 
effects, the expected increase in mutation rate in this group may be too small 
to be realistically detected. Therefore, the results obtained in the present study 
seem to show that there is no big increase in the examined minisatellite mutation 
rates due to a father’s radiation exposure, presuming that the increase in the 
minisatellite mutation rate in the studied Estonian cohort was not too tiny to 
detect. Alternatively, it is possible that the lack of minisatellite induction is a 
result of the duration of exposure. Since the majority of male germline cells are 
DNA repair-proﬁcient (Adler 1996) the damage induced by discrete radiation 
exposure may be repaired preventing minisatellite hyper-instability. 
The studies by Dubrova et al. (1996, 1997, 2002a, b) differed from the 
present study as their populations were exposed largely internally and chronically 
and the maternal as well as paternal germ cells, and the developing embryo and 
foetus, were all exposed to radiation. In the ﬁrst two studies by Dubrova et al. 
(1996, 1997) multilocus probes (33.15 and 33.6) were also used which cannot 
distinquish paternal and maternal mutations from each other. In these studies, 
the control population was from the United Kingdom, which has a different genetic 
background than the exposed population. When only the paternal single locus 
minisatellite mutations were taken into consideration, the minisatellite mutation 
frequency increased 1.5-fold (Dubrova et al. 1997) (Table 5). The induction of 
minisatellite mutation in Belarus, Kazakhstan, and Ukraine (Dubrova et al. 
1997, 2002a, b) may reﬂect inability to repair DNA damage arising from constant 
internal low level exposure. 
In the Japanese atomic bomb survivor studies (Kodaira et al. 1995; Satoh 
and Kodaira 1996; Satoh et al. 1996), radiation exposure was acute gamma and 
neutron irradiation and conception occurred long after the exposure. Therefore, 
the mutation rate may have decreased back to the normal level with the passage 
of time. This was shown to occur in the 3-generation study of the Kazakhstan 
population around the Semipalatinsk nuclear test site, where the increase in the 
minisatelllite mutation rate was 1.8-fold in the highly exposed P0-generation and 
it decreased to 1.5-fold level in the much less ex-posed F1-generation (Dubrova 
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et al. 2002a) (Table 5). In the present study, all children were conceived quite 
close to the radiation exposure of the father. Even the youngest children were 
conceived within three years of the father’s exposure. Thus minisatellite mutation 
frequencies have not had time long enough to return to normal levels and despite 
this, the mutation frequencies detected in the present study were not higher than 
1.2-fold. However, Livshits et al. (2001) detected that the CEB1 minisatellite 
mutation frequency among Ukrainian Chernobyl cleanup workers fell from 
18% to 13% among children conceived up to 2 months or at least 4 months 
(respectively) after the father had stopped cleanup work at Chernobyl. In the 
present study, 21 children were conceived up to 2 months and 133 children were 
conceived at least 4 months after the father has returned from cleanup work at 
Chernobyl. CEB1 mutations were detected in these groups in 5% and 13% of the 
children. Therefore, in the present material, the fast decrease of minisatellite 
CEB1 mutations could not be detected, but the result may be biased due to the 
small number of children conceived before 2 months after father’s return from 
Chernobyl. 
In the Ukrainian study (Dubrova et al. 2002b), 16% (27/171) of the studied 
families included children born before and after the Chernobyl accident. Results 
from these 27 families were not given separately in the publication, but according 
to Dubrova paternal minisatellite mutation rate was 0.0415 in the control group 
and 0.0585 in the exposed group among the 27 families. These mutation rates give 
a mutation rate ratio of 1.4 which does not differ substantially from the mutation 
rate ratio of 1.6 detected in the whole material. However, the present study is 
so far the only one in which a perfect match of exposed and unexposed children 
has been possible in each of the studied families. This was achieved by using 
intrafamily controls, i.e., comparing the children born after Chernobyl to children 
born before Chernobyl in the same family. This study design guaranteed that 
the genetic and environmental factors in the studied children were as identical 
as possible and that the individual minisatellite mutation rates (depending, e.g., 
on the repeat length) varying from father to father were the same between the 
children compared. 
Because of the ideal study design of the present study, it was possible to 
compare children from the same families and it was detected that 16% (7/44) of 
the fathers having a minisatellite mutation in the post-Chernobyl child had it also 
in the pre-Chernobyl child and 20% (7/35) of the fathers having a minisatellite 
mutation in the pre-Chernobyl child had it also in the post-Chernobyl child. 
In 5 of these 7 sibling pairs, the mutations were at different minisatellites in 
pre-and post-Chernobyl children and in 2 sibling pairs, mutations were at the 
minisatellite CEB1 in both children. In addition, 9 post-Chernobyl and 7 pre-
Chernobyl children had two different minisatellite mutations. These ﬁgures 
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may reﬂect the detected phenomenon of individual sensitivity to the induction 
of minisatellite mutations (inter-individual variation in mutation frequency) 
(May et al. 2000). The similarity of these ﬁgures in pre- and post-Chernobyl 
children also casts some doubt over the causality of the low radiation exposure 
of the father to these detected minisatellite mutations. 
5.4 Effect of the father’s radiation dose on the minisatellite 
mutation rates 
For testing the correlation of the minisatellite mutation rates and the father’s 
radiation dose, possible radiation-induced minisatellite mutations were explored 
by subdividing the cleanup workers according to their radiation dose. Children 
born to fathers with estimated doses of 200 mSv or more had a higher, but 
statistically non-signiﬁcant increase in the minisatellite mutation rates (OR 3.00, 
95% CI 0.97-9.30) compared with those with lower recorded doses (Table 14). 
Even though the result did not quite reach statistical signiﬁcance, this was the 
strongest evidence we found for the hereditary effects of radiation.
Father’s estimated  
dose  
Pre-Chernobyl 
children1 
Post-Chernobyl  
children1 
Odds ratio  
(95% CI) 
43-99 mSv 16/61 17/66 0.95 (0.44-2.05) 
100-199 mSv 12/48 14/52 1.14 (0.47-2.77) 
200-300 mSv 6/37 13/35 3.00 (0.97-9.30) 
1Number of children with minisatellite mutation(s)/total number of children. 
Table 14. Number of minisatellite mutations and odds ratios in relation to a father’s 
estimated dose.
Even the highest estimated doses (300 mSv) were moderate and for the 
examination of the question if dose rate could be critical; the minisatellite 
mutations were further explored by subdividing the cleanup workers according 
to their radiation dose rates (Table 15). By doing this, the results did not change 
substantially. Children born to fathers with the highest estimated dose rates of 
5-6.8 mSv/d had a higher increase in the minisatellite mutation rate (OR 3.50) 
but showed a poorer signiﬁcance (95% CI 0.73-16.80) than the group with the 
highest estimated dose (95% CI 0.97-9.30).
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Table 15. Number of minisatellite mutations and odds ratios in relation to a father’s 
estimated dose rate.
Father’s estimated 
dose rate       
Pre-Chernobyl 
children1 
Post-Chernobyl 
children1 
Odds ratio  
(95% CI) 
0.004-1.9 mSv/d 25/101 29/110 1.08 (0.59-1.97) 
2.0-4.9 mSv/d 5/23 7/22 1.50 (0.42-5.31) 
5.0-6.8 mSv/d 4/22 8/21 3.50 (0.73-16.80) 
1Number of children with minisatellite mutation(s)/total number of children. 
When the intrafamily control children (pre-Chernobyl children) were 
excluded and only the post-Chernobyl children (“exposed” group) were statistically 
tested, there was no signiﬁcant correlation between the father’s estimated 
dose and the frequency of minisatellite mutations (Table 16). There was some 
indication of a higher risk (OR 1.51) in the highest dose group, but it was 
statistically insigniﬁcant (95% CI 0.70-3.44).
Table 16. Minisatellite mutation risk in relation to a father’s estimated dose in post-
Chernobyl children (exposed group) alone.
Father’s estimated  dose Odds ratio (95% CI) 
43-99 mvS 1.00 (0.97-1.08) 
100-199 mSv 1.04 (0.48-2.25) 
200-300 mSv 1.51 (0.70-3.44) 
Concerning dose response analysis, earlier studies on the induction of 
minisatellite mutations in mice have failed to produce any reliable relationships 
between radiation dose and mutation frequency (Dubrova et al. 1993; Sadamoto 
et al. 1994; Fan et al. 1995). However, later Dubrova et al. (1998a, b) showed a 
linear dose-effect relationship for mutations in pre-meiotic spermatogonia and 
stem cells, with a doubling dose of 0.33 Gy. The estimated doses and dose rates of 
the fathers in the present study were quite low. Only 25% of the fathers received 
a radiation dose of 200 mSv or higher and just 14% of the fathers received a dose 
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rate of 5.0 mSv/d or higher. The estimated doses were not absolute, but merely the 
best estimates of doses that could be obtained as all of the fathers did not wear 
a personal dosimeter while working at Chernobyl. As 75% of the studied fathers 
received low or moderate doses (<200 mSv), their doses were clearly below the 
doubling dose detected in mice and even further apart from the doubling dose 
of 1 Gy recommended for humans by UNSCEAR (2001). Thus, the lack of the 
correlation of the minisatellite mutation rates and the father’s radiation dose 
in the present study may be due to low radiation exposure of the fathers as the 
doses were probably under the detection limit of the method used. However, the 
obtained results could be interpreted so that total radiation doses received were 
more critical for minisatellite mutation induction in the male spermatogenesis 
than the dose rate.
5.5 Effect of the father’s age on the minisatellite mutation 
rates
Examination of the paternal age effect on the minisatellite mutation rates 
showed that the mutation rates were not associated with the father’s age (OR 
1.04, 95% CI 0.94-1.15). Human mutations are known to increase with increasing 
paternal age, but since we compared children of the same father (difference in 
father’s age between children was 1.0–12.9 years, median 3.8 years), the effect of 
father’s age was nearly the same in both (or all) children. Thus, due to colinearity 
with division into pre- and post-Chernobyl children, no meaningful adjustment 
for the effect of father’s age was possible.
For further analysis of the paternal age effect, the children were individually 
divided into different subgroups according to their birth order (pre-Chernobyl 
children, post-Chernobyl children and additional control children) and mutation 
status (mutation, no mutation). There were no signiﬁcant differences in the 
median ages of father’s in these different subgroups (Table 17). In each subgroup 
of children, the median ages of the fathers were higher in the group of children 
without minisatellite mutation than in the group of children with minisatellite 
mutation. According to this study, there seems to be no father’s age effect in 
minisatellite mutation frequencies. Age-related increase in paternal germline 
mutation rate has not been shown in human minisatellites (Livshits et al. 2001; 
Dubrova et al. 2002b), although such a trend has been detected at human protein-
coding genes (Vogel and Rathenberg 1975).
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Table 17. Median age of the father in different subclasses of children.
                         Father’s median age (y)   
 Children with  minisatellite mutation 
Children without  
minisatellite mutation 
Pre-Chernobyl children 24.5 25.3 
 
Post-Chernobyl  
children 
29.3 30.3 
 
Additional control  
children 
27.0 28.1 
5.6 Effect of the stage of spermatogenesis on the 
minisatellite mutation rates
When the effect of the stage of spermatogenesis on the minisatellite mutation 
rates was examined, no obvious differences were found in the time interval 
between the birth of the child and father’s return from Chernobyl (Table 18). 
However, children born more than 49 weeks after the return date had the highest 
odds ratio (1.45, 95% CI 0.84-2.52). There were three children born 49–52 weeks 
(corresponding to exposure of spermatogonia) following the return date, all having 
a minisatellite mutation, while no mutations were found in their unexposed 
siblings. Due to the small number (n = 3) of these children, the result may well 
be a chance ﬁnding.
Human spermatogenesis lasts for 74 days (Figure 2) and sensitivity 
to mutagens varies during this time. Spontaneous minisatellite mutations 
occur at meiosis and it is therefore likely to be the most vulnerable stage 
of spermatogenesis. Also minisatellite mutation data show that minisatellite 
mutations in the paternal germline most likely occur at meiosis (Jeffreys et 
al. 1994; May et al. 1996; Jeffreys and Neumann 1997; Tamaki et al. 1999; 
Buard et al. 2000; Stead and Jeffreys 2000). If so, then exposure to ionising 
radiation could potentially affect the stability of minisatellite loci over a very 
short interval of meiosis. As protracted exposure would result in exposure 
at meiosis to successive gamete generations, it may induce mutations more 
effectively than acute exposure. To judge from the results of the present study, 
the meiosis appears to be highly unlikely candidate for the most vulnerable 
stage of the spermatogenesis. Given a relatively high initial exposure from the 
short-lived radionuclides, the preferential targeting of meiosis should result in 
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Table 18. Number of minisatellite mutations and odds ratios in relation to the time 
between father’s return from Chernobyl and the date of a child’s birth.
Time between father’s 
return from Chernobyl 
and date of child’s birth      
Pre-Chernobyl  
children1 
Post-
Chernobyl   
children1 
Odds ratio 
(95% CI) 
38-44 weeks2 3/9 1/9 0.33 (0.03-3.20) 
45-48 weeks3 3/11 3/11 1.00 (0.14-7.10) 
>49 weeks4 28/126 40/133 1.45 (0.84-2.52) 
1Number of children with minisatellite mutation(s)/total number of children. 2Stage of 
spermatogenesis assumed to be post-meiotic (spermatozoa, spermatids) when the gestation 
age at birth of the child was presumed to be 40 weeks. 3Stage of spermatogenesis assumed 
to be meiotic (spermatocytes) when the gestation age at birth of the child was presumed to 
be 40 weeks. 4Stage of spermatogenesis assumed to be pre-meiotic (spermatogonia, stem 
cells) when the gestation age at birth of the child was presumed to be 40 weeks. 
a considerably elevated paternal mutation rate during the ﬁrst year after the 
Chernobyl accident. 
However, we found no substantial differences between children born in 
the ﬁrst year or later following father’s return from Chernobyl. If anything, the 
minisatellite mutation frequency tended to show a slight increase with time since 
exposure (at least until 52 weeks). The highest risk (OR 1.45, 95% CI 0.84-2.52) 
was observed in the >49 week category (Table 18) corresponding to exposure 
of spermatogonia and stem cells. It therefore appears that pre-meiotic diploid 
stem cells and spermatogonia could accumulate radiation-induced damage, 
elsewhere in genome, that subsequently affects the stability of minisatellite loci 
at meiosis. This would ﬁt well with the concept (see 2.8.) that spermatogonial 
stem cells and resting oocytes have the highest risk of accumulating radiation-
induced genetic damage (Searle 1987). This delayed stimulation of minisatellite 
mutation in meiotic cells is reminiscent of the phenomenon of radiation-induced 
genomic instability (see 2.6.3). However, it has to be kept in mind that the other 
categoria than the >49 week category were also far too small to reach statistical 
signiﬁcance. 
However, stages of spermatogenesis were not determined with optimal 
accuracy in the present study since it was not possible to obtain the actual 
pregnancy weeks at delivery and thus, the pregnancies were assumed to be full 
term pregnancies at 40 weeks. Pregnancies are not allowed to last over 42 weeks 
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(= 40 weeks from fertilisation) during maternity care, but pre-term pregnancies 
can naturally have deviation from the assumed 40 week duration of pregnancy. 
In boundary value cases, even a one-week change in the length of pregnancy can 
thus change the category of the stage of spermatogenesis to which an individual 
belongs to in Table 18.
5.7 The applicability of the linear dose response 
The results of the present study could neither favour nor oppose the linear dose 
response model, as the statistical power of the present study was insufﬁcient. 
Furthermore, the fact that changes in minisatellite repeat sequences can arise 
as a result of radiation damage outside the sequence concerned and the likely 
involvement of some sort of signal transduction in the minisatellite mutation 
process makes the determination of the nature of the radiation dose response 
impossible. However, Dubrova et al. (2002a) have detected a negative correlation 
of minisatellite mutation rate with the parental year of birth and thus the time 
passing from the exposure. They state that the correlation implies the presence 
of a dose response for minisatellite mutation induction and suggests that an 
elevated mutation rate in the affected families is indeed radiation-induced.
5.8 The doubling dose estimate 
The individual dosimetry used in this study potentiated the assessment of the 
doubling dose. In linear unconditional analysis, the doubling dose of minisatellite 
mutations was estimated at 0.5 Sv, but there was considerably uncertainty 
(95% CI 0.1 mSv-¥). The statistical power of this study was insufﬁcient to give 
a reliable estimate of the doubling dose due to the relatively small number of 
mutations observed and the limited range of exposure. Therefore, the present 
minisatellite study could not give more precise estimate of the assumed germline 
doubling dose of round 1 Gy for germline mutation in humans (Sankaranarayanan 
and Chakraborty 2000a; UNSCEAR 2001). 
5.9 Comparison of paternal and maternal minisatellite 
mutation rates
In addition to paternal mutations, maternal mutations were also detected in 
the studied Estonian families, where the father of the family had been exposed 
to radiation during the cleanup work at Chernobyl (Table 19). The B6.7 and 
CEB1 mutations frequently seen in males were rarer in females where most 
mutations were detected, as expected (Table 10), at the MS1 minisatellite locus. 
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Table 19. Maternal minisatellite mutation frequencies among children in paternally 
exposed Estonian families
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1In addition to these 21 mutations, there were 6 mutations (2 at CEB25, 2 at CEB36, 1 at MS1 and 1 at MS31) 
in post-Chernobyl children in 22 families, which were excluded from the published study due to the missing 
pre-Chernobyl children. The addition of these mutations would have caused only a minor increase (27/1414 = 
0.019) in the detected mutation frequency of 0.017. 
 
 Pre-Chernobyl children Post-Chernobyl children 
Probe No. of  mutations 
No. of  
maternal 
meioses 
Mutation  
frequency 
No. of 
mutations 
No. of 
maternal 
meioses 
Mutation 
frequency 
B6.7 2 146 0.014 3 153 0.020 
CEB1 1 148 0.007 0 155 0 
CEB15 1 148 0.007 2 155 0.013 
CEB25 2 148 0.014 3 155 0.019 
CEB36 2 148 0.014 3 155 0.019 
MS1 7 148 0.047 5 155 0.032 
MS31 1 148 0.007 0 155 0 
MS32 1 148 0.007 5 155 0.032 
Total 17 1182 0.014 211 1238 0.017 
Maternal minisatellite mutations were more common than expected at locus 
MS32 and less common than expected at locus B6.7. However, allele speciﬁc 
mutation frequencies and the small number of the offspring studied inabled 
closer comparisons of the minisatellite mutation rates.
In the present study, the maternal mutation frequency was 0.014 in the 
pre-Chernobyl children and 0.017 in the post-Chernobyl children. Therefore, 
the maternal mutation frequencies found were less than half the frequencies 
detected in the father’s germline (Table 12). This is in concordance with the 
observations in the literature that minisatellite mutations are less frequent 
in females (Table 10). However, both the maternal and paternal minisatellite 
mutations were increased 1.2-fold in the post-Chernobyl children compared to 
their pre-Chernobyl siblings in spite of the fact that the fathers, not the mothers, 
were exposed to radiation. This could be explained by the low and fractionated 
radiation doses of the fathers making it impossible to detect any effects of 
radiation in minisatellite mutation rates. Therefore, mothers as well as fathers 
could be considered as non-exposed.
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Maternal minisatellite mutations have not been as extensively studied as 
the paternal ones, but published maternal minisatellite mutation rates are in 
concordance with the results of the present study. Dubrova et al. (1997) detected 
a doubling of the maternal minisatellite mutation rate in Belarus from 0.009 
in the controls to 0.018 in the exposed group. However, their controls cannot be 
regarded ideal because they were from the United Kingdom. Therefore, Dubrova 
prefers comparison between the exposed group in Belarus and a control group 
in Ukraine. When this is done with the maternal mutation rates of 0.0188 and 
0.0143 then a 1.32-fold increase is detected in mutation rate in this group. 
However, the conﬁdence interval of this ratio is wide (95% CI 0.43-2.69), basically 
meaning that there is not enough statistical power to test any hypothesis. In 
another study by Dubrova et al. (2002b), mutation rate in the germline of exposed 
mothers from Ukraine was not elevated, i.e., it was 0.0143 in the control group and 
0.0145 in the exposed group. However, given again the wide conﬁdence interval 
of the ratio of maternal mutation rates in the exposed group to control group in 
that study (95% CI 0.38-2.00), the authors could not exclude the possibility of 
an elevated mutation rate among the irradiated mothers. 
Currently, there are no studies speciﬁcally examining the effect of maternal 
exposure to radiation on minisatellite mutation rates. The main problem with 
maternal minisatellite mutation studies is the fact that minisatellite mutation 
rates in the maternal germline are quite low (Table 10). Proper analysis of 
maternal minisatellite mutation rates would require a study containing at least 
1 000 offspring from each group. Therefore, the present study as well as the 
former studies (Table 5), were all too small to provide enough statistical power 
for detecting an elevated maternal mutation rate in the exposed cohorts. It 
remains to be seen whether pre-meiotic, meiotic, and post-meiotic female germ 
cells respond in a manner similar to the male germline for minisatellites and 
whether similar mechanisms operate in male and female germ cells.
5.10 Minisatellite mutation rates in other Estonian control 
families
In the additional 44 control families from Estonia, 13 paternal mutations were 
detected at the eight tested minisatellite loci, giving a mutation frequency of 0.037 
(Table 20). These additional control families gave an external reference rate for 
assessment of generalizability (selection). The observed mutation frequency was 
in concordance with the mutation frequency of 0.036 detected in pre-Chernobyl 
children (Table 13). Thus, these results afﬁrmed that the study group used 
reﬂects the general spontaneous minisatellite mutation frequency in Estonia. 
Interestingly, no mutations were observed at minisatellite locus B6.7 in these 
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additional control families compared with 6.9% and 5.9% mutation frequencies 
among pre- and post-Chernobyl children (Table 12). On the other hand, the 
paternal CEB1 mutation frequency was higher among additional control children 
(18%) than among the pre-Chernobyl control children (10%). Furthermore, 8 
maternal mutations were found in these additional control families, giving a 
mutation frequency of 0.023 (Table 20), which is somewhat higher than the 
observed maternal mutation frequency (0.017) in the exposed families.
Table 20. Paternal and maternal minisatellite mutation frequencies among children in 
the additional control families.
 Paternal minisatellite mutations Maternal minisatellite mutations 
Probe No. of  mutations 
No. of  
paternal 
meioses 
Mutation  
frequency 
No. of  
mutations 
No. of  
maternal 
meioses 
Mutation 
frequency 
B6.7 0 44 0 0 44 0 
CEB1 8 44 0.182 0 44 0 
CEB15 1 44 0.023 1 44 0.023 
CEB25 1 44 0.023 1 44 0.023 
CEB36 0 44 0 1 44 0.023 
MS1 2 44 0.045 3 44 0.068 
MS31 1 44 0.023 1 44 0.023 
MS32 0 44 0 1 44 0.023 
Total 13 352 0.037 8 352 0.023 
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6 Conclusions and future prospects
Minisatellites provide the most powerful tool currently available for monitoring 
heritable DNA mutations caused by ionising radiation or genotoxic agents. In 
the present study, a minisatellite mutation screening system using eight single 
locus probes was evaluated for the assessment of radiation-induced hereditary 
risks in humans. The PCR-based mutation screening method turned out to be 
a fast and reliable method for paternity testing. The minisatellite loci used 
efﬁciently revealed non-paternity. However, the PCR-based minisatellite method 
was not applicable to the mutation screening of loci with the highest spontaneous 
mutation frequencies, since an unacceptable amount of alleles were too long to 
be reliably ampliﬁed with PCR.
Therefore, the rates of heritable minisatellite mutations in the radiation-
exposed population of Estonian Chernobyl cleanup workers were examined 
with the Southern blot-based minisatellite mutation screening system. It 
was shown that the minisatellite loci used in this study were well suited for 
mutation detection and the rate of minisatellite mutations was easily and 
reliably measured by the used eight single locus minisatellite probes, as all the 
detected mutations were conﬁrmed in two independent experiments. The high 
frequency of spontaneous and induced mutations at these minisatellite loci 
allowed mutation induction to be evaluated at low doses of exposure. Dubrova 
states that the increase in minisatellite mutation rates that he and his collegues 
have detected in several populations is indeed caused by radiation exposure of 
the studied persons. It seems possible that minisatellite mutations are good 
indicators of radiation exposure. The nature of the damage signal created by 
radiation, whether in DNA or some other sensor molecule, and the mechanism 
of subsequent induced mutagenesis, remain major goals of future research. As 
a few minisatellites are also situated near important disease-related genes (see 
2.2.1.5), the induction of minisatellite mutations should not be ignored in the 
context of potential hereditary risks.
The minisatellite mutation risk of children born after Chernobyl showed 
to be somewhat higher than the mutation risk of children born before Chernobyl, 
but statistically signiﬁcant differences were not shown. The total radiation 
doses received by the fathers appeared to be somewhat more important for 
the minisatellite mutation induction than the dose rates they received, but no 
signiﬁcant correlation between the father’s estimated dose and the frequency of 
minisatellite mutations was detected. Testing of the applicability of the linear 
dose response model to this material was not possible. In addition, the doubling 
dose based on the material used in the present study contained considerably 
uncertainty.
114
STUK-A208
However, statistically signiﬁcant differences in the amount of minisatellite 
mutation induction between exposed and unexposed fathers could not be reached 
with doses below 200 mSv. The studied minisatellite mutation screening system 
enabled germline mutation detection in humans and more signiﬁcant results 
would perhaps have been obtained if the radiation exposure had been higher. 
In other Estonian control families, the minisatellite mutation rates were shown 
to correspond to mutation rates in pre-Chernobyl control children as expected 
because they were non-exposed to radiation. The maternal mutation rate was 
of the same magnitude in all studies of Estonian families.
As expected, the paternal minisatellite mutation rates were shown to be 
higher than the maternal ones. However, the paternal age effect could not be 
seen in the detected minisatellite mutation frequency and due to the lack of 
knowledge of the absolute length of the pregnancies, no deﬁnitive conclusions 
could be drawn considering the effect of the stage of the spermatogenesis in the 
minisatellite mutation rate of the radiation-exposed men.
In summary, minisatellite mutation rates were compared within a family 
between the children born prior to and after the father was exposed to radiation 
while working in the cleanup activities at Chernobyl. Thus, the optimal reference 
material for genetic and environmental factors was used. The minisatellite 
screening system used had several potential advantages for monitoring germline 
mutation in men compared with standard genetic approaches. The probable 
selective neutrality of the minisatellite mutants used ensured that the mutants 
were not lost prenatally, as can occur at protein coding loci. The very high 
spontaneous mutation rates made it, in principle, possible to detect induced 
mutations in a relatively small population sample. 
The application of minisatellite loci to the radiation risk assessment still 
requires much research and validation. Further application of minisatellites 
as a reliable indicator of the genetic consequences of radiation exposure is 
currently limited mainly because the mechanisms for the induction of minisatel-
lite mutation by ionising radiation remain unknown. Minisatellite mutations 
do not confer hereditary defects, i.e., they themselves are not adverse genetic 
effects. As far as it is known, minisatellite mutations cause no known decline 
in the ﬁtness or health of their carriers. An understanding of the mechanisms 
involved in induced minisatellite instability is required before any attempts 
to postulate on hereditary risks can be made. Additional studies are needed in 
order to clarify whether an increase in minisatellite mutations will or will not 
be indicative of an increase in mutations at some other, more essential genomic 
regions that do lead to human diseases. Given the unusual mechanism of germline 
instability resulting from gene conversion or recombination, and the indirect 
nature of induced mutations, it is not intuitive how induced instability may relate 
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to instability at other genome regions. It is possible that the indirect nature 
involves alterations in gene expression or repair enzymes, which may similarly 
affect other areas of the human genome. However, showing this would require 
germline mutagenicity studies, which in turn require a precise understanding of 
the timing of mutation induction and an evaluation of dose response parameters. 
These data are difﬁcult to obtain due to current lack of appropriate animal models 
for studies on minisatellites. Also, the different mutation mechanisms that act 
in somatic cells prevent the extrapolation of results from human somatic cell 
cultures to germ cells. Unfortunately, the current study on minisatellite mutations 
in Estonian post-Chernobyl families clariﬁed neither the timing of mutation 
induction nor the dose response parameters.
Among the 30 000 genes in the human genome, some genes can possibly 
respond directly to radiation exposure, but they have not yet been found. Since 
radiation mostly produces multigene deletions, it would seem plausible that 
those human processes that depend on the greatest number of genes would be 
the ones most vulnerable to the loss-of-function of several genes. Embryonic 
development and brain function are two human processes meeting these criteria. 
Potential phenotypes could share some common features such as multisystem 
developmental abnormalities or mental retardation. However, these phenotypes 
are not easily differentiated from corresponding phenotypes caused by some other 
reason. As the minisatellites are so far the only model for efﬁciently studying 
human heritable mutations directly, it would be sensible to explore the induction 
of minisatellite mutations after irradiation and the possible consequences of these 
mutations for human health. The development of human molecular genetics 
will give better understanding of changes and their function in so far poorly 
known phenomena, e.g., individual radiosensitivity, genomic instability, and the 
bystander effect, thus potentiating the more reliable assessment of radiation 
risks.
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